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Background: One-third of stroke patients are dependent on others to get outside their homes. This can
cause people to become housebound, leading to increased immobility, poor health, isolation and misery.
There is some evidence that outdoor mobility rehabilitation can reduce these limitations.
Objective: To test the clinical effectiveness and cost-effectiveness of an outdoor mobility rehabilitation
intervention for stroke patients.
Design: Multicentre, parallel-group randomised controlled trial, with two groups allocated at a 1 : 1 ratio
plus qualitative participant interviews.
Setting: Fifteen UK NHS stroke services throughout England, Scotland and Wales.
Participants: A total of 568 stroke patients who wished to get out of the house more often, mean age of
71 years: 508 reached the 6-month follow-up and 10 were interviewed.
Intervention: Control was delivered prior to randomisation to all participants, and consisted of verbal
advice and transport and outdoor mobility leaﬂets. Intervention was a targeted outdoor mobility
rehabilitation programme delivered by 29 NHS therapists to 287 randomly chosen participants for up to
12 sessions over 4 months.
Main outcome measures: Primary outcome was participant health-related quality of life, measured by
the Short Form questionnaire-36 items, version 2 (Social Function domain), 6 months after baseline.
Secondary outcomes were functional ability, mobility, number of journeys (from monthly travel diaries),
satisfaction with outdoor mobility (SWOM), psychological well-being and resource use [health care and
Personal Social Services (PSS)] 6 months after baseline. Carer well-being was recorded. All outcomevii
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ABSTRACT
viiimeasures were collected by post and repeated 12 months after baseline. Outcomes for the groups were
compared using statistical signiﬁcance testing and adjusted for multiple membership to account for the
effect of multiple therapists at different sites. Interviews were analysed using interpretive phenomenology
to explore conﬁdence.
Results: A median of seven intervention sessions [interquartile range (IQR) 3–7 sessions], median duration
of 369 minutes (IQR 170–691.5 minutes) per participant was delivered. There was no signiﬁcant difference
between the groups on health-related quality of life (social function). There were no signiﬁcant differences
between groups in functional ability, psychological well-being or SWOM at 6- or 12-month follow-ups.
There was a signiﬁcant difference observed for travel journeys with the intervention group being 42%
more likely to make a journey compared with the control group [rate ratio 1.42, 95% conﬁdence interval
(95% CI) 1.14 to 1.67] at 6 months and 76% more likely (rate ratio 1.76, 95% CI 1.36 to 1.95) at
12 months. The number of journeys was affected by the therapist effect. The mean incremental cost
(total NHS and PSS cost) of the intervention was £3413.75 (95% CI –£448.43 to £7121.00), with an
incremental quality-adjusted life-year gain of –0.027 (95% CI –0.060 to 0.007) according to the European
Quality of Life-5 Dimensions and –0.003 (95% CI –0.016 to 0.006) according to the Short Form
questionnaire-6 Dimensions. At baseline, 259 out of 281 (92.2%) participants in the control group were
dissatisﬁed with outdoor mobility but at the 6-month assessment this had reduced to 77.7% (181/233),
a 15% reduction. The corresponding reduction in the intervention group was slightly greater (21%) than
268 out of 287 (93.4%) participants dissatisﬁed with outdoor mobility at baseline to 189 out of
261 (72.4%) at 6 months. Participants described losing conﬁdence after stroke as being detrimental to
outdoor mobility. Recruitment and retention rates were high. The intervention was deliverable by the NHS
but had a neutral effect in all areas apart from potentially increasing the number of journeys. This was
dependent on the therapist effect, meaning that some therapists were more successful than others.
The control appeared to affect change.
Conclusions: The outdoor mobility intervention provided in this study to these stroke patients was not
clinically effective or cost-effective. However, the provision of personalised information and monthly diaries
should be considered for all people who wish to get out more.
Trial registration: Current Controlled Trials ISRCTN58683841.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment; Vol. 18, No. 29. See the NIHR Journals Library website
for further project information.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Impaired mobility affects half of all stroke patients, with one-third still being dependent on others to get
outside 6 months after stroke. As a result, stroke patients become housebound, leading to increased
immobility, poor health, isolation and misery. This diminution of quality of life provides the justiﬁcation for
an intervention aimed at enhancing outdoor mobility for those with mobility restrictions.
Stroke guidelines do not contain evidence-based recommendations to treat patients who have outdoor
mobility limitations. In the UK, the routine care for outdoor mobility limitations is provision of leaﬂets and
verbal information. A Cochrane review concluded that the passive provision of leaﬂets is not effective.
An outdoor mobility intervention for people with stroke was developed and evaluated in a single-centre
pilot randomised controlled study. This pilot study found clear beneﬁts in people who received the
intervention, with 65% being able to get out of the house as much as they wished compared with
35% in the control group. In addition, the participants who received the intervention took signiﬁcantly
more journeys.Aim
Although the intervention and its components in relation to the care pathways and social and health
contexts were well developed, it was not clear whether:
1. the beneﬁts could be replicated by other therapists across the health system
2. the intervention could improve health-related quality of life
3. such an approach was cost-effective.Design
A multicentre, multitherapist, multisetting, parallel-group randomised controlled study [randomised
controlled trial (RCT)] with economic evaluation and nested qualitative study. Randomisation was provided
by the Nottingham Clinical Trials Unit (NCTU). The groups were compared at 6 and 12 months, accounting
for baseline differences and adjusting for the multiple membership random effects caused by having
numerous therapists delivering the intervention in several sites. The incremental cost-effectiveness of the
intervention compared with control, was analysed using a UK NHS and Personal Social Services (PSS)
perspective. Qualitative interviews were completed with a subset of intervention participants to explore
feelings of conﬁdence.Setting
The study was conducted within the stroke pathway in 15 NHS stroke services throughout England,
Scotland and Wales.xxi
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SCIENTIFIC SUMMARY
xxiiParticipants
People who had experienced a stroke were identiﬁed between November 2009 and August 2011 through
general practices, primary care therapy teams, community stroke teams or outpatient clinics. Overall,
11,126 patient invitations were sent, with 1448 (13%) interested people replying. Research assistants
contacted respondents to arrange 852 (8%) baseline visits.
People were eligible if they provided written informed consent, were > 18 years old, had a stroke at least
6 weeks previously and wished to get out of the house more often. People were not eligible if they were
not able to comply with the protocol and therapy programme or if they were in active rehabilitation.
In total, 568 invited people (5.1%) were eligible to take part and were randomly allocated to the
rehabilitation intervention group (287) or control group (281). Participants ranged in age from 32 to
96 years [mean of 71.6 years, standard deviation (SD) 12.1 years] and the time since stroke was from 2 to
479 months (mean of 40 months, SD 52.7 months). Overall, 253 (44%) were men and 315 women
(56%). Ten intervention participants took part in the qualitative study.Intervention and control
All participants received the control, which was verbal advice and leaﬂets given at the baseline assessment
visit. Research assistants at each site provided a personalised pack of local travel information containing, for
example, leaﬂets and bus timetables. The intervention group received additional face-to-face rehabilitation
from NHS therapists, up to 11 times over 4 months. This was a mixture of exercise and practical activities to
increase outdoor mobility; psychological interventions to improve conﬁdence and targeted information with
therapist training; and a treatment manual. Treatment ﬁdelity was assessed by a research assistant in 10%
of intervention sessions, who compared treatment records and treatment sessions with a checklist.Main outcome measures
Outcomes were collected 6 and 12 months after recruitment and by monthly travel diaries.
The primary outcome was health-related quality of life, as measured by Social Function domain score
from the Short Form questionnaire-36 items, version 2 (SF-36v2) at 6 months’ follow-up. These
two questions ask participants to rate their social activity away from home.
The secondary outcome measures at 6 and 12 months were (1) functional activity using the
Nottingham Extended Activities of Daily Living Scale; (2) mobility using the Rivermead Mobility Index;
(3) the number of journeys (travel journeys) made outside the house, using participant-completed travel
diaries; (4) satisfaction with outdoor mobility using a yes/no question: ‘Do you get out of the house as
much as you would like?’; (5) psychological well-being using the General Health Questionnaire-12 items
(GHQ-12); (6) carer psychological well-being using the GHQ-12; (7) quality-adjusted life-years (QALYs)
using the European Quality of Life-5 Dimensions (EQ-5D) and Short Form questionnaire-6 Dimensions
(SF-6D); (8) resource use (NHS, PSS, carer input and some patient-borne costs); and (9) participant
mortality collected from NHS Information Centre (NHS-IC)/NHS Central Register.
The statistical methods of analysis were stated prior to the start of the study. All main outcomes were
presented descriptively by group and then the results of the multivariable analysis adjusting for age,
baseline outcome value, therapy effect and site effect were presented as differences in means for
continuous data, odds ratios for binary data or rate ratios for count data (adjusted results), with
95% credible intervals as a measure of signiﬁcance. The analysis was adjusted for therapist effectNIHR Journals Library www.journalslibrary.nihr.ac.uk
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the intervention from a number of therapists. Site and therapy effect sizes were presented for each of the
outcomes, apart from travel journeys (analysed as rate ratios) for which these were not calculable.
No serious adverse events were recorded. Study-speciﬁc adverse events were collected from the
intervention group: any fall that resulted in assistance of a health-care professional. In addition, all
participants had the opportunity to record falls on the travel diary.Interview study
Ten intervention participants were interviewed. A semistructured interview was used to guide a digitally
recorded interview in the participants’ own homes. The interviews were transcribed and analysed using
interpretive phenomenology by two researchers.ResultsFollow-up rates
In total, 264 out of 287 (92%) intervention participants and 239 out of 281 (85%) control participants
completed the 6-month follow-up, and 232 out of 287 (81%) intervention participants and 211 out of
281 (75%) control participants completed the 12-month follow-up. The differences in follow-up rates
between the two groups did not affect the power of the study. A total of 192 carers completed the
baseline assessment: 148 out of 192 (77%) completed the 6-month follow-up and 127 out of 192 (66%)
completed the 12-month follow-up. Follow-up was completed in August 2012.Characteristics of the participants
The two groups were well matched in age, ethnicity, residence, functional ability, functional ability and
psychological well-being. Time from stroke to recruitment was 6 months less in the control group (mean
37 months vs. 43 months) than the intervention group and there were more men in the control group
(47%) than intervention group (42.2%). Adjustment for gender had no effect on the primary outcome.Characteristics of the intervention
In total, 29 therapists delivered the intervention a median of seven times [interquartile range (IQR) 3–11
times] per participant, with a median duration of 369.5 minutes (IQR 170–691.5 minutes). The intervention
was completed satisfactorily 67.3% of the time and delivered 100% of the time according to the protocol.Primary outcome measure
The variability of the social function score was similar in the two groups, although the mean score was
slightly higher in the intervention group (47.0) at 6 months compared with the control group (43.9).
The adjusted difference in means between groups was 4.630, with a 95% credible interval of
–0.549 to 9.848.Secondary outcome measures
No signiﬁcant difference was observed for the secondary outcome measures at 6 or 12 months for
psychological distress, activity, mobility or satisfaction with outdoor mobility (52 of the control group said
‘yes’, 72 of the intervention group said ‘yes’). Adjusting for therapist and site effect did not affect these
results. Participants in the intervention group took more journeys than the control group when the results
were adjusted for therapist and site effect. Those in the intervention group were 42% more likely to make a
journey than those in the control group at 6 months [rate ratio 1.42, 95% conﬁdence interval (95% CI) 1.14
to 1.67] and 76% were more likely to make a journey at 12 months (rate ratio 1.76, 95% CI 1.36 to 1.95).xxiii
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xxivEconomic evaluation
In the base-case analysis, the mean incremental cost (total NHS and PSS cost) of the intervention was
£3413.75 (95% CI –£448.43 to £7121.00) with an incremental QALY gain of –0.027 (95% CI –0.060 to
0.007) according to the EQ-5D and –0.003 (95% CI –0.016 to 0.006) according to the SF-6D. Thus, the
intervention was not estimated to be cost-effective compared with the control. The probability that
the intervention was cost-effective, compared with the control, was 5.2% at a threshold of £20,000 per
QALY (based on the EQ-5D). The sensitivity analyses support these conclusions, as the 95% CI surrounding
the incremental net beneﬁt was never wholly positive at the £20,000-per-QALY threshold.Exploratory analysisEffect of the control
There was very strong evidence that the control group improved markedly. At baseline 259 out of
281 (92.2%) participants were dissatisﬁed with outdoor mobility but at the 6-month assessment this
had reduced to 78% (160/205), a 15% reduction. The corresponding reduction in the intervention group
was slightly greater (18%), with 268 out of 287 (93.4%) expressing dissatisfaction with outdoor mobility
at baseline and 17 out of 227 (75.5%) expressing this at 6-month assessment.Falls
The total group had a median of three (IQR 1–6.5) falls per year. Fall rates between the control and
intervention groups were the same.Qualitative interview study
All participants said they understood the term conﬁdence but found it difﬁcult to describe. However, they
were able to describe how loss of conﬁdence had ‘robbed them of identity’, ‘made them fearful’, made
them ‘reliant on others’, and that they had ‘lost their role’, ‘lost skills’ and ‘felt low self-worth’.
Interviews identiﬁed that fear of falling and fear of another stroke was a huge barrier to participating in
outdoor mobility. Avoidance behaviours further limited competence and conﬁdence in these activities.
Conﬁdence appeared to have a temporal component and increased conﬁdence in one domain impacted
on other areas. Meaningful roles, such as, gardener, cook or driver, or engagement in replacement roles
such as volunteer or card maker, were associated with a positive increased conﬁdence. Social conﬁdence,
fear of social interactions and stigma were identiﬁed as leading to a poor
psychosocial outcome.DiscussionMain findings
An intervention provided by NHS therapists to improve outdoor mobility neither improved health-related
quality of life (social function) or any other health outcomes measured nor did it prove more cost-effective
than the control intervention. There was strong evidence that some participants were able to make
signiﬁcantly more journeys and that personalised outdoor mobility information and self-completed daily
travel diaries could improve satisfaction with outdoor mobility (SWOM). Stroke patients wish to improve
their conﬁdence.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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all stroke patients. However, the provision of personalised information and monthly diaries should be
considered for all people who wish to get out more and some patients could increase their outdoor
mobility through face-to-face intervention sessions from therapists with certain skills.Research in context to other studies
There is only one study to which we can compare the results. This was the single-centre study on which
this multicentre study was based. The intervention provided in the multicentre study was similar in number
and duration to that in the single-centre study [median of six sessions (IQR 4–6 sessions), duration
240 minutes (IQR 180–310 minutes)] but was delivered by 29 therapists over 15 sites instead of one
therapist in one site. The participants were similar in age. The two studies differed in two areas.
Control-group participants in the present study were provided with personalised outdoor mobility
information and monthly travel diaries. This was an augmented version of that provided in the
single-centre study and completely different to routine care late after stroke, which would be no
intervention. The second difference was participants in the single-site study were 1 year after stroke,
whereas participants in the present study were 3.5 years after stroke.Strengths and limitations
Strengths
Recruitment rates were consistent over the duration of the study, the target sample size was reached,
participant retention rates were high, eligibility criteria was inclusive and the intervention was delivered in
a pragmatic manner by NHS therapists in numerous locations, making the results generalisable across
the UK.
A strength was that the sample size and between-group comparisons were analysed using a therapist and
site adjustment. This type of analysis is not yet routinely used but is recommended for this type of trial.
We accept that the only one secondary outcome became signiﬁcantly in favour of the intervention when
the adjustment was applied, so the results need to be read with caution.Limitations
A limitation of this study was that the control participants were inadvertently provided with an intervention
that may have affected a change in the SWOM scores.
Another limitation was that no process evaluation was completed to let us understand how some
therapists were able to increase journeys.Clinical implications
l Stroke patients are not getting out of the house as much as they would like.
l An outdoor mobility intervention can be delivered by NHS occupational therapists and physiotherapists
at a range of geographical locations.
l There was no observed improvement in health-related quality of life (social function), psychological
distress and functional activity in the intervention group over the control group.
l The intervention was not cost-effective compared with control.
l Some therapist/participant combinations are more successful than others.
l The provision of information and the daily completion of travel diaries improved participant SWOM.
l Outdoor mobility does not cause falls.
l Loss of conﬁdence can affect outdoor mobility.xxv
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xxviResearch implicationsl Recruitment, retention and follow-up rates provide evidence that high-quality stroke rehabilitation
research can be completed.
l Multicentre studies of rehabilitation interventions are possible.
l Stroke patients are able to successfully complete outcome assessments and monthly travel diaries.
l Using data adjustments for therapist and site effect needs further exploration.
l The control intervention needs evaluation.
l The relationship between number of journeys and quality of life needs examining.Trial registration
This study is registered as ISRCTN58683841.Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29Chapter 1 IntroductionIntroductionIn 2009 the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme
funded a proposal to investigate the clinical effectiveness and cost-effectiveness of delivering a targeted
outdoor mobility therapy provided within stroke services aimed at helping people get out of the house
more often following a stroke. This report details the results of the Getting out of the House Study.The effect of stroke on functioning, and rehabilitationStroke can have a devastating effect on people’s lives, with half of survivors being dependent on others
6 months later,1 one-third feeling socially isolated, one-quarter having abnormal moods, and half not
getting out of their houses as much as they would like.2 These are worldwide health-care issues but, with
130,000 people a year having a stroke in England and Wales,3 and stroke increasing with age, the number
of people needing UK health and social care services is set to rise. The cost of stroke to the UK NHS is
estimated to be over £2.5B per year3 in addition to the cost to social care services and to the stroke survivors.
In the UK most people who have a stroke are admitted to hospital for acute care but are discharged on
average 19.5 days later.4 Treatment is then transferred to community-based teams and social care services.
Stroke unit care has been found to be the best way to organise inpatient care for stroke patients,5 allowing
them to be transferred to evidenced-based Early Supported Stroke Discharge services6 when they go home.
Once home, stroke rehabilitation interventions provided by occupational therapists have been shown to
increase activity7,8 by helping people to regain independence in personal and domestic activities of daily
living. Most stroke rehabilitation research has been conducted on people in the ﬁrst year after their stroke.
Although many consequences of stroke persist beyond a year there is little evidence for the beneﬁt of
interventions delivered after 1 year.9 The early treatment and rehabilitation of stroke necessarily focuses on
reducing neurological impairments but as time goes by after a stroke the activity and participation become
more important. Also, the ﬁrst goal of patients in hospital tends to be to get home, which requires a focus
on self-care activities, but, once home, they set goals in terms of being able to optimise participation, and
these tend to require an ability to get out of the house or to engage in social activities. However, these
rehabilitation areas are rarely targeted.Outdoor mobility after a stroke, and rehabilitationStroke can leave people with long-term and persistent impairments, leading to activity limitations and
restriction in participation. These restrictions occur in addition to other impairments resulting from
comorbidities, such as osteoarthritis or dementia, making recovery and evaluation of treatments difﬁcult
and complicated. In addition, stroke often leaves people with perceptual and cognitive impairments that
can reduce performance of everyday activities, such as shopping, hobbies, cooking or using the bus.
Lowering of mood, feelings of becoming a different person and lack of conﬁdence are also common after
stroke.10 These hidden impairments often go untreated and, alongside the more obvious physical ones,
contribute to activity limitations especially when people are discharged from health services. There is
evidence that stroke patients may delay getting back to a normal life, even although they may have made a
good physical recovery.11 Hellstrom et al.12 argued it is not until people go home after a stroke and attempt
to try everyday activities that the real impact is realised.12 In response to this, it is recommended that all
stroke patients receive a 6-month review, with rehabilitation being available to enable people to maintain1
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INTRODUCTION
2participation, reduce long-term misery and improve quality of life. These are priority areas identiﬁed in the
Department of Health of England and Wales Stroke Strategy.13
Limitations in outdoor mobility affect 42% of stroke patients,2 with 33% remaining permanently
dependent on others long term.3 Stroke patients can become housebound, leading to poor mental health,
isolation and misery.14 This can be devastating for patients and carers, and increase their reliance on home
visits from medical staff, home care, social services and home adaptations. Stroke tends to affect older
people, median age 77 years [interquartile range (IQR) 68–84 years],15 and, as outdoor mobility – including
walking outside – declines with age, mobility disorders may also be due to impairments and social factors
associated with ageing and comorbidity. People aged ≥ 80 years of age make half the number of outdoor
journeys and travel less than one-quarter of the distance of those aged 50–54 years.16 There is evidence
that elderly people ﬁnd it difﬁcult to participate in transport services, owing to an inability to carry heavy
loads and a fear of crime when outside at night.14 People who are dependent on walking frames are,
on average, getting out of the house less than twice each week.17 Outdoor mobility is usually achieved by
a combination of walking, cars and public transport, with very few people using specialist transport such
as the provision of a taxi service for people with disabilities.16,18
Speciﬁc outdoor mobility rehabilitation interventions exist for people with limited vision, learning disabilities
and those who use wheelchairs19 but these are not routinely used for people who have had a stroke. The
National Clinical Stroke Guidelines do not contain any evidence-based recommendations to guide therapists
in how to treat outdoor mobility limitations.20 However, the clinical guidelines recommend that stroke
patients are encouraged to take physical exercise, as there is an increasing body of evidence that exercise is
of beneﬁt to stroke survivors.21 In the UK the routine treatment for outdoor mobility problems is to provide
information in a leaﬂet and verbally, delivered by a health-care professional. A Cochrane review22 concluded
that the passive provision of leaﬂets is not effective and leaﬂets can be difﬁcult to understand after a stroke.
It is more likely that a multimodal rehabilitation intervention that includes exercises to decrease impairments
(these can be physical and mental), education to provide information and behaviour change regimes, use of
adaptive equipment and support from other people, both formal or informal sources, would be more
effective at improving outdoor mobility. This study aimed to ﬁll this evidence gap.Justiﬁcation for the current studyAn outdoor mobility intervention for people with stroke was developed using qualitative interview ﬁndings,
published literature, correspondence with the Department of Transport and expert opinion.23 This intervention
was evaluated in a single-centre randomised controlled study.24 The study found clear beneﬁts in outdoor
mobility for people who received the intervention. The patients who received the intervention took twice as
many journeys, many of these walking, as those in the control group, 4 and 10 months after recruitment into
the study, and were signiﬁcantly more likely to be satisﬁed with their outdoor mobility activity. Although the
study was based on a real clinical need, recruited to target, had excellent follow-up and was published in a
peer-reviewed journal, it had some limitations. The intervention was delivered by a single therapist, who was a
stroke specialist, with experience in the delivery of community-based treatment. It was delivered in one UK city
and no health economic evaluation was completed. Although this study has already inﬂuenced practice, alone
it is insufﬁcient to inform evidence-based guidelines.
Thus, the next step was to conduct a multicentre randomised controlled trial (RCT), using the lessons learned
from the single-centre study. We completed a multicentre RCT to try and answer the following questions.
1. Whether:
i. the results of the pilot study were generalisable to other therapists and other sites.
ii. the intervention could be implemented across a health system.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Parkiii. the intervention improves overall health and, if so, whether such an approach is conventionally
cost-effective.Structure of the Health Technology Assessment monographThe monograph has been separated into methods and results for the randomised controlled study,
including delivery of the intervention and clinical effectiveness, followed by methods and results for both
the economic evaluation and the qualitative substudy. Finally, all results are discussed, followed by
overall conclusions.
Appendices include the summary of the intervention manual and the statistical analysis plan.3
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This chapter describes the methods for the delivery and assessment of the intervention and collection ofdata to assess clinical effectiveness.
Summary of study designThe Getting out of the House Study was a multicentre, parallel-group RCT comparing clinical effectiveness
and cost-effectiveness for two groups, an intervention group and a control group. The methodology used
was, as far as possible, a replication of that used in the single-centre study.24 Figure 1 summarises the study
design. Patients aged ≥ 18 years, who had experienced a stroke > 6 weeks previously were considered
initially eligible for the study. The majority of patients were contacted by a patient invitation letter sent from
either their general practitioner or from the local community rehabilitation or local hospital stroke service
register. If interested, patients replied to their local research team, who contacted them and screened them
by telephone call to further determine eligibility. Final conﬁrmation of eligibility and subsequent consenting
was carried out by the research assistant (RA) at the patient’s home. Following consent, a baseline
assessment was completed and all participants received the control. They were provided with travel diaries
in the form of 12 months of ‘travel calendar’ to record the number of journeys that they made and any
falls that they had. All participants were then randomised by the local therapist, using the web-based
randomisation system that was controlled by the Nottingham Clinical Trials Unit (NCTU), to either targeted
outdoor mobility therapy (the intervention) or no further therapy contact (control). Those randomised to the
intervention received up to 12 visits over a maximum of 4 months (from baseline). No further therapy
contact was received after 4 months, allowing 2 months before the primary and secondary outcome data
were collected. Outcomes were assessed at 6 and 12 months after recruitment by postal questionnaire and
by monthly travel diaries. Local RAs blinded to treatment allocation were available to assist the participant
with completion of questionnaires if needed. RAs recorded incidents where they were unblinded. A subset
of participants at a single site were asked to participate in a nested qualitative study investigating
conﬁdence issues surrounding stroke.
Primary objective
To test the clinical effectiveness and cost-effectiveness of treating people who have had a stroke with an
outdoor mobility rehabilitation intervention in addition to routine care compared with routine care alone.Secondary objectivesThe secondary objectives were to measure whether the intervention was associated with:
l improved:
¢ mobility in and outside the house
¢ patient well-being
¢ participation in everyday activities
¢ carer well-being
¢ health-related quality of life.5
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Logan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
Stroke registers GP invites
Pre-consent screening (telephone) by RA
Consent by RA
Collect baseline data, deliver control
Randomisation by therapist via NCTU web-based
system
Outpatient clinic visit
Intervention delivered within
4 months of baseline
Subset approached
for qualitative
‘confidence’
interviews
6-month follow-up with primary end point via:
(a) Postal questionnaire direct to participant
(b) Local RA-assisted completion
12-month follow-up via:
(a) Postal questionnaire direct to participant
(b) Local RA-assisted completion
Control
FIGURE 1 Study design flow chart. GP, general practice.
RANDOMISED CONTROLLED STUDY METHODS
6Primary outcome measureThe primary outcome measure was the Social Function domain score of the Short Form questionnaire-36
items, version 2 (SF-36v2)25 measured at 6 months, as recorded in their questionnaire response. This is one
of the eight domains of the SF-36v2 and was scored and transformed on to a scale of 0 (worst possible
health state) to 100 (best possible health state).Secondary outcome measuresThe secondary outcome measures were:
1. functional activity in participants measured by the Nottingham Extended Activities of Daily Living
(NEADL) scale26,27
2. mobility reported by participants in the completion of the Rivermead Mobility Index (RMI)28
3. the number of journeys as recorded by participants in the travel calendars
4. satisfaction with outdoor mobility (SWOM) as reported by participants in the completion of a yes/no
question: ‘Do you get out of the house as much as you would like?’
5. psychological well-being as reported by participants in the completion of General Health Questionnaire 12
(GHQ-12).29NIHR Journals Library www.journalslibrary.nihr.ac.uk
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7. health-related quality of life as reported by participants in the completion of European Quality of Life-5
Dimensions (EQ-5D)30 and Short Form questionnaire-6 Dimensions (SF-6D)25 (based on a subset of
questions from the SF-36 v231)
8. the resource use of health and social care, carer input and provision of equipment as reported by
participant in the completion of the service use questionnaire and data collected relating to
intervention visits
9. participant mortality (death data) as collected from NHS Information Centre (IC)/NHS Central Register.Recruitment processThere were three methods of patient identiﬁcation: searching general practice (GP) databases, searching
stroke registers in secondary care hospitals, community hospitals or primary care community teams and
approaching patients attending post-stroke outpatient clinics as they were discharged from rehabilitation.
If the search team also had access to local stroke service rehabilitation records they cross referenced for
any active stroke-related rehabilitation that may be ongoing.
All potential participants received a version of the participant information sheet (PIS) prior to the baseline
visit and had sufﬁcient time to consider the information. In addition, if required, an aphasic PIS and a
summary PIS were available for participants and their carers.
Other recruitment strategies included placing adverts within local newspapers, local trust publications and
relevant websites (e.g. the Stroke Association), establishing a study website, various articles within local
trust publications and local press, visiting local stroke groups and widespread distribution of the study
poster to relevant areas (e.g. GPs, rehabilitation teams, stroke groups, etc.).Sample sizeOur sample size calculations were based on the primary outcome measure, the Social Function domain
of the SF-36v2 at 6-month follow-up. Although this was not used in the pilot study, a recent study
had suggested a minimally clinically important difference (MCID) for the Social Function domain was
12.5 points.32 The estimate of the standard deviation (SD) was taken from Brittle’s study33 and this
closely matched the standard deviation obtained by assuming that the distribution of the nine possible
integer-valued scores followed a roughly right-angled triangular distribution (i.e. that was positively
skewed). This followed the general approach suggested by Deming34 for schematic distributions. Assuming
a power of 90% and a two-sided signiﬁcance level of 5%, we estimated that to detect a difference in
mean SF-36 scores of 12.5 points, assuming a common SD of 28.2 points,33 a sample size of 135 patients
per group was required. This calculation assumed an attrition rate of 20% over a 6-month period.
Clustering by delivery of treatment was allowed for by generating simulated data to mimic the multilevel
structure of the proposed study, with site-speciﬁc variation between therapists. The likely existence of
sharing of therapists by patients was addressed by a multiple membership model, and the variance of the
treatment effect so found was compared with that of a regression model ignoring clustering (both models
treating centre as a ﬁxed effect). The data sets and analyses were performed in Stata v10 (StataCorp LP,
College Station, TX, USA). The variance inﬂation observed was insensitive to variation in the simulated
between-site variance and the average between-therapist variance, and a rounded value of 2.5 was
selected as the multiplier for a sample size based on a naive analysis. After the allowance for clustering by
delivery of treatment, a sample size of 338 participants per arm was required, with an overall sample size
of 676, allowing for 20% lost to follow-up.7
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8Revised sample size
Owing to an increase in the expected number of sites, the sample size was revised.
As more information had become available after the original sample size calculation was performed we
developed an alternative method of calculating a sample size that was easier to replicate. This analytic
approach was based on the same assumptions of the original sample size calculation and assumed that
within each site there would potentially be four therapists delivering the intervention in the intervention
group and one therapist delivering the control in both groups. In these calculations we assumed a
therapist effect intraclass correlation coefﬁcient (ICC) of 0.02 (Professor Stephen Walters, University of
Shefﬁeld, 30 October 2008, personal communication) and a site effect ICC of 0.04 [obtained from
Aberdeen University’s database of ICCs (www.abdn.ac.uk/hsru/epp/iccs-web.xls)]. For comparison, based
on seven sites this method gave a sample size of 746, allowing for 20% lost to follow-up. This method
was adopted to provide a revised sample size.
As the number of sites had increase from the assumed 7 to 14 (at that time) we conducted further power
calculations assuming a lower sample size and investigated the effect of varying the number of sites. This was
based on detecting a difference in means of 12.5 (as in the original sample size calculation) and assuming
a total sample size of 440 with the number of sites ranging from 7 (as originally planned) to 14. These
calculations were based on the same assumptions made in the analytic sample size above (i.e. SD = 28.2 sites,
two-sided signiﬁcance level of 5%, ICC of 0.02 for therapist effect, and ICC of 0.04 for centre effect). These
indicated that a sample size of 440 would have a power of 86% (assuming no attrition) and a power of 82%
(assuming lost to follow-up rate of 20%) to detect a difference in means of 12.5 if there were seven sites and
if there were 12 or more sites the corresponding power would be at least 90%. There were a total of 15 sites
in this study so this met the latter calculations.
Sample size calculations can be performed only if a number of assumptions are made and although our
calculations were based on the best estimates we could obtain at the time that there was some
uncertainty about the true values of the ICCs used to adjust for clustering. Therefore, we decided to be
cautious and aimed to recruit a sample size of 506 participants (440 + 15%) to ensure that we had
recruited enough participants. This was agreed with the Trial Steering Committee (TSC).Setting and locationsThe study was coordinated by the NCTU and involved 15 sites from across England, Scotland and Wales.
Initially seven sites were planned but during the course of recruitment an additional eight were added.
The sites were a mixture of settings, split in broad terms as follows.Primary care community stroke rehabilitation service1. NHS Nottingham City.
2. NHS Nottinghamshire County.
3. Gateshead Primary Care Trust (PCT).
4. NHS North Somerset.
5. Wolverhampton PCT.
6. Kent Community Health Trust.
7. Tower Hamlets PCT.
8. Norfolk Community Health and Care NHS Trust/NHS Norfolk.
9. NHS Bristol.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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2. NHS Grampian.
3. Cardiff and Vale University Health Board.
4. Cwm Taf Health Board.Secondary care stroke service1. United Lincolnshire Hospitals NHS Trust.
2. Southend Hospital NHS Foundation Trust.Eligibility criteriaPatients were eligible for the study if they provided written informed consent and if they:
i. were aged ≥ 18 years
ii. had experienced a stroke at least 6 weeks previously, and
iii. wished to get out of the house more often.
Patients were not eligible for the study if they were:
i. not able to comply with the requirements of the protocol and therapy programme – in the opinion of
the assessor
ii. still in post-stroke intermediate care or active rehabilitation, or
iii. previously enrolled in this study.
Patients who had suffered a transient ischaemic attack were not included.Screening and baseline assessmentThe majority of preconsent screening was undertaken over the telephone by the RA in response to a
patient reply to a patient invitation, and involved a general discussion of the study background and
participation requirements. In addition, key eligibility questions were asked in relation to wishing to get
out of the house more often and establishing potential outdoor mobility goals related to the intervention
manual. Following this process, if the potential participant remained eligible then a baseline visit would
be arranged.
The baseline visit was conducted in the potential participant’s home. The visit consisted of four elements:
ﬁrst, conﬁrming eligibility against inclusion and exclusion criteria; second, consenting (see Consent, below);
third, baseline data collection; and, fourth, delivery of the control (see Control, below).
Only limited numbers of data were collected, including basic demographics, time since stroke and
contact details.ConsentParticipant information sheets were available in several different formats, including full length, abbreviated
leaﬂet style, summary and aphasic. In practice, a combination of all four of these were often used, as
appropriate, for each individual participant. Only people who had the mental capacity to consent to9
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Logan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
RANDOMISED CONTROLLED STUDY METHODS
10participation, deﬁned against the criteria in the English Mental Capacity Act,35 were eligible to take part. If
there were communication problems then the participant’s carer or relative was involved in the process. In
addition, owing to potential physical limitations with completion of the consent forms, it was acceptable
for the participant to mark the consent form, accompanied by a witness signature to complete the consent
process. If the physical challenges were more severe then a witness (usually a member of the participant’s
family, carer or neighbour) could complete the consent form on the participant’s behalf.
During the baseline visit, carer information sheets and questionnaires were provided to all carers. They
were allowed to complete them immediately or later, and the process of completing and returning the
questionnaire was considered to be implied consent.Control informationAll participants in the study received the control information during the baseline visit by the RA. The control
information was provision of verbal and written local mobility and transport information. This information
was site speciﬁc. Each site collated a pack of local information and leaﬂets as guided by the research
team. They were asked to include information about bus times, local community transport, taxi services,
wheelchair services, disabled persons’ car badges, wheelchair borrowing schemes and mobility equipment.
These individualised packs were given to the participant after their content had been discussed.RandomisationFollowing consent and completion of the baseline assessments and delivery of the control information,
the participant’s details were passed to the local therapist. The therapist accessed the remote, secure
web-based electronic case report form (eCRF) and randomisation system developed and maintained by
the NCTU and entered basic demographic details. Once these details had been entered irrevocably into
the system, the group to which the participant was randomly allocated was provided to the therapist.
Randomisation was created using Stata/SE version 9 statistical software with a 1 : 1 allocation to
intervention group or control. Participants and therapists were aware of the intervention allocation,
whereas the RA responsible for assisting with collection of the outcome measures was kept blinded to
the allocation throughout the study.
Randomisation was based on a computer-generated pseudorandom code using random permuted
balanced blocks of randomly varying size, set up and maintained by the NCTU in accordance with its
standard operating procedure and held on a secure server. The randomisation was stratiﬁed by age
(< 65 years and ≥ 65 years) and site. Sixty-ﬁve years of age was chosen as a cut-off point because Mobility
Allowance – a monetary allowance – was no longer available for people aged > 65 years and over. Access
to the sequence was conﬁned to the NCTU Informartion Technology (IT) Manager. The sequence of
treatment allocations was concealed until all participants had been randomly assigned to a treatment
group and recruitment, data collection and all other study-related assessments were complete.
If the participant was randomised to the intervention group then the therapist contacted the participant to
arrange an initial goal-setting visit. If the participant was randomised to the control group the therapist
would either, based on site staff preference, not contact the participant or contact the participant to
explain their allocation. It was not recorded which approach was used for which participant.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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identify ‘barriers and need’ theories. A group of senior and specialist therapists met to discuss the
interviews and developed an intervention based on the results, their clinical skills and training.
The intervention training manual that was used to train therapists in each site was developed using a
systematic approach. Initially, a literature review was performed using the search strategy for the following
terms ‘rehabilitation’, ‘stroke’, ‘occupational therapy’ and ‘outdoor mobility’, with the results reviewed by a
panel of expert stroke clinicians from which a draft training manual was developed. This was then
reviewed by a focus group of therapists (n = 15) who had either delivered the intervention in the pilot
study or were clinical experts in stroke. The intervention training manual used for this study contained:
l standardised assessments
l case vignettes of treatment plans
l goal planning and activity analysis guidelines
l protocol for a ﬁrst outing walking, using the bus and using a taxi
l checklist of beneﬁts and barriers to going outside
l motivational and conﬁdence-building strategies
l examples of skills needed to catch a bus or train
l examples of skills needed to be able to operate an outdoor mobility scooter.
The aim of the intervention was to increase outdoor mobility participation by alleviating physical
difﬁculties, developing skills to maximise the individual’s potential and overcoming psychological barriers.
The main component of the intervention was for participants to repeatedly practise outdoor mobility. This
included buses, taxis, walking, voluntary drivers and mobility scooters until they felt conﬁdent to go alone
or with a companion. The number of intervention sessions depended entirely on the participant. If they felt
they did not require any further intervention, for whatever reason, then the intervention stopped. If they
felt they required additional intervention for whatever reason, they could continue the intervention up to a
maximum of 12 visits. We recorded the duration of each intervention visit, including the time taken to
deliver the intervention, and travel to and from the participant’s home. A description of the intervention
has been published37 and a training manual developed. A more detailed summary of the training manual
can be found in Appendix 2.Training therapists to provide the interventionTherapists in each site were trained by Pip Logan [chief investigator (CI) and sole therapist in the pilot
study] to deliver the intervention using the intervention training manual and a standard presentation over
the course of 2 hours. Following this face-to-face training, the majority of therapists attended an update
session each year. On an ongoing basis they were able to e-mail other therapists on the study to discuss
treatments and were able to contact the study CI with any queries relating to the intervention.
Each therapist was registered on the eCRF database and when the record of a particular intervention visit
was added to the eCRF then a therapist, or therapists, had to be assigned to that particular visit, therefore
providing an accurate record of the delivery of the intervention, which could be correlated against the
training records.Data collectionThere were four methods of data collection: eCRF, questionnaire booklets, travel diaries and intervention
records. The NCTU performed quality control checks on all aspects of data collected and entered onto the11
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12eCRF to ensure accuracy and completeness. Speciﬁcally, a 100% check of primary end points and a 10%
check of all other data were completed.Electronic case report form
Only the therapist [and principal investigator (PI)] at each site had access to the eCRF. The baseline
demographic details, including the NHS number, were recorded and supplied to the NHS IC/NHS Central
Register to allow mortality checks prior to follow-up. In addition, data for duration of visit, the occurrence
of any adverse events and end of intervention details was also collected and directly entered on the eCRF,
often transcribed from paper records (either study worksheets or the intervention records).Questionnaire booklets
Baseline participant questionnaires were completed by participants, with assistance from the RA if needed,
during the baseline screening assessment. Alternatively, the RA left the questionnaire for the participant
to complete later and post direct to the NCTU. We asked participants to record at baseline and both
the 6- and 12-month assessments, whether they completed the questionnaire themselves or required
assistance. This was to indicate who physically completed the questionnaire and it was assumed that the
participant answered the questionnaires regardless of who ﬁlled in the form. If the RA assisted with
completion of the baseline questionnaire, they informed the NCTU that the participant would also require
assistance at 6 and 12 months. The RA sent the baseline questionnaire booklets to the NCTU for entry
onto the database. Baseline carer questionnaires were either completed during the baseline screening
assessment, if the carer was available, or left with the participant for completion later.
Six- and 12-month participant and carer questionnaire data were collected either by post or with
assistance of a blind-to-allocation RA. Following baseline assessment, each participant was assigned to
the postal approach unless otherwise indicated by the RA. The NCTU tracked all questionnaires with the
option to send a reminder letter or to telephone to assess the situation. If difﬁculties were encountered at
any time during the study then participants were switched from the postal approach to the RA approach.
These methods were found to be successful in the single-centre pilot study, with a 90% postal return rate
of active participants (i.e. those who had not withdrawn, died or been lost to follow-up) with the further
10% collected by an independent assessor, the equivalent of the RA in this study.Travel diary
Travel diaries were completed by all participants on a daily basis. This was in the form of a calendar with
the participants entering the number of journeys made for each day. In addition, in order for the study
team to assess safety, participants indicated whether they had experienced a fall on each day. The
participant was provided with a 12- or 13-month calendar, depending on the date of the baseline visit.
Training in the completion and return of the travel diaries was provided by the RA at baseline. A prepaid
envelope was sent to participants at the end of each month for them to return the diaries. No reminder
letters were sent.
Data from travel diaries were entered on to the database on a month-by-month basis but only if a journey
was recorded (i.e. ≥ 1 journey for any given day). Months that contained only ‘0’ were also recorded. If the
month was blank then no data were entered for that particular month.Intervention recordsAs well as the intervention duration being recorded in the eCRF, therapists also completed a paper
intervention record form detailing goals set, visit-by-visit clinical details plus a breakdown of therapy
activities. These were collected at the end of the study and collated into a separate database. Therapists
were trained to use the form as part of the intervention training. The type and duration of intervention
within any given visit were recorded under the following headings: goal setting, mobility, conﬁdence,
adaptive equipment, information, other rehabilitation and referral on to other agencies. For eachNIHR Journals Library www.journalslibrary.nihr.ac.uk
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agreed outdoor mobility goals and kept running records of each treatment session as they would in
routine clinical care. The intervention records were kept in the NHS clinical setting until the end of the
study when they were copied and collated by the central coordinating centre.Treatment ﬁdelityTo assess the ﬁdelity of the intervention therapy provided, 20% of clinical records were monitored (10%
of all participants). A RA who was independent of the site visited the site and checked the treatments
being delivered against a predeﬁned checklist by accompanying the therapist on a number of treatment
visits and by monitoring the intervention records. The last question on the checklist (a yes/no question as
to whether the assessor believed that treatment provided met the required standard) was used to indicate
whether the intervention had been delivered as speciﬁed and, therefore, implied ﬁdelity of treatment.Adverse events/safety evaluationThe main risk identiﬁed from this study was the potential to increase the chance of a participant having a
fall, as a result of increased mobility. For adverse event purposes we adopted the following deﬁnition: ‘A
recordable adverse event is any fall that occurs during or following the ﬁrst outdoor mobility intervention
and for the remaining period of intervention in the study that speciﬁcally requires the assistance of a
health-care professional’. If these criteria were met then an adverse event form was completed. We
adopted the following approach to capture this information – the therapist would ask, during an
intervention visit, the following questions:
l ‘Have you had any falls since my last visit?’
l If yes, ‘How many?’
l ‘How many required health-care professional help?’
Therefore, adverse events were only recorded from the intervention group, as the control group did not
receive any visits post baseline. No other adverse events were collected. The occurrence of a serious
adverse event as a result of participation within this study was not expected and no serious adverse event
data were collected.
In order to capture information from both groups for comparison and a further measure of safety, we
adopted a second approach. Participants indicated a fall on the travel diary by marking or circling the
preprinted ‘f’, denoting that ≥ 1 fall had occurred for that participant on that day. These would not be
classed or recorded as adverse events. Also, a comparison was made of any untoward changes in the
well-being score of all participants by comparing the baseline GHQ-12 score with the 6- and
12-month score.
In the event of a pregnancy occurring in a study participant then they were allowed to continue in the
study regardless of which arm they had been randomised to.Concealment of allocation during outcome assessments
Participants and therapists were aware of treatment allocation. However, the treatment allocation was
concealed from the RA so that they were able to assist the participant with completion of the 6- and
12-month questionnaires, if necessary. In order to measure concealment of allocation we asked the RAs to
complete a blinding assessment for each post-randomisation visit, indicating whether they were unblinded
prior to or during the visit.13
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14Participant retention and withdrawalsTo try and reduce the bias in participant retention caused by people wishing to withdraw before the
primary end point because they were not allocated to the intervention group, we allowed participants to
stop completing the travel diaries and asked them whether they would be happy to remain in the study
and complete the 6-month questionnaire.
No speciﬁc withdrawal criteria were deﬁned for this study. If a participant left the study prematurely
(i.e. prior to completion of the protocol), the primary reason for discontinuation was determined and
recorded if at all possible. Withdrawn participants were not replaced. Participants were made aware
(by the information sheet and consent form) that should they withdraw, the data collected prior to the
withdrawal date would not be erased and would still be used in the ﬁnal analysis.
For this study, and in reference to the CONSORT (Consolidated Standards of Reporting Trials) diagram
(see Figure 3), the following deﬁnitions were applied in relation to the participants and the data:
Withdrawn consent The participant formally withdrew from the study and no further data were collected
from that point. This was measured in relation to completion of 6- or 12-month follow-up and not the
time of withdrawal, for example, if a participant withdrew after 7 months and did not complete their
6-month follow-up then they would be recorded as ‘withdrawn prior to 6-month follow-up’.
Lost to follow-up The study coordinating centre and/or local site staff were unable to contact the
participant. This was recorded in relation to completion of 6- or 12-month follow-up as above.
No follow-up data The study coordinating centre and/or local site staff were in contact with the
participant but follow-up data were not received; however, the participant was not formally withdrawn
from the study. These participants at 6-month follow-up were classed as ‘no follow-up data’ on the
CONSORT diagram and continued to participate in the study. These participants at 12 months’ follow-up
were also classed as ‘no follow-up data’ on the CONSORT diagram.Statistical methodsFull descriptions of the statistical methods of analysis are detailed in the statistical analysis plan
(see Appendix 1).
Intervention and goals descriptive analysis A description of the components of the intervention was
undertaken with the type of intervention therapy received by participants (e.g. mobility, goal setting,
conﬁdence, etc.) summarised in terms of number and percentage of participants who received the
different types of therapy sessions and the mean, SD, median, IQR, and the minimum and maximum of
the number of sessions for each type of therapy session. The goals set by each participant during the
intervention sessions were recorded verbatim and this information was then sorted into categories
of the goal types. These data were then analysed through calculating the number and percentage of
participants who set each type of goal.Comparison between treatment arms
All analyses were undertaken on an intention-to-treat basis, in that participants were analysed according
to the group to which they were randomised, regardless of whether they received the intervention or not.
Analyses were conducted on available case data. A sensitivity analysis, using multiple imputation (MI) to
replace missing values, was performed for all outcome measures except travel journeys (see Sensitivity
analysis adjusting for missing data section below for further information).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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check for outliers. If, after additional investigation, there was no evidence that these were errors then the
analyses were repeated after Winsorising the data to assess the robustness of the results. Winsorising
involves replacing extreme values (outliers) with a speciﬁed percentile of the data.38 In this case, we
replaced data values below the 5th percentile with the 5th percentile value and to replace data values
above the 95th percentile with the 95th percentile value.Descriptive analyses
Continuous data that were approximately normally distributed were summarised in terms of the mean,
SD and number of observations. Skewed data were presented in terms of the median, lower and upper
quartiles, minimum, maximum, and number of observations. Categorical data were summarised in terms
of frequency counts and percentages.Analysing primary and secondary outcomes
The mean social function score of the SF-36v2 was compared between treatment groups using a multiple
membership form of mixed-effects multiple regression analysis, adjusting for site (as a random effect), age
and baseline social function score as covariates, and therapist as a multiple membership random effect.
A three-level hierarchical regression model was used with site at level 3, multiple membership effect of
therapists at level 2, and participants at level 1. Regression coefﬁcients and 95% credible intervals were
presented. The robustness of these ﬁndings was assessed by repeating the analysis and including baseline
variables that are likely to be associated with the outcome variable (namely gender and residential status)
as covariates in the model.
Satisfaction with outdoor mobility was compared between treatment groups using a multiple membership
form of a mixed-effects logistic regression model adjusting for site (as a random effect), baseline answer to
the question and age as covariates, and therapist as a multiple membership random effect. Odds ratios
and 95% credible intervals were presented.
Travel journeys were compared between treatment groups using a multiple membership form of a
mixed-effects Poisson regression model, adjusting for site (as a random effect) and age as covariates, and
therapist as a multiple membership random effect. Rate ratios and 95% credible intervals were presented.
Travel journeys were presented as number of journeys per day. The analysis assumed that for a particular
month for which journeys had been recorded then all other days were imputed with ‘0’. All months that
were returned blank were not included in the analysis. When no travel diary was returned then that month
was not included in the analysis.
All remaining secondary outcome variables were analysed using the same methods as for the primary
outcome measure. We acknowledge the potential for type 1 errors associated with signiﬁcance testing for
multiple end points and, therefore, we consider the analyses of the secondary outcome measures to be
partly exploratory in nature, and partly conﬁrmatory of the ﬁndings for the primary outcome measure.Sensitivity analysis adjusting for missing data
We assessed the effect of missing data on the overall conclusions of the study using MI. We used the Stata
‘ice’ command to generate 10 imputed data sets, and estimated the intervention effect in each imputed
data set. We then used ‘Rubin’s Rules’ to combine these estimates into a pooled estimate of the
intervention effect.39
This process was conducted for all outcomes (except the travel journeys) for 6- and 12-month data.
We considered the use of this process for the travel journeys to be inappropriate because, in addition to
imputing the total number of journeys made, we would also have had to impute the number of days on
which journeys were taken. Furthermore, there was no prior information available at baseline on the
number of journeys made or the numbers of days on which the participants had made journeys that could
be used to predict the data for 6 and 12 months.15
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16Multiple membership random effect
In many studies, outcome measures are inﬂuenced by an intervention, such as a drug or a single person
delivering an intervention, and, in these studies, assessing the effects of the drug or person on the
outcome is clear. In our study, participants in the control group were treated by only one therapist but in
the intervention group participants may have been treated by multiple therapists and some therapists may
have delivered more therapy sessions to a speciﬁc individual than others. This means that the outcome
obtained from a participant receiving treatment from different therapists may have been inﬂuenced by
more than one person and, as some therapists may have delivered more therapy sessions to a participant
than others (and the therapists may differ in their effectiveness), it is important to take account of this in
the analysis. We used multiple membership random-effects models to deal with this situation and adjusted
for the effect of the therapist by placing weights on the therapists delivering the intervention. We placed
the greatest weight on the therapist who delivered the most therapy sessions for a particular participant.
If two therapists delivered the same number of therapy sessions to a participant, equal weight was applied
to each therapist, whereas if one therapist delivered one-third of the therapy sessions and another
therapist delivered two-thirds of the therapy sessions (i.e. twice as many), the therapist who provided the
most sessions was given the greatest weight (in this case, twice the weight of the other therapist). For
participants treated by only one therapist, all weight was placed on that therapist, as only that therapist
inﬂuenced the outcome. The weight applied to each therapist treating an individual therefore reﬂected the
potential amount of inﬂuence that they may have had on the outcome with low weights indicating less
inﬂuence on the outcome than higher weights.Presentation of primary and secondary results
All main 6- and 12-month primary and secondary outcome data were presented descriptively by treatment
group using means and SDs for continuous data or frequency counts and percentages for categorical data
(unadjusted results), and then the results of the multivariable analysis – adjusting for therapy effect and
site effect – were presented as differences in means for continuous data, odds ratios or rate ratios for
binary and count data, respectively (adjusted results), with 95% credible intervals as a measure of
signiﬁcance. In addition, the ICCs indicating the size of the therapy effect and site effect were presented,
apart from travel journey, for which these effects were not calculable. The interpretation of the results of
the multivariable analysis of the 6- and 12-month primary and secondary outcome data are as follows:
1. Difference in means Where a score of ‘0’ indicates ‘no difference’ and hence if the 95% credible
interval crossed the value ‘0’ then the result (difference in means between the two treatment groups)
was not statistically signiﬁcant. This approach was used for the primary outcome, NEADL, RMI and
GHQ-12 outcome measures.
2. Odds ratio Where a score of ‘1’ indicates ‘no difference’ and hence if the 95% credible interval crossed
the value ‘1’ then the result (the odds of getting out of the house as often as they would like in the
intervention group relative to the control group) was not statistically signiﬁcant. This approach was used
only for the outcome SWOM.
3. Rate ratio Where a score of ‘1’ indicates ‘no difference’ and hence if the 95% credible interval crossed
the value ‘1’ then the result was not considered to be statistically signiﬁcant. This parameter was used
for travel journeys.Exploratory/other analyses
The following analyses were prespeciﬁed in the analysis plan:
1. NEADL by category Descriptive summaries (by treatment group) for the NEADL scale categories
‘Mobility’, ‘Kitchen’, ‘Domestic’ and ‘Leisure’.
2. Number of sessions by site Descriptive analysis of number of intervention visits by site compared with
perceived successful completion of the intervention.
3. Number of travel journeys by intervention session Descriptive analysis comparing the number of travel
journeys within the intervention group by participants who had received fewer than six sessions orNIHR Journals Library www.journalslibrary.nihr.ac.uk
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pre-existing threshold of fewer than six or ≥ six or more sessions was used in this analysis.
4. Falls by age category and treatment allocation The total number (%) of ‘fall-days’ was described by
treatment arm and age category (< 60 years of age and ≥ 60 years).
5. Satisfaction with outdoor mobility changes over time To explore the effect of the control information a
descriptive comparison in the change of the SWOM scores from baseline to 6 months for each group.
6. Six-month follow-up by approach A descriptive comparison of collection of 6-month follow-up data
from postal or RA approach.Compliance in reference to CONSORTCompliance in this study was effectively a measure of completeness of follow-up data. Baseline
questionnaires were required to be completed before randomisation so that baseline CONSORT-presented
numbers randomised. The CONSORT diagram presented compliance for this study as the number of
returned questionnaires for the 6- and 12-month follow-ups, regardless of completeness of the
questionnaire booklets.
For individual analyses of outcome measures, as the analysis relies on a comparison between follow-up
data and the baseline data, the ‘n’ presented in the results section was a measure of the number of
participants who completed the outcome measure at both baseline and follow-up. Data from participants
who answered some, but not all, of the questions within a questionnaire based outcome measure were
still included in the analysis; however, if the whole of the questionnaire was missing then their data were
not used.Study management and oversightA number of committees were assembled to ensure the management and conduct of the study, and to
uphold the safety and well-being of participants.Trial Management Group
The Trial Management Group (TMG) oversaw the operational aspects of the study, which included the
processes and procedures used and the day-to-day activities involved in study conduct.Trial Steering and Data Committee
The Trial Steering and Data Committee (TSDC) had the overall responsibility for ensuring a scientiﬁcally
sound study design, a well-executed study, and accurate reporting of the study results.
The data monitoring part of this committee evaluated the outcome and safety data in the context of the
overall study and the currently existing information about the study. They considered the appropriate time
frame for reviewing the data during the course of the study. The TSDC had access to grouped study data.
However, as part of the process of calculating a revised sample size, an ad hoc independent Data
Monitoring Committee (DMC) was convened, which reviewed the suitability and legitimacy of the
proposed revision.Amendments to the study
Eligibility To simplify the screening process we removed ‘Able to comply with the requirements of the
protocol’ as an inclusion criterion, and ‘Signiﬁcant cognitive impairment which will impede ability to
complete the assessments’ and ‘Diagnosis likely to interfere with rehabilitation or outcome assessments
e.g. terminal illness’ as exclusion criteria. In their place we added a single exclusion ‘Not able to comply with
the requirements of the protocol and therapy programme, in the opinion of the assessor/GP/investigator’.17
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18These amendments were made prior to the start of recruitment. We amended ‘At least 6 weeks but no
longer than 5 years since stroke’ to ‘At least 6 weeks since stroke’ as an inclusion, as there was no valid
reason for the 5-year limit and participant invitations asked participants whether the mobility issues were as
a result of their stroke, so time frame was not relevant. Hence it was more inclusive to potential
participants. This amendment was made after 4 months of recruitment.
Sample size Following consultation with the funders and the TSC, it was agreed that we would calculate a
revised sample size, based on an increase in the number of sites. This revision is described in the ‘Revised
sample size’ section earlier in the chapter. Independent statisticians from outside the study checked
the validity of all calculations and assumptions. These amendments were made after 16 months
of recruitment.
Summary of changes to recruitment material After initially using a standard PIS, in full and summary
form, we introduced a supplementary PIS leaﬂet, in addition to rewording the PIS, consent form and
patient invites. These were amended in order to make the aims of the study more transparent and patient
friendly. Another signiﬁcant change was the introduction of an aphasia-speciﬁc PIS consisting of images
and key words. Though initially designed for aphasic patients it was used extensively, in conjunction with
more standard formats, for other stroke patients. These amendments were made after 4 months
of recruitment.
Qualitative study A study investigating conﬁdence after stroke was incorporated into the existing
study protocol with a view to interviewing existing study participants about issues relating to conﬁdence
and how it affected their recovery from stroke. This part of the study was only in Nottingham for
10 participants. The qualitative study is described in more detail in Chapter 5. This amendment was made
after 11 months of recruitment.
Recruitment timelines Initial recruitment timelines were 12 months; however, ﬁnal recruitment timelines
were extended to 22 months. This was managed through a combination of efﬁciencies within the overall
project timelines and an extension to the overall project from 36 months to 40 months.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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This chapter reports recruitment and retention of participants, and collection and analysis of studydata speciﬁcally relating to the delivery and ﬁdelity of the intervention, primary outcome measured at
6 months, and secondary outcomes measured at 6 and 12 months.Study recruitment and follow-upThe study recruited 568 out of 506 (112.3%) of the required sample size from November 2009 to
August 2011. Participants were recruited from 15 sites across England, Scotland and Wales, with
an average recruitment of 38 participants (range from 5 to 99) per site, with nine sites recruiting
> 30 participants. The participant involvement in the trial ended in August 2012, following completion
of recruitment and follow-up. Figure 2 shows that, after an initial lag phase, steady recruitment was
achieved with no noticeable seasonal variation.
Table 1 provides a breakdown of screening ﬁgures collected from all sites, in terms of number of
invitations sent, number of ‘yes’ replies, number of home screening visits, number randomised and the
proportion of recruits per 100 invites. The different approaches were used to varying extents: GP-based
approaches being responsible for recruiting 158 out of 568 (27.8%) of randomised participants at a rate
of 2.5 per 100 invites, and stroke register-based approaches recruiting 410 out of 568 (72.2%) of
randomised participants at a rate of 8.5 per 100 invites. The stroke register data includes participants
recruited at outpatient clinics.
Follow-up (CONSORT)
Figure 3 shows the CONSORT diagram for the study. The identiﬁcation of participants was from 11,126
invites, either by letters of invitations or face-to-face approach. The exact breakdowns were not recorded;
however, the majority were by letter of invitation. We had ‘yes’ replies from 1448 out of 11,126 (13.0%)
approaches to participate in the study with 9678 out of 11,126 (87%) either not responding or providing
negative replies. We did not record the number of ‘no’ replies. After initial pre-consent screening, usually by
telephone, a further 596 out of 11,126 (5.4%) were considered ineligible. The main reason for ineligibility0
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ABLE 1 Breakdown of participant identiﬁcation, screening and recruitment numbers from two alternative
ontact approaches
Approach Invites
‘Yes’ replies
(% of invites)
Screening visits
(% of ‘yes’ replies)
Randomised
(% of ‘yes’ replies)
Recruits/
100 contacts
GP database 6329 679 (10.7) 261 (38.4) 158 (23.3) 2.5
Stroke register 4797 769 (16.0) 591 (76.9) 410 (53.3) 8.5
Overall 11,126 1448 (13.0) 852 (58.8) 568 (39.2) 5.1
RESULTS: RANDOMISED CONTROLLED STUDY
20T
cwas that the potential participants felt they got out of the house as much as they wished already. Therefore,
852 out of 11,126 (7.7%) had a further screening visit in their own home from the RA. Overall, 568 out of
852 (66.7%) were found to be eligible to take part. Of the 11,126 letters sent, 568 people were included
(5.1%). Of the 284 out of 11,126 (2.6%) who did not enter the study, only 1 out of 11,126 (0.01%)
explicitly refused to participate (owing to their desire to be in the intervention group only).
The baseline questionnaire was completed by 567 out of 568 (99.8%) participants, with the one
outstanding being left with the participant and never being received by the study coordinating centre.
Following randomisation, 287 out of 568 (50.5%) participants were allocated to the intervention group
and 281 out of 568 (49.5%) to the control group. In the control group, 1 out of 281 (0.4%) participants
received two intervention visits in error. In the intervention group, 281 out of 287 (97.9%) of participants
received at least one intervention visit. There was no evidence of crossover between the two groups.
Six-month follow-up was measured by the receipt of the 6-month questionnaire booklet by the research
team. For the intervention group, 264 out of 287 (92.0%) reached 6-month follow-up. Of the 23 out of
287 (8.0%) who did not reach 6-month follow-up, 3 out of 287 (1.0%) were lost to follow-up, 14 out
of 287 (4.9%) withdrew consent and 4 out of 287 (1.4%) died. A further 2 out of 287 (0.7%) did not
complete the follow-up but remained in the study, with 266 participants remaining in the intervention
group after 6-month follow-up. For the control group, 239 out of 281 (85.1%) reached 6-month follow-up.
Of the 42 out of 281 (14.9%) who did not reach 6-month follow-up, 8 out of 281 (2.8%) were lost to
follow-up, 29 out of 281 (10.3%) withdrew consent and 5 out of 281 (1.8%) died. Therefore, there were
239 participants remaining in the control group after 6-month follow-up.
Completion of 6- and 12-month follow-ups was deﬁned as return of the fully/partially completed
questionnaire booklet to the NCTU. It does not indicate the level of completeness. Six- and 12-month
results for individual measures presented later in the chapter indicate the number of participants from
which we have analysable data.
There was a differential follow-up rate between the two groups for the 6-month follow-up, with 92.0%
collected for the intervention group and 85.1% collected for the control group. However, these were both
less than the predeﬁned 20% attrition rates.
Successful data collection at 12-month follow-up was measured by receipt of the 12-month questionnaire
booklet. For the intervention group, 232 out of 287 (80.8%) reached 12-month follow-up. Of the 34 out
of 287 (266 – 232 = 34; 11.8%) who did not reach 12-month follow-up, 3 out of 287 (1.0%) were lost to
follow-up, 17 out of 287 (5.9%) withdrew consent and 8 out of 287 (2.8%) died. A further 6 out of
287 (2.1%) did not complete the follow-up but remained in the study. For the control group 211 out of
281 (75.1%) reached 12-month follow-up. Of the 28 out of 281 (239 – 211 = 28; 10.0%) who did not
reach 12-month follow-up, 4 out of 281 (1.4%) were lost to follow-up, 15 out of 281 (5.3%) withdrew
consent and 7 out of 281 (2.5%) died. A further 2 out of 281 (0.7%) did not complete the 12-month
follow-up but remained in the study.NIHR Journals Library www.journalslibrary.nihr.ac.uk
Patient invites sent
(n = 11126)
Replied ‘yes’ to invite
(n = 1448)
Had a screening visit
(n = 852)
Did not meet inclusion criteria
(n = 596)
No reply or replied ‘no’
(n = 9678)
Did not meet inclusion criteria (n = 283)
Declined to participate (n = 1)
Number randomised
(n = 568)
Allocated to intervention group (n = 287)
Received intervention (n = 281)
Did not receive intervention (n = 6)
No follow-up dataa (n = 2)
Lost to follow-up (n = 3)
Withdrew (n = 14)
Deceased (n = 4)
Lost to follow-up (n = 8)
Withdrew (n = 29)
Deceased (n = 5)
No follow-up dataa (n = 6)
Lost to follow-up (n = 3)
Withdrawn (n = 17)
Deceased (n = 8)
No follow-up dataa (n = 2)
Lost to follow-up (n = 4)
Withdrawn (n = 15)
Deceased (n = 7)
Allocated to control group (n = 281)
Received control (n = 281)
Receive intervention (n = 6)
6-month follow-up (n = 264) 6-month follow-up (n = 239)
12-month follow-up (n = 232) Reached 12 months (n = 211)
FIGURE 3 Final CONSORT diagram. a, Participant remained in the trial but no data were collected at that time point.
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29As with the 6-month follow-up, there were differential follow-up rates between the two groups for
the 12-month follow-up. A total of 232 out of 287 (80.8%) of questionnaires were collected for the
intervention group and 211 out of 281 (75.1%) collected for the control group. Although the control group
follow-up rate was within the deﬁned 20% attrition rate, the overall number of participants with 12-month
follow-up data (n = 443) was within the threshold to ensure that the study had adequate power.
Table 2 summarises the results of who completed the questionnaire and indicates a consistent proportion
of participants completed the questionnaires themselves, whereas at 6 and 12 months there were
consistent completion rates for both carer and other (16% and approximately 37%, respectively). The
‘other’ completions at baseline were due to the presence of the RA.21
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ABLE 2 Proportion of who completed baseline and follow-up questionnaires
Questionnaire
Who completed the questionnaire
You (%) Carer (%) Other (%)
Baseline (n = 567a) 234 (41.3) 32 (5.6) 301 (53.1)
6-month follow-up (n = 503) 230 (45.7) 81 (16.1) 192 (38.2)
12-month follow-up (n = 443) 208 (47.0) 74 (16.7) 161 (36.4)
a No baseline questionnaire data were returned for one participant.
RESULTS: RANDOMISED CONTROLLED STUDY
22TCarer questionnaire follow-up
We received 192 carer questionnaires at baseline, with 100 out of 192 (52.1%) and 92 out of 192
(47.9%) from carers of participants in the intervention and control groups, respectively. We received
148 carer questionnaires at 6-month follow-up, with 84 out of 100 (84.8%) and 64 out of 92 (69.6%)
from carers of participants in the intervention and control groups, respectively. We received 127 carer
questionnaires at 12-month follow-up, with 71 out of 100 (71.0%) and 56 out of 92 (60.9%) from carers
of participants in the intervention group and control, respectively.Travel diary follow-up
Owing to the volume of travel diaries and the challenges of tracking their status, a decision was taken not
to send reminders if the travel diary was not received. Overall, 70.6% of all expected travel diary months
were received and assigned, regardless of whether they contained data, to 508 out of 568 (89.4%) of
participants (Table 3); 73.6% were received for the intervention group and 67.5% from the control group.
Overall, 55.1% of participants returned diaries for the full 12 months.
Baseline characteristics
Table 4 presents a summary of key baseline characteristics of each group. Baseline characteristics of the
sample showed the majority of participants to be women, living with others, with a mean age of 71 years
(SD 12.1 years). At baseline there was a slight gender imbalance, with a higher proportion of men in the
control group than the intervention group (47% vs. 42.2%). Residential status was well balanced
between groups with only a slightly higher proportion living alone in the control group (35.2% vs. 33.4%).
The average time since stroke was 37 months (SD 43.8 months) for the control group and 43 months
(SD 60.1 months) for the intervention group.
Baseline scores for mobility, activity measures, GHQ-12 and SWOM were similar in the two groups.
However, for the primary outcome measure of quality of life (social functioning score), the control group
had a higher mean (50.1 vs. 45.9) and median (50 vs. 37.5) than the intervention group.
Satisfaction with outdoor mobility scores indicated that overall 93.3% of participants were not currently
satisﬁed with their level of outdoor mobility. The remaining participants who indicated SWOM (n = 38)
were spread across both groups, in all sites except one, and had no other unusual characteristics.TABLE 3 Travel diary follow-up rates
Travel diaries
Overall
(expected n = 7363)
Control group
(expected n = 3644)
Intervention group
(expected n = 3719)
n % n % n %
Total received 5198 70.6 2462 67.5 2736 73.6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 4 Participant baseline characteristics
Variable Parameter
Allocation
Control Intervention
Total n (%) 281 (49.5) 287 (50.5)
Age at inclusion (years) Mean (SD) 71.5 (12.1) 71.7 (12.1)
Median (IQR) 75 (63–81) 73 (64–81)
Min. to max. 36–95 32–96
Sex Women n (%) 149 (53) 166 (57.8)
Men 132 (47) 121 (42.2)
Ethnicity White n (%) 263 (93.6) 270 (94.1)
Black: Caribbean 7 (2.5) 4 (1.4)
Black: African 2 (0.7) 1 (0.3)
Black: other 1 (0.4) 3 (1)
Pakistani 0 (0) 0 (0)
Indian 5 (1.8) 4 (1.4)
Bangladeshi 2 (.7) 2 (0.7)
Chinese 0 (0) 0 (0)
Mixed 0 (0) 1 (0.3)
Not given 1 (0.4) 1 (0.3)
Other 0 (0) 1 (0.3)
Residential status Lives alone n (%) 99 (35.2) 96 (33.4)
Lives with others 170 (60.5) 179 (62.4)
Living in care home 12 (4.3) 12 (4.2)
Time since stroke (months) Mean (SD) 37 (43.8) 43.2 (60.1)
Median (IQR) 21.3 (10.2–47.6) 24.5 (12.8–44)
Min. to max. 1.6–392.6 2–479.3
Social functioning score Mean (SD) 50.1 (30.7) 45.9 (30.3)
Median (IQR) 50 (25–75) 37.5 (25–62.5)
Min. to max. 0–100 0–100
NEADL score Mean (SD) 10.1 (5.7) 8.8 (5.2)
Median (IQR) 10 (5–14) 9 (4–13)
Min. to max. 0–22 0–22
RMI score Mean (SD) 8.9 (4.1) 8.1 (3.9)
Median (IQR) 10 (6–12) 8 (5–11)
Min. to max. 0–15 0–15
continued
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TABLE 4 Participant baseline characteristics (continued )
Variable Parameter
Allocation
Control Intervention
SWOM Yes n (%) 20 (7.1) 18 (6.3)
No 259 (92.2) 268 (93.4)
General Health Questionnaire (participant) Mean (SD) 15.1 (6.8) 14.9 (6.5)
Median (IQR) 13 (10–19) 14 (10–19)
Min. to max. 1–36 1–35
Max., maximum; min., minimum.
RESULTS: RANDOMISED CONTROLLED STUDY
24It is important to clarify the relationship between the ‘SWOM’ (Do you get out of the house as much as
you would like?) question as part of the baseline questionnaire and the eligibility criteria of ‘Wishing to
get out of the house more often’. On 38 out of 568 (6.7%) occasions, 20 out of 281 (7.1%) in the control
group and 18 out of 287 (6.3%) in the intervention group, the participant indicated that he or she met
the eligibility criteria during the consent process but answered ‘Yes’ to the ‘SWOM’ question during
completion of the baseline questionnaire. On further investigation it appeared that certain participants
were viewing these questions within a different context. The eligibility question was related to aspirational
view of getting out of the house (i.e. ‘Wishing to get out of the house more often’), whereas the SWOM
question was related to day-by-day coping views of getting out of the house. Hence these participants
were not classed as ineligible and were included in the analyses.Delivery of the intervention
Number of therapists by site
There were 29 therapists taking part in this study, who delivered at least one treatment session. There was
no restriction on how many therapists delivered the intervention at each site. This was mainly determined
by how the service was structured, availability of staff to perform the research activity, and delivery of
research and treatment costs to the relevant department. The therapists ranged from junior to senior
(Agenda for Change bands 4–740). Three were physiotherapists, 17 were occupational therapists and nine
were assistant practitioners. The number of therapists per site ranged from 1 to 4, with a median of two
per site. A small proportion of visits were attended by two therapists (65/1939; 3.4%). These were mainly
as a result of training junior staff and training as part of handover to replacement staff. Generally, only
one therapist delivered the intervention while the second therapist observed as part of training.Number and duration of intervention sessions
The intervention group received a median of seven intervention sessions (IQR 3–11 sessions), mean
6.80 sessions (SD 4.01 sessions). Figure 4 illustrates the distribution of intervention visits received by
participants, ranging from zero intervention sessions (6/287, 2.1%) to the maximum 12 (61/287, 21.3%);
138 out of 287 (48.1%) received less than the median of seven visits, with 149 out of 287 (51.9%)
receiving ≥ 7 visits. These were calculated from eCRF intervention visit data.
Of the 287 intervention participants, paper intervention records completed by the therapists were
returned for 269 out of 287 (93.7%) participants, 264 out of 287 (92.0%) of whom had received at
least one treatment session. The median duration in total, in minutes, of intervention provided for these
264 participants was 369.5 minutes (IQR 170–691.5 minutes), mean 454.6 minutes (SD 352.20 minutes).
These were calculated from intervention records data.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Table 5 summarises the types of goals set for each participant. Of the 287 participants in the intervention
group, information on goals set was recorded for 243. Participants were able to set more than one goal
during the process. However, we have no direct measure, relating to individual goals set, to indicate the
proportion of goals that were achieved. Instead, we have an overall measure of whether the intervention
was delivered to the satisfaction of the therapist, detailed later in Table 11. The most common goal was a
long walk of > 100m, set by 55.1% of participants, whereas increasing conﬁdence was set for 36.2%.
There was a wide range of goals set and the vast majority were considered appropriate for an intervention
aimed at getting participants out of the house and were also considered attainable.
Description of the key elements of the intervention
The average duration of an intervention visit, including travel to and from the participant’s home, was
96.6 minutes with a range of 10–390 minutes. A total of 1856 out of 1939 (95.7%) intervention visits
were completed within the protocol guidelines of 4 months post baseline visit. The other 4.3% were
outside the 4-month protocol guidance, although not all were recorded as protocol deviations by
the therapists.
Table 6 summarises the proportion and type of intervention delivered to participants. Goal setting was
delivered for 243 (92.1%) participants, with a median of two sessions provided (IQR 1–4 sessions). Mobility
training was delivered the most often for a median of 5.5 visits for 222 participants (84.1%), and had the
longest duration, with a median of 212.5 minutes (IQR 80–390 minutes) (data not reported in the table).
Conﬁdence building was used with 202 (76.5%) participants, with a median of four sessions provided
(IQR 2–8 sessions). The least used treatment method was adaptive equipment training, with 63 (23.9%)
participants receiving a median of one session (IQR 1–2 sessions). All treatment techniques listed on the
record form were used at least once by each site.
Treatment fidelity
Of the 15 sites delivering the intervention, 14 were assessed for ﬁdelity of treatment.
Treatment ﬁdelity forms were completed for 59 out of 287 (20.6%) intervention participants. Fidelity of
treatment assessments were not performed equally across sites, ranging from the intervention sessions for
10 out of 59 (17.0%) participants assessed at one site to 1 out of 59 (1.7%) participant at each of
two sites, and no participants at one site.25
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TABLE 5 Summary of type of goals set with participants in the intervention group
Goal type n participants Percentage of 243 participants
Long walk > 100m 134 55.1
Increase conﬁdence 88 36.2
Short walk < 100m 83 34.2
Othersa 78 32.1
Stamina 56 23.1
Access local shop 54 22.2
Bus 50 20.6
Attending social clubs/social activity 46 18.9
Training outdoor mobility equipment 37 15.2
Mobility scooter 29 11.9
Increase independence 28 11.5
Access town centre 23 9.5
Powered wheelchair 16 6.6
Crossing roads 14 5.8
Taxi 12 4.9
Car transfers 12 4.9
Increase journeys 12 4.9
Driving 10 4.1
Dial-a-Ride 8 3.3
Walk inside 6 2.5
Day centre 6 2.5
Shopmobility 6 2.5
Car 1 0.4
a Unable to categorise.
TABLE 6 Summary of type of intervention and the number of sessions the intervention type was delivered
Intervention type Participants, n (%)a
No. of sessions
Mean (SD) Median (IQR) Min. to max.
Goal setting 243 (92.1) 3.32 (3.13) 2 (1–4) 1, 12
Mobility 222 (84.1) 6.06 (3.89) 5.5 (2–10) 1, 12
Information 205 (77.7) 3.89 (3.28) 3 (1–10) 1, 12
Conﬁdence 202 (76.5) 5.13 (3.53) 4 (2–8) 1, 12
Other rehabilitation 139 (52.7) 3.55 (2.91) 2 (1–5) 1, 11
Referral 104 (39.4) 2.04 (1.32) 2 (1–3) 1, 7
Adaptive equipment 63 (23.9) 1.92 (1.24) 1 (1–2) 1, 6
Max., maximum; min., minimum.
a Percentage out of 264 participants from which we have data.
RESULTS: RANDOMISED CONTROLLED STUDY
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DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29Initially, the ﬁdelity of treatment assessment was a combination of checking treatment records against a
predeﬁned checklist and also accompanying the treating therapists on visits. However, owing to the
possibility that accompanying the therapists on visits might inﬂuence how a therapist undertook these
sessions, it was decided that only reviewing the participants’ notes would be completed for the remainder.
Of the 59 ﬁdelity of treatment assessments, 12 (20.3%) were completed using the visit and the treatment
notes and 47 out of 59 (79.7%) were completed by just assessing the treatment notes.
The ﬁnal question asked the assessor to make a judgement as to whether the intervention had met the
standard based on the checklist. They indicated that in 100% of the cases they believed it had.Completion of intervention
At the end of the participant’s intervention period the therapist indicated in 193 out of 287 (67.3%) of
participants that they, the therapists, felt that the participant had completed the intervention to the
therapist’s satisfaction (i.e. a surrogate marker for achieving their set goals).Contamination
There was one participant allocated to the control group who received two intervention visits in error. This
was recorded as a protocol deviation and is reported later in the chapter. The nature of the study, with
the intervention requiring a visit to the participant’s home, as well as the fact that all participants were not
currently within the rehabilitation service, meant that participants in the control group were unlikely to
have any contact with local site therapists and hence contamination was unlikely to occur. There is no
evidence of any contamination within this study.Numbers analysedFigure 2 illustrates the ﬂow of participants and their data; however, it does not provide the details on an
outcome-by-outcome basis. A partially completed outcome at the particular follow-up was required for
unadjusted measures. In order for any unadjusted outcome measure (apart from travel journeys) to be
calculated, the particular measure must be at least partially completed at both baseline and at the
particular follow-up. For travel journeys, the participant had to return at least one travel diary to be
included in either unadjusted or adjusted analysis. Table 7 details the number of participants analysed for
both adjusted and unadjusted outcome measure analysis.TABLE 7 Numbers analysed for each outcome measure
Outcome
Numbers analysed
6 months 12 months
Unadjusted Adjusted Unadjusted Adjusted
SF-36 (SF domain) 500 493 425 422
NEADL 494 493 438 437
RMI 499 497 442 440
GHQ-12 495 493 436 434
GHQ-12 (carer) 148 145 127 125
SWOM 494 491 432 429
Travel journeys 504 504 504 504
27
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28Primary outcome
The primary outcome was the Social Function domain within the SF-36v2 relating to an improvement in
participant’s quality of life. The predeﬁned MCID was 12.5.32
Table 8 summarises the primary outcome analysis. The variability of the social function score was similar in
the two groups although the mean score was slightly higher in the intervention group (47.0) at 6 months
compared with the control group (43.9). The adjusted difference in means between groups was 4.630
with a 95% credible interval of –0.549 to 9.848. This suggests a slightly higher social function score in the
intervention group but this was not signiﬁcant and it is less than the pre-deﬁned MCID. The ICCs for the
therapist (ICC = 0.0051) and site effects (ICC = 0.0099) are small, and less than we anticipated in our
sample size calculations.
Sensitivity analyses of the primary outcome
Sensitivity analysis was conducted, as per the statistical analysis plan, to assess the effect of outliers and
missing data. The results of the sensitivity analyses were consistent with those from the main analysis and
did not result in any difference in the conclusions drawn.Secondary outcomes at 6 monthsTable 9 summarises the secondary outcome analysis at 6 months. The unadjusted mean scores in both
groups were similar at 6 months for all secondary outcome measures. In the adjusted analyses there was aTABLE 8 Primary outcome analysis at 6 months
Outcome
Unadjusted Adjusted ICC
Control,
mean (SD)
Intervention,
mean (SD)
Difference
in means
95% credible
interval Therapist Site
Social Function domain 43.9 (29.8)
(n = 239)
47.0 (30.5)
(n = 261)
4.630 –0.549 to 9.848 0.0051 0.0099
TABLE 9 Secondary outcomes at 6 months split by adjusted measure of outcome
Outcome
Unadjusted Adjusted ICC
Control
mean (SD)
Intervention
mean (SD)
Difference
in means
95% credible
interval Therapist Site
NEADL 9.9 (5.7),
(n = 233)
9.0 (5.5),
(n = 261)
0.207 –0.371 to 0.799 0.0052 0.0155
RMI 8.4 (4.2),
(n = 236)
7.8 (4.2),
(n = 263)
0.145 –0.288 to 0.581 0.0111 0.0060
GHQ-12 (participant) 15.4 (6.6),
(n = 234)
14.2 (6.0),
(n = 261)
–0.958 –1.907 to 0.012 0.0028 0.0035
GHQ-12 (carer) 14.4 (6.4),
(n = 64)
13.6 (5.9),
(n = 84)
–0.682 –2.472 to 1.088 0.0176 0.0234
SWOM Yes = 52,
no = 181,
(n = 233)
Yes = 72,
no = 189,
(n = 261)
1.37 0.89 to 2.22 0.0289 0.0123
Travel journeys/day 1.1 (1.2),
(n = 241)
1.0 (1.0),
(n = 263)
1.42 1.14 to 1.67 – –
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being 42% more likely to make a journey than the control group [rate ratio 1.42, 95% conﬁdence interval
(95% CI) 1.14 to 1.67]. There were no other outcome differences between groups.
There was evidence of a therapist effect on the travel journeys taken but not for any of the other outcome
measures. ICCs for therapist and centre effects were small, with ICCs for therapist effect being no greater
than 0.0289 and ICCs for site effect being no greater than 0.0234. Therapy effect and site effect could
not be calculated for travel journeys.
The other domains from the SF-36v2 were also analysed at 6 months and showed no signiﬁcant difference
between groups.Outcome measures at 12 months
Table 10 summaries the secondary outcomes analysis at 12 months. The variability of the social function
score in both groups at 12 months was similar to that observed at 6 months but, unlike the 6-month
ﬁndings, the unadjusted mean social function score at 12 months was slightly less in the intervention
group (45.5) compared with the control group (48.1) (see Table 10). The adjusted difference in means
(–1.24) indicated that the intervention group scores were lower than the control, although the difference
was not signiﬁcant and no therapy or site effect was observed for this outcome measure.
The unadjusted mean scores in both groups were similar for all outcome measures. In the adjusted analysis
there was a signiﬁcant difference for travel journeys in the intervention group; rate ratio 1.76 journeys
(95% CI 1.36 to 1.95 journeys). NEADL, RMI, SWOM and GHQ-12 (participant and carer) did not show
any observable differences between groups. The ICCs for therapist effect were larger than those calculated
for all secondary outcome measures at 6 months, with the exception of GHQ-12 (carer). The ICCs for siteTABLE 10 Secondary outcomes at 12 months split by adjusted measure of outcome
Outcome
Unadjusted Adjusted ICC
Control,
mean (SD)
Intervention,
Mean (SD)
Difference
in means
95% credible
interval Therapist Site
Social Function domain 48.1 (28.7),
(n = 207)
45.5 (31.6),
(n = 221)
–1.238 –6.671 to 4.096 0.0025 0.0597
NEADL 9.9 (5.9),
(n = 210)
9.0 (5.8),
(n = 228)
0.487 –0.216 to 1.168 0.0012 0.0171
RMI 8.4 (4.2),
(n = 210)
7.6 (4.4),
(n = 232)
–0.044 –0.530 to 0.432 0.0134 0.0057
GHQ-12 (participant) 14.3 (6.6),
(n = 208)
15.2 (6.6),
(n = 228)
1.069 –0.045 to 2.150 0.0075 0.0043
GHQ-12 (carer) 13.7 (5.9),
(n = 56)
13.7 (5.3),
(n = 71)
–0.399 –2.338 to 1.543 0.0136 0.0066
Outcome
Unadjusted Adjusted ICC
Control Intervention Odds ratio
95% credible
interval Therapist Site
SWOM Yes = 45,
no = 160,
(n = 205)
Yes = 56,
no = 171,
(n = 227)
1.15 0.70 to 1.93 0.0315 0.0093
Outcome
Unadjusted Adjusted ICC
Control,
mean (SD)
Intervention,
mean (SD) Rate ratio
95% credible
interval Therapist Site
Travel journeys/day 1.1 (1.3)
(n = 241)
1.0 (1.1)
(n = 263)
1.76 1.36 to 1.95 – –
29
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30effect, however, were smaller at 12 months than at 6 months, apart from NEADL and participant-reported
GHQ-12. There was a signiﬁcant therapist effect for travel journeys at 12 months; however, we are unable
to estimate the size of the effect because this is not calculable for this type of data (see Table 10).Robustness of results
We assessed the robustness of the ﬁndings by repeating all analyses and adjusting for the baseline
variables gender and residential status in addition to the other covariates already adjusted for in the
models. The results of the analyses were consistent with those obtained from our original analysis.
We were unable to conduct this analysis for the GHQ-12 carer outcome because the models would
not converge.Sensitivity analyses
The only potential outliers we found were for the GHQ-12 outcome measures for the participant and
carers. After Winsorising these potential outliers we re-analysed the data but the ﬁndings were consistent
with the original analysis. We also conducted a sensitivity analysis using MI to replace missing data but this
did not change the ﬁndings of the study.Exploratory/other analyses
Nottingham Extended Activities of Daily Living by category
No signiﬁcant differences between groups were found for any of the four categories (mobility, kitchen,
domestic and leisure) at 6 or 12 months.Number of sessions by site
Table 11 details a site-by-site breakdown of the number of sessions delivered by therapists and the
corresponding percentage of participants who completed the intervention to satisfaction. The median
number of visits for this study was seven so this is a suitable point of comparison within the context of this
study. Of the seven sites with a median of < 7 visits, only 3 out of 7 sessions (42.9%) had > 50% of
participants who completed the intervention to satisfaction. Of the eight sites whose median was
≥ 7 visits, 8 out of 8 sessions (100.0%) had > 50% of participants who completed the intervention
to satisfaction.
The pilot study, however, showed that the intervention was effective with a median of six visits,24 so this is
a suitable predeﬁned point of comparison in terms of potential clinical effect. Of the ﬁve sites that had a
median of < 6 visits, only 2 out of 5 sessions (40.0%) had > 50% of participants who completed the
intervention to satisfaction. Of the 10 sites that had a median of ≥ 6 visits, 9 out of 10 sessions (90.0%)
had > 50% of participants who completed the intervention to satisfaction. The results are exploratory but
are suggestive that the more intervention visits a participant had the more likely they were to complete the
intervention to satisfaction.Number of travel journeys by intervention session
A further exploratory comparison of travel journeys within the intervention group, based on the number of
sessions they received, was carried out (Table 12). From the pilot study there was evidence that receiving six
intervention visits would increase the number of journeys made, therefore it is considered to be a clinically
important pre-existing threshold. The difference between travel journeys made by participants in the
intervention group was summarised by < 6 and ≥ 6 or more intervention visits at both 6 and 12 months.
These data show that participants who had six or more intervention visits were more likely to have a
higher number of journeys at both 6 months (167 vs. 148) and 12 months (316 vs. 291). The results are
exploratory but suggest that the more intervention visits a participant has the more likely they are to take
more journeys beyond the completion of the intervention.NIHR Journals Library www.journalslibrary.nihr.ac.uk
ABLE 12 Number of journeys made within the intervention group by number of intervention sessions
Follow-up Outcome measure
No. of intervention sessions
< 6 (n = 109) ≥ 6 (n = 156)
6 months No. of journeys 16,141 25,979
Mean (SD) 148 (176) 167 (169)
Median (IQR) 92 (36–199) 111 (61–247)
Min. to max. 0–1088 0–1152
12 months No. of journeys 31,679 49,214
Mean (SD) 291 (385) 316 (321)
Median (IQR) 160 (54–381) 208 (94–464)
Min. to max. 0–2195 0–2015
Max., maximum; min., minimum.
TABLE 11 Percentage intervention completed to satisfaction by site and average number of session delivered
Site
Percentage who completed
intervention to satisfaction
No. of sessions
Mean (SD) Median (IQR) Min. to max.
A 18.4 3.93 (3.79) 2 (1–6) 1, 12
B 90.5 5.3 (4.16) 4 (2–9) 1, 12
C 40 5 (4.18) 4 (1–10) 1, 11
D 37.5 4.86 (2.67) 5 (2–5) 2, 10
E 66.7 6.67 (3.79) 5 (4–11) 4, 11
F 90.9 7.18 (3.84) 6 (4–12) 2, 12
G 50 6.25 (3.01) 6.5 (4.5–8) 1, 11
H 77.8 6.78 (3.14) 7 (4–9) 1, 12
I 70.6 7.41 (3.89) 7 (5–11) 1,12
J 77.4 7.03 (3.47) 8 (4–10) 1, 12
K 77.8 7.74 (3.24) 8 (5–11) 2, 12
L 80.0 8.7 (3.32) 9.5 (6–12) 2, 12
M 85.7 8.57 (3.63) 10 (5.5–12) 1, 12
N 100 8.71 (3.55) 10 (5–12) 3, 12
O 84.2 10.37 (3.37) 12 (11–12) 2, 12
Max., maximum; min., minimum.
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All data described in this section were collected from travel diaries.
Table 13 presents falls data described by age, either < 60 years of age or ≥ 60 years. At randomisation,
104 participants (18.3%) were < 60 years of age, whereas 464 (81.7%) were ≥ 60 years. A total of 52
out of 104 (50%) of the participants aged < 60 years and 216 out of 464 (46.6%) of the participants aged31
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ABLE 13 Falls data summary by age
Fall-days < 60 year ≥ 60 years Total
Participants, n (%) 104 (18.3) 464 (81.7) 568 (100)
Participants with recorded falls, n (%) 52 (50) 216 (46.6) 268 (47.2)
Total of fall days, n (%) 704 (36.1) 1246 (63.9) 1950 (100)
Mean (SD) 13.5 (22.2) 5.8 (10.2) 7.3 (13.7)
Median (IQR) 3 (1–13) 3 (1–5.5) 3 (1–6.5)
Min. to max. 1, 89 1, 79 1, 89
Max., maximum; min., minimum.
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32T≥ 60 years had falls. In total, there were 1950 fall-days: 704 (36.1%) in the < 60 years age group and 1246
(63.9%) in the ≥ 60 years group. The median number of fall-days overall was 3 per year (IQR 1–6.5 fall-days).
There appeared to be no difference between the median fall days of the two age groups.
Table 14 presents falls data described by treatment allocation. The proportion of participants who had a
fall was similar in each group: 133 out of 281 (47.4%) in the control group and 135 out of 287 (47%) in
the intervention group.
Comparing changes in satisfaction with outdoor mobility over time
There was very strong evidence that the control group improved markedly. At baseline, 259 out of 281
(92.2%) participants were dissatisﬁed with outdoor mobility, but at the 6-month assessment this had
reduced to 78% (160/205), a 15% reduction. The corresponding reduction in the intervention group was
slightly greater (18%), with 268 out of 287 (93.4%) expressing dissatisfaction with outdoor mobility at
baseline and 171 out of 227 (75.5%) expressing this at 6-month assessment. This suggests that the
control (consisting of the baseline visits and completion of the travel diary) may have affected a change.Six-month follow-up by follow-up approach
Table 15 details the questionnaire data collection from the different methods of approach. For 6-month
questionnaires we received the questionnaire booklets for 503 out of 568 (88.6%) participants.
The overall average difference in days from actual completion to expected due date was +4.7 days
(range –33 to +133 days). Of those received, 280 out of 503 (55.7%) were via postal approach, 185 out
of 503 (36.8%) were via the RA approach, with the remaining 38 out of 503 (7.6%) via the RA approach
after switching from postal approach. RA assistance did not necessarily mean that the RA completed theTABLE 14 Falls data summary by treatment allocation
Fall-days
Allocation
TotalControl Intervention
Participants, n (%) 281 (49.5) 287 (50.5) 568 (100)
Participants with recorded falls, n (%) 133 (47.3) 135 (47.0) 268 (47.2)
Total of fall days, n (%) 934 (47.90) 1016 (52.10) 1950 (100)
Mean (SD) 7.0 (13.0) 7.5 (14.5) 7.3 (13.7)
Median (IQR) 2 (1–7) 3 (1–6) 3 (1–6.5)
Min. to max. 1, 80 1, 89 1, 89
Max., maximum; min., minimum.
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TABLE 15 Proportion of questionnaire received according to approach used, at 6 months
Six months Total received Percentage of total
Total postal approach 280 55.7
Postal to RAa 38 7.6
Total RA approach 185 36.8
Total 503 100
a ‘Postal to RA’ indicates that postal approach was used initially before switching to RA approach.
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29questionnaire, just that assistance was provided; however, in the majority of cases the RA would ask the
questions and complete on the participant’s behalf.Adverse eventsAdverse events records (i.e. a fall that required the assistance of a health-care professional) were collected
from only participants in the intervention group over the course of delivering the intervention visits. There
were 20 adverse events from 17 participants, with the majority of falls occurring at home. Two were
recorded as ongoing, with the average mean duration of event being 5.6 days and median duration of
1 day (range 1–44). Overall, there was no effect on the delivery of the intervention and only one led to
permanent discontinuation of the intervention.
Overall, 24 participants died, 12 in each group, indicating that the intervention group did not have an
increased risk of death compared with what would be expected for this patient group. As part of the
safety analysis there was also no signiﬁcant difference in GHQ-12 score observed between the groups.Protocol deviationsThere were 68 protocol deviations recorded, with 37 out of 68 (54.4%) for visits not performed within
the 4-month window (the majority of these were as a result of adverse weather conditions or temporary
participant or therapist unavailability). However, from eCRF intervention data there were a total of 83 visits
delivered outside the 4-month window, so there was an issue recording these as protocol deviations.
Twenty-ﬁve out of the 68 participants (36.8%) recorded other intervention therapy, which refers the
intervention being delivered via non-protocol-deﬁned methods (in all of these cases the intervention was
delivered either by telephone or letter).
One out of 68 participants (1.5%) in the control group received the intervention (two visits); 1 out of
68 participants (1.5%) was in active rehabilitation at point of recruitment; and 1 out of 68 participants
(1.5%) was an eligibility deviation, as the participant was unwell and not ﬁt to receive treatment,
whereas 1 out of 68 participants (1.5%) had a consent issue that was later resolved. Finally, 2 out of
68 participants (2.9%) had an intervention delay owing to unforeseen circumstances.
We considered these all to be minor deviations and that they were unlikely to have any effect on the
outcome measure. As a result, no action was taken and all of these participants remained in the study and
in the ﬁnal analysis.33
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34Concealment of allocationThere was a total of 223 RA-assisted participant visits at 6 months (see Table 15), for which the
participant-reported primary outcome measure was collected. We received blinding assessments for 171
out of 223 (76.7%) [intervention group 88 out of 171 (51.5%); control group 83 out of 171 (48.5%)]
RA-assisted participant visits at 6 months (Table 16). The RA was unblinded for 87 out of 171 (50.9%) of
those visits, with 13 out of 171 (7.6%) unblinded prior to the visit and 74 out of 171 (43.3%) unblinded
during the visit. The RAs were unblinded more frequently for participants in the intervention group (48/87,
55.2%) than for those in the control group (39/87, 44.8%), although this is not indicative of any
signiﬁcant difference in unblinding rates between the two groups.
Summary
l The study reached its recruitment targets and achieved strong retention rates at 6 months.
l Differential follow-up occurred but not to an extent as to affect the power of the study. The attrition
rates were greater within the ﬁrst 6 months of follow-up.
l The quality of life (social function) measure (primary outcome) showed no signiﬁcant difference
between groups at 6 months or at 12 months.
l Six- and 12-month measures for functional mobility, SWOM, and participant and carer well-being
showed no signiﬁcant differences between groups.
l The 6- and 12-month measure of travel journeys showed a signiﬁcant difference in favour of the
intervention group when the therapist and site effect was taken into consideration.
l There was no evidence of a therapy or site effect in any of the outcome measures at either 6 or
12 months, apart from travel journeys at 6 and 12 months.
l The intervention was delivered a median of seven times across the study as a whole, with 67.3%
completed to the satisfaction of the participant; however, there was considerable variation amongst
the sites for both these outcomes.
l Exploratory data suggest that the more intervention visits a participant receives, the more likely they
are to take more journeys beyond the completion of the intervention.
l Exploratory data suggest that the more intervention visits a participant had, the more likely they were
to complete the intervention to satisfaction.
l The control group appears to have beneﬁtted from inclusion in the study by becoming more satisﬁed
with their outdoor mobility over time.TABLE 16 Awareness of treatment allocation of RAs prior to, or during, RA-assisted participant visits of 6 months
primary outcome collection
Six months Prior During Total
n visits 171
n unblinded 13 74 87
% n visits 7.6 43.3 50.9
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resultsHealth economic evaluation: methods usedThis component of the study aimed to extend the evidence base by estimating for the ﬁrst time the
incremental cost-effectiveness of an outdoor mobility rehabilitation intervention, compared with control,
from a health and personal social services perspective. In addition, carer time and certain patient-borne
costs were also estimated. It was decided that medication costs would not be monitored, as it was
considered that the intervention would not inﬂuence these. A within-trial analysis was conducted over a
12-month period, where an available case analyses approach41 was adopted. Thus, for each variable, we
analysed all available data, which meant a different sample n was used for different variables. For example,
the EQ-5D and SF-6D may have different response rates. Additionally, in the base-case analysis, it should
be noted that when calculating levels of cost-effectiveness [see Cost-effectiveness, below, for a deﬁnition
of incremental cost-effectiveness ratio (ICER)] we included only those participants who had both complete
cost and effect data. As such, the number of participants for whom these data are available may well
differ from the n for which separate cost and effect data are available.Methods
Measuring costs
Overview
For each participant the total NHS and Personal Social Services (PSS) costs were estimated by summation of
the intervention cost and other NHS and PSS costs. Carer input (coated in terms of lost productivity) and
certain patient-borne costs were also estimated. Costs were estimated in UK sterling (£) at 2010–11
ﬁnancial year levels.Intervention
Training
Therapists were provided with training in order to deliver the intervention. Three types of training were
provided: (1) group training in Nottingham; (2) individual training to a particular site therapist; and
(3) within-site cascade training. The time inputs by all members of staff were estimated for each of these
training methods, including preparation and travel time. The unit cost of NHS community therapy time, as
estimated by Curtis et al.42 was assumed to apply to all time inputs, where this was adjusted to be grade 7
for the individual and group trainer (compared with grade 5 for the cascade trainer and for those receiving
the training and subsequently delivering the intervention). Travel distances were also estimated, and
assigned a travel cost of 54p per mile.42 Total training costs (the sum of staff and travel costs) were
apportioned across all participants allocated to the intervention arm of the study.Therapy contacts
Participants in both arms received a baseline visit; this was assumed to last 1 hour, including preparation,
travel time and the writing up of notes, as well as the patient contact. Generally, this was provided by one
therapist, although two therapists may undertake this (or subsequent visits) if there were issues relating to
handover/safety, thus those who provided the intervention were asked to note which therapist(s) attended
each visit (if this was not recorded it was assumed that one therapist provided the intervention). The
associated travel costs for the baseline, and all subsequent therapy visits, were estimated in the following35
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36manner. After discussion with those who delivered the service, it was assumed that a travel time of
12 minutes would apply to each visit (this is in line with a previous assumption in relation to GP home
visits42). Assuming an average speed of 29.9 miles per hour (mph) (the average free-ﬂow vehicle speed in a
30-mph limit,43 this would equate to a total mileage of 5.98 miles per visit. Applying a travel cost of
54p per mile,42 this would equate to a travel cost of £3.23 per visit.
Those in the intervention arm received extra intervention visits, where the time associated with these visits
(including travel to and from the participant’s home) was prospectively recorded by the therapist providing
the intervention. It was additionally assumed that, for each visit, there would be 5 minutes’ preparation
time and a further 10 minutes to write up associated patient records. Again for these visits the associated
travel time was assumed to be 12 minutes, with a travel cost of £3.23 per visit. Thirty-minute supervisor
meetings were also assumed to occur (one per site per month) for the duration of the study, where these
were assumed to be 1 : 1 (therapy grade 7 and grade 5). Total supervisor meeting costs were equally
apportioned across all visits. No other costs were included, as these were considered negligible
(e.g. occasional bus trips with the participant, as part of the intervention).Other NHS and Personal Social Services costs
Levels of resource use
The UK National Institute for Health and Care Excellence (NICE) recommends that costs can be calculated
from the perspective of the NHS and PSS.44 Accordingly, at both 6 and 12 months post randomisation,
participants were asked to complete a resource-use questionnaire and return it by post. In this they were
asked the number of times they had received different NHS and PSS services, any other care and certain
patient costs that had been incurred. Speciﬁc questions with regard to health-care professional visits (and
where they took place), hospital attendances and admissions, residential/nursing home admissions, home
help (from community care assistant/someone who lives with them/other friends or family), Meals on
Wheels and equipment purchased (to help with a health problem) were included.Assumptions made in order to assign costs to items of resource use
Previously estimated unit costs42,45 were assigned to levels of resource use, where the following
assumptions were made. Within Curtis et al.,42 the length of time and/or cost associated with patient
contacts (including home visit) is not stated for many health professionals, although the cost per hour of
employment is generally available. Costs in terms of per hour of employment, per practice visit and per
home visit are available, however, for the GP. Thus, the ratio of 1 hour of employment compared with
(1) a practice visit and (2) a home visit can be calculated. This ratio was applied to the costs per hour of
employment of other staff to estimate associated practice/hospital visit and home visit costs. Where the
cost per hour of employment, for a particular health professional, was not reported within Curtis et al.42
the average cost across the following health professionals was used: general practitioner, practice nurse,
district nurse, dietitian, physiotherapist, occupational therapist, social worker, speech and language
therapist, for the respective type of visit (GP, home or hospital). If the place of a health professional visit
was not reported then it was assumed that the patient travelled to the health professional (patient travel
costs were not estimated/included).
With regard to hospital admissions (in the past 6 months), if the length of a hospital admission was not
reported the mean length of stay (per admission) for other respondents (who reported both the number of
admissions and the accompanying length of stay) was applied to each admission that was reported but
had no accompanying length of stay.
We also asked about the number of times a person had been admitted to both a residential home and a
nursing home (in the past 6 months). We did not request that participants report the length of any
associated stays in such care home we thereby made the assumption that each time a person reported
they were admitted to a residential/nursing home they had stayed there for three of the preceding
6 months (the average length of stay in a care home has been estimated to be 801 days46 and weNIHR Journals Library www.journalslibrary.nihr.ac.uk
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one admission was reported, it was assumed the participant had been in the home for the whole 6-month
period in question.
Participants were asked whether they had attended a day-care centre in the past 6 months, and if they
had, how many times per week they attended. The number of reported day centre attendances per week
was assumed to apply to all weeks in the 6-month period in question.
Participants were asked to report the number of times (in the past week) they had home help or a visit
from a community care assistant, and how long that person stayed. We requested that participants report
the average time per visit. If the average time per visit was not reported, the average time per visit for
other respondents (who reported both the number of times and the accompanying average time per visit)
was applied to each visit that was reported but had no accompanying time per visit. Additionally, some of
the responses were higher than what we considered to be a possible visit length. For example, one
participant reported 28 visits and a visit length of 960 minutes (16 hours). This equates to more hours than
there are in a week. We thereby assumed that this participant, and all others for whom the product of the
number of visits and the associated time was greater than the number of hours in a week (a total of four
participants at 6 months and ﬁve participants at 12 months), had misinterpreted the question and reported
the total length of contact in the week, rather than the average per visit. Thus for these participants the
reported visit length was assumed to be the total for the whole week. Again, it was assumed that
the number of visits/hours reported for the week in question applied to all weeks in the past 6 months.
In line with the therapist intervention, the associated travel time for each home help visit was assumed
to be 12 minutes, with a travel cost of £3.23 per visit.
Participants were additionally asked how many times they had received help from someone they lived
with, in the past week and the average associated length of time. They were also asked to report the level
of such help from people they do not live with. In both these questions, we requested that people report
the average length of time (per visit) for the help they received. If the average time per visit was not
reported, the average time per visit for other respondents (who reported both the number of times and
the accompanying average time per visit) was applied to each visit that was reported but had no
accompanying time per visit. Also, for some participants, the product of the number of visits and the
associated time was greater than the number of hours in a week (with regard to someone they lived with
this occurred for a total of two participants at 6 months and two participants at 12 months, and for
people they do not live with this occurred for one participant at 6 months). We thereby assumed that
these participants had misinterpreted the question and reported the total length of contact in the week,
rather than the average per visit. Thus for these participants the reported visit length was assumed to be
the total for the whole week. Again it was also assumed that the number of visits/hours reported for the
week in question was equivalent to the average per week across all weeks in the past 6 months. Within
both these questions, participants were asked whether the person who provided the help had had to take
time off work to provide this help. In order to provide an estimate of lost productivity, a cost was only
applied to the total number of hours they were estimated to have received (both for people they live with,
and do not live with) if they reported that the person that provided the care had to take time of work to
provide such care. In this case, the average hourly earnings47 was applied to these times, consistent with
the human capital approach.48 However, as the costing of such care is sometimes considered
controversial,49 these costs are also reported separately to the aforementioned NHS and PSS costs.
Participants were asked to report if they had Meals on Wheels and, if so, the number that they had
received in the past week, and, if they paid for them, the amount they cost. Meals on Wheels that were
not reported to be paid for by participants were assigned a previously estimated unit cost50 and classiﬁed
as a PSS cost. The costs for those who reported that they paid for them themselves were classiﬁed as
patient-borne costs. Again, it was assumed that the number of meals reported for the week in question
was equivalent to the average per week across all weeks in the past 6 months.37
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38Participants were also asked to report any equipment they had bought, or been given, to help with a
health problem and, if so, to state the equipment, who paid for it (the participant/social services) and the
cost of the item. Items that were not reported to be paid for by social services were classiﬁed as a patient-
borne cost. When a cost was not stated, where possible, previously estimated unit costs were assigned to
items (where these were taken from, e.g. Curtis et al.42). When a unit cost for an item could not be
identiﬁed, or the type of item was not reported, either the cost of what was considered to be a similar
item or the average cost of all items for which a unit cost was identiﬁed was assigned to the item in
question. This question did not specify the time frame over which it was interested in equipment
purchases; consequently, even although all other questions speciﬁed the previous 6 months, it is possible
that some of the reported items may have been purchased before the participant joined the study. The
potential impact of this was reduced, however, as the equivalent annual cost of equipment purchases was
calculated,48 for which the discount rate was assumed to be 3.5% per annum and the lifespan of the
equipment was assumed to be 7 years.Categorisation of costs
The above enabled a cost to be assigned to each of the resource-use questions. These were then
categorised, as follows, where all costs relate to the 12-month post-intervention period: the costs
associated with health professional or home help visits; visits to accident and emergency, walk-in centres,
outpatients, day centres; and admissions to hospital, residential homes and nursing homes.
Meals on Wheels and equipment, for which the participant did not pay, were summed to estimate other
NHS and PSS costs. Table 17 provides details of the resources monitored within each question. These were,TABLE 17 Description of the costs associated with the intervention and control
Resource item Level of resource use
Associated
unit cost (£)
Associated
total cost (£)
Per-participant
cost (£)
Provision of training 35.75 hours of (central)
trainer time
44.74 per houra 1599.59
Associated travel costs
(800 miles)
0.54 per milea 432.00
14 hours of cascade
training
30.78 per houra 430.92
Receipt of training 62 hours 30.78 per houra 1908.38
Associated travel costs
(900 miles)
0.54 per milea 486.00
Overall training cost 4856.89 16.92
Therapy contacts Therapist time
(mean = 6.76 visits)b,c
30.78 per houra 125,058.31
Associated travel costs
(12 miles per visit)
0.54 per milea 6257.15
Supervision meetings 1 per month (over
18 months) in each of
the 15 sites
38.00 per meeting 10,153.09
Overall intervention cost 146,325.44 509.84
Control visit 1 visit, 1 hour in
durationc
34.78
Incremental cost of the
intervention
475.07
a Based on Curtis et al.42
b Average contact time equals 84.61 minutes with 12 minutes’ travel.
c Costs for more than one therapist have been included, if applicable.
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analysis). The costs associated with help from people they live or do not live with were added together to
provide an estimate of lost productivity. Similarly, the costs associated with Meals on Wheels and
equipment, for which the participant did pay, provided an estimate of the costs borne by the patient.
Finally, overall costs were estimated by the summation of intervention costs, other NHS and PSS costs,
lost productivity and patient-borne costs.
Overall and incremental costs
For each of the aforementioned cost categories, the mean incremental cost of the intervention (over the
12-month follow-up period) was calculated by subtracting the mean cost for the control group from
the mean cost for intervention group.Measuring outcomes
To estimate the impact on health-related quality of life, participants were asked to complete the EQ-5D51
at baseline, 6 and 12 months post randomisation. The EQ-5D has ﬁve questions, through which the
respondent is asked to report the level of problems they have (no problems, some/moderate problems, and
severe/extreme problems) with regard to mobility, self-care, usual activities, pain and anxiety/depression.30
The three-level version of the EQ-5D (EQ-5D-3L) was used. Responses to these ﬁve dimensions are
converted into one of 243 different EQ-5D health-state descriptions, which range between no problems
on all ﬁve dimensions (11111) and severe/extreme problems on all ﬁve dimensions (33333). A utility score
(a scale where death = 0 and full health = 1) was assigned to each of these 243 health states using the
York A1 tariff52 (associated EQ-5D scores range between –0.594 and 1.00). Completion of the EQ-5D
enabled a cost–utility analysis to be undertaken, in which the beneﬁts of different health-care treatments
can be compared on a common utility scale.53 The area-under-the-curve method53 was used to estimate
the mean quality-adjusted life-year (QALY) gain/loss over the 12-month trial period for both groups.
Within these QALY calculations, those who died within the study period were assigned a utility score of ‘0’
upon death.
In a similar way, responses to 11 of the questions on the SF-3654 were used to estimate a score on the
SF-6D.25 The SF-6D is composed of six dimensions (physical functioning, role limitations, social functioning,
pain, mental health and vitality), which have between four and six levels. A non-parametric model (which
uses Bayesian methods)55 was used to estimate SF-6D health-state utility values for each of 18,000
potential health states (associated SF-6D scores range between 0.203 and 1.00). QALY gains/losses were
again calculated, as for the EQ-5D, and those who died were, again, assigned a score of ‘0’.
As the EQ-5D and SF-6D utility measures are based on both different health-state descriptions and use
different valuation techniques, they could produce different utility scores for the same group of patients.
This study therefore sought to explore the impact the choice of utility measure had on estimates of
cost–utility, as further research has been argued to be necessary in this area.56 It should be noted,
however, that NICE currently recommends that the EQ-5D be used within the reference case analysis,39
and thus this constituted our main base-case analysis (see below).Base-case analysis
Multiple regression57 was used to estimate the mean cost difference (incremental cost) and mean QALY
difference (incremental effect) between the two treatment groups, where both the overall cost and the
mean QALY gain/loss over the 12-month period were adjusted for baseline utility, age, sex and residential
status (the last three variables were chosen as they were the only participant variables that were available
for all participants who had complete cost and QALY data). The mean QALY difference was estimated for
both the EQ-5D and SF-6D. In line with the clinical analysis, within the base-case analyses only participants
with complete cost and QALY data were included.39
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40Cost-effectiveness
After checking that dominance was not apparent (this would occur if one intervention were less costly and
more effective than another),53 the incremental cost per QALY gain (ICER) associated with the intervention
was calculated (mean incremental cost/mean incremental QALY gain). In line with NICE guidance44 we
compared the ICER to a cost-effectiveness threshold (λ) of £20,000 per QALY.Decision uncertainty
The bootstrap technique58 (with 5000 replications) was used to estimate the 95% CIs surrounding
the incremental cost and incremental effect (where appropriate), the 95% CI was estimated
using the percentile method.59 As the ICER has the potential to be misinterpreted,60 we also estimated the
incremental net beneﬁt (INB) (and associated 95% CI) at a threshold of £20,000 per QALY. A negative INB
would indicate that the intervention was not cost-effective at this threshold. The bootstrap samples were
also used to estimate the cost-effectiveness acceptability curve (CEAC) for each group, where the CEAC
depicts the probability that an intervention is cost-effective at different levels of λ.61 The probability of the
intervention being cost-effective was speciﬁcally estimated at the (λ) of £20,000 per QALY.Sensitivity analysis
We assessed how robust conclusions were to the following changes:
1. Received six or more intervention visits:
i. On the assumption that those who received more visits might beneﬁt more, here, only intervention
participants who were included in the base-case analysis and had six or more visits were included in
the analyses. The control group was the same as for the base case.
2. MI:
i. To impute missing data in this data set, we used regression methods to predict these values based on
their relationship with other covariates (age, sex, residential status, cost and utility data). Imputation
took place in 10 cycles, the estimates from which were then pooled and calculated using Rubin’s
Rules. All MI was performed for incomplete cost and outcomes components at the patient level using
the mi impute mvn procedure in Stata 11.
3. Winsorising:
i. As outlined previously, for the clinical data, we replaced data values below the 5th percentile with
the 5th percentile value and to data values above the 95th percentile with the 95th percentile value.
This was applied to the cost and QALY data for those individuals included in the base-case analysis.
One reason for undertaking this analysis was the wide variation in some of the resource-use data that
was reported, e.g. home help. This approach reduces the inﬂuence of extreme values and may
partially test whether or not some of the assumptions in relation to these costs were correct.
ii. Different cost perspective.Results were re-estimated from an overall cost perspective.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Costs
Training
Training costs were as follows (see Table 17). Total trainer time associated with group training (provided to
eight sites at once) and individual training (to a further nine sites) was estimated to be 35.75 hours
(including travel and preparation). Total trainer time for the cascade training (provided at seven sites) and
time for receipt of all types of training (including travel) was estimated to be 14 and 62 hours, respectively.
Trainer (group and individual) unit costs were estimated to be £45, compared with £31 per hour for
cascade trainers and trainees. The total cost of all staff time associated with all aspects of training was
thereby estimated to be £3938.89, with the addition of £918 for travel costs to sites (eight people
attending the group training and nine site visits, with an average return trip of 100 miles), this gave a total
training cost of £4856.89. Apportioned across all 287 participants in the intervention arm, this equates to
£16.92 per participant.Therapy contacts
All participants received a baseline visit. This was the only contact for those in the control arm and the
associated mean total cost (staff time and travel costs) was estimated to be £34.78 per participant
(see Table 17). (It should be noted that one participant in the control received two intervention visits – no
associated intervention costs were assigned to this participant as this was provided in error.) The costs
associated with therapist visits to those in the intervention arm are summarised in Table 17. On average,
participants in the intervention arm received a further 6.76 visits (range 0–12). The associated time for
these visits was recorded for all but 1 of the 1939 visits, for which the mean time was 96.61 minutes
(assuming a travel time of 12 minutes, this equates to an average contact time of 84.61 minutes). This
mean value was assumed to apply to the visit where the time was not recorded. Each supervisor meeting
was estimated to cost £37.87, one per month per site were estimated to occur across the 18-month
period for which the intervention was provided. This equates to a total cost of £10,153.09 across all sites:
£5.24 per visit undertaken. Visit, preparation and records’ write-up time were each costed at £31 per hour
and, after adding the supervision cost (£5.24 per visit) and travel cost (£3.23 per visit), the mean cost of
the intervention was estimated to be £492.92 per participant, where this increased to £509.84 after
including the aforementioned training costs. The incremental intervention cost, compared with the
baseline visit provided to the control arm (cost £34.78) was thereby estimated to be £475.07
per participant.Other NHS and Personal Social Services costs
The 6-month resource-use questionnaire was returned by 259 out of 287 participants in the intervention
arm and 235 out of 281 in the control arm; the numbers at 12 months were 230 and 209, respectively.
However, not all returned questionnaires were fully completed and we accordingly note the response rate
to each of the individual questions in Table 18. (Note: A response was required at both 6 and 12 months
in order for the 12-month cost to be estimated.) Mean levels of resource use, relating to each of the
cost questions, are shown in Table 18, in which it can be seen that participants frequently visit health
professionals, outpatients and receive home help. The unit costs applied to the reported levels of resource
use are summarised in Table 19. Subsequently, costs were categorised into the following groups: other
NHS and PSS costs, total NHS and PSS costs, lost productivity, and overall costs (see Table 18 for details of
which questions contributed to each cost category). The mean cost (per participant) for the intervention
and control groups, for each of these cost categories, are presented in Table 20, in which it can be seen
that, for each of these cost categories, the mean costs are estimated to be higher for the intervention
group. It should be noted, however, that the number of participants for whom complete cost data are
available falls when a broader perspective is taken. This can be explained largely by the fact that responses
are required to a greater number of resource-use questions.41
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TABLE 18 Estimated levels of resource use and associated cost (mean per participant over the 12-month period)
Item
Respondents, n Levels of resource use Mean cost (£)
Intervention Control Intervention Control Intervention Control
No. of health professional
visitsa
212 202 8.81 5.53 626.78 413.45
No. of hospital admissionsa 218 201 0.63 0.43 938.25 1078.05
No. of A&E visitsa 217 203 0.48 0.58 49.82 61.09
No. of walk-in centre visitsa 209 192 0.18 0.28 7.26 11.32
No. of outpatient visitsa 200 189 2.36 3.06 346.92 449.56
No. of admissions to
residential homesa
208 186 0.22 0.16 652.31 451.58
No. of admissions to nursing
homesa
207 187 0.05 0.09 451.55 649.79
No. of day centre visitsa 201 190 0.68 0.93 633.31 871.96
No. of home help visitsa 199 177 7.80 5.07 7097.08 6599.36
Hours of help from someone
they live withb
188 177 6.68 6.50 412.28 398.83
Percentage who took time
off work
202 193 4.00% 3.10%
Hours of help from someone
they do not live withb
212 196 1.51 1.49 154.38 32.27
Percentage who took time
off work
215 195 1.90% 3.10%
Meals on Wheels 208 193 0.09 0.12
Cost when the participant
did not paya
5.25 14.55
Cost when the participant
paidc
5.38 14.55
Equipment 208 194 84.10% 77.80%
Cost when the participant
did not paya
Cost when the participant
paidc
624.48 745.66
A&E, accident and emergency.
a Relate to other NHS and PSS costs.
b Relate to estimated carer input (lost productivity costs are applied only when time off work was reported).
c Participant-borne costs.
ECONOMIC EVALUATION: METHODS AND RESULTS
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TABLE 19 Unit costs attached to different items of resource use, with associated source
Item Estimated unit cost (£)
GP visita 30.00
Practice nurse visita 9.90
District nurse visita 13.20
Dietitian visita 9.30
Physiotherapist visita 9.60
Occupational therapist visita 9.60
Social worker visita 11.40
Speech and language therapist visita 9.30
Cost per day in hospital (non-elective inpatient excess bed-day cost) 246.0045
A&E visit (non-admitted cost used) 106.0042
Walk-in centre visit (non-admitted cost used) 41.0042
Outpatient visit 147.0042
Admission to residential home (weekly cost) 497.0042
Admission to nursing home (weekly cost) 719.0042
Day centre (per visit cost) 36.0042
Home helpb (cost per hour of face-to-face contact) 22.0042
Help from someone they live with (who took time off work) (cost per hour) 14.6562
Meals on Wheels (where the participant did not pay) 6.0042
Equipment:c
Grab rail 94.0042
Hoist 934.0042
Alarm system 380.0042
Stair lift 2611.0042
Concrete ramp 646.0042
Wheelchair 402.0042
A&E, accident and emergency.
a Costs presented are for a visit to the professional by the participant (hourly employment costs were taken from Curtis:42
see Methods for assumptions used to estimate unit costs). Estimated home visits costs, and the costs associated with
visits to other health professionals, are available from authors.
b Assumed to cost equivalent to a home care worker.
c Participants were asked to report the cost of equipment if they paid for it themselves. Examples of unit costs applied to
equipment reported to be provided by social services are provided.
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From the perspective of the NHS and PSS, the mean cost (per participant) was estimated to be
approximately £2500 higher for the intervention group than the control group, and mean overall costs
were estimated to be approximately £4500 higher. The conﬁdence intervals in Table 20 do show,
however, the large variations in relation to these ﬁgures. It can also be seen that the mean cost of the
intervention is small in relation to other NHS and PSS costs incurred by this population group.Outcomes
The mean baseline 6- and 12-month EQ-5D scores for both groups are shown in Table 20. It can be seen
that in the intervention arm, compared with baseline, the mean EQ-5D scores were lower by 0.022 at
12 months. Conversely, the mean EQ-5D score for the control group improved by 0.022 over the same
period. Based on those who had complete EQ-5D data at baseline, 6 and 12 months, the mean QALY gain
was 0.396 for the intervention group and 0.429 for the control group. The baseline score, however, was
slightly higher for the control arm (we adjust for this in subsequent analyses). With regard to the SF-6D,
both groups had slightly lower mean scores at the 12-month follow-up point than at baseline (see
Table 20). The mean QALY gains were also similar in both groups.Base-case analysis
For those who had both complete cost and QALY data (based on the EQ-5D), after adjusting for
covariates, the mean incremental cost (total NHS and PSS cost) was estimated to be £3413.75
(95% CI –£448.43 to £7121.00), with an incremental QALY gain of –0.027 (95% CI –0.060 to 0.007) (see
Table 21 for details of the numbers included in the analysis). An ICER was not calculated for this group, as
the intervention was, on average, both more expensive and less effective. With regard to the SF-6D, the
incremental cost was £2393.38 (95% CI –£2017.58 to £5999.37), with an incremental effect of –0.003
(95% CI –0.016 to 0.006). The intervention was thereby estimated to be dominated by the control group.
The associated CEACs are shown in Figures 5 and 6, for the EQ-5D and SF-6D, respectively. The probability
that the intervention was cost-effective was < 20% at all cost-effectiveness thresholds.
Sensitivity analysis The results of each of the sensitivity analyses are presented in Table 21. Within all these
analyses it can be seen that the 95% CI surrounding the INB is never wholly positive. Thus, in line with
the base-case analysis, we are unable to conclude that the intervention is signiﬁcantly (p < 0.05) more
cost-effective at a λ of £20,000 per QALY. Indeed, the INB was more commonly negative and there
was no suggestion that the intervention was more cost-effective for those who received six or more
intervention visits.
One additional point to note is that although there is some consistency in these results (at a λ of £20,000
per QALY the 95% CI surrounding the INB is never wholly positive), there is some variation in the mean
estimates. For example, in the base-case analysis (based on available data), compared with control, the
intervention is estimated to be (on average) more costly and less effective. Conversely, when we look at
the results based on MI, the intervention is estimated to be (on average) less costly and more effective.
As such, at a λ of £20,000 per QALY, there is wide variation in the probability of the intervention being
cost-effective (see Table 21).
Summary In the base (complete)-case analysis, the mean incremental cost of the intervention (total NHS
and PSS costs) was estimated to be £3413.75 (95% CI –£448.43 to £7121.00), with an incremental QALY
gain of –0.027 (95% CI –0.060 to 0.007), according to the EQ-5D. This suggests that the intervention was
not cost-effective. The sensitivity analyses tended to support this conclusion as, at a cost-effectiveness
threshold of £20,000 per QALY, the CIs around the mean INB were never wholly positive.45
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DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29Chapter 5 Qualitative study: methods and resultsIntroductionThis chapter presents the aims and methods of the qualitative study, which explores the meaning of
conﬁdence after stroke, as described by the intervention participants. The principles of interpretive
phenomenology analysis (IPA) were applied in both the collection and analysis phases of the study,
resulting in broadening our understanding of the meaning of ‘conﬁdence’ after having a stroke.AimsThe aims of the qualitative study were to answer the following questions:
1. How does having a stroke affect self-conﬁdence?
2. How do stroke survivors describe their experiences of regaining conﬁdence after stroke?
3. What do stroke survivors identify as barriers to regaining conﬁdence?Sampling strategy and recruitmentAll participants were selected from the ‘getting out of the house’ trial as IPA recommends that participants
should be experts in the phenomenon being studied. ‘Lack of conﬁdence’ was cited in the single centre24
as a reason for not getting out of the house, so it was felt that participants in the multicentre study were
likely to have a perspective of individual conﬁdence. To achieve maximum diversity a purposefully selected
sample, ranging from no symptoms at all after stroke to severe disability, were recruited. The Modiﬁed
Rankin Scale63,64 was used to identify this range, which was considered reﬂective of the stroke population.
Ten potential participants were contacted by the qualitative researcher and invited to consent.
All 10 participants agreed to be interviewed and a willingness to tell their stroke story was observed.Participant sample characteristicsThe sample was drawn from two trial sites for geographical convenience. Five men and ﬁve women were
included in the study. One presented with no symptoms after stroke, three with slight disability, four with
moderate disability, and two with moderately severe disability. Five lived alone, three lived with their
spouses, and the remaining two lived with their spouses and children. Nine participants were of white
British origin and one was of black Caribbean origin.Data collection: interviewing approachSemistructured, in-depth interviews that sought the perceptions of stroke survivors were the favoured
method of data collection. It is advocated that in-depth interviews are the best ways to attain rich,
comprehensive, ﬁrst-person experience.65 Interviews were conducted in participants’ own homes, which
aimed to provide a safe and familiar context. A reﬂective journal to capture feelings and thoughts
throughout the interview process was maintained.49
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QUALITATIVE STUDY: METHODS AND RESULTS
50An interview guide was developed for two pilot interviews, and improved for next eight interviews. This
proved a useful tool for steering the interview. However, the ﬁrst interview question elicited the majority of
the data. ‘Tell me about your stroke, what happened when you had your stroke?’ The natural responses
and ﬂow of the interview as a result of this question, enabled participants to articulate meanings around
losing conﬁdence and regaining conﬁdence, through their experiences, in their own words. Ten completed
interviews were transcribed verbatim, using digital dictation transcription software. Transcripts reﬂected
words, laughter, signiﬁcant pauses and silences.Data analysisThe framework for the data analysis was selected on the basis of the methodology. A six-stage process
following IPA principles was chosen in favour of using a computer software package, such as, NVivo. IPA is
interested in understanding the content of the data, rather than measuring frequency of words, or
imposing a more tapered approach to the data. Therefore, principles advocated by an IPA expert65 were
applied, and six-stage analysis process followed:
1. Reading and re-reading the data, making initial notes in margins.
2. Initial noting, taking one participant’s data at time, applying no rules and, therefore, making this stage
as exploratory as possible.
3. Key data were then captured during the next analytical stage and the development of emergent
themes progressed.
4. Stage four involved looking for patterns and connections across emergent themes and interpretation
within these data was applied.
5. Stage ﬁve involved a repetition of stages 1–4 across all participants.
6. The ﬁnal stage was a process that aimed to capture the essence of each individual story and also seek
out differences and similarities within the data.
This process was audited by an experienced researcher in order to verify that all stages had been followed,
adding to the trustworthiness of the data ﬁndings.Presentation of the ﬁndingsThe ﬁndings section follows with six key emergent themes that describe the phenomenon of conﬁdence
after a stroke. Although each participant provided a unique account, surprisingly, the emergent themes
identiﬁed shared many concepts, despite difference in stroke impairments and personal context. The
themes represent the essence of ‘conﬁdence’ for the participants.
As there is an argument for the deﬁnition of conﬁdence being different dependent upon who is asked,66
embedded in the interview data were a direct question about what conﬁdence meant to participants in
this study, conducted on the basis of providing some introductory data. Box 1 illustrates these ﬁndings:NIHR Journals Library www.journalslibrary.nihr.ac.uk
BOX 1 Examples of what confidence means
What does confidence mean to you?
Bob 12.16 ‘Going out and doing what you want to do’
Ryan 9.13 ‘Conﬁdence to me, in relation to this, is doing something you want to do, when you
want to do it.’
Mick 26.5 ‘It’s some way of going back to normal life. Being conﬁdent to leave the house, walking again,
trying to talk erm . . .’
Ted 5.14 ‘Phewww God [quietly] [long pause] I’m thinking. Difﬁcult one and I can’t really answer
the question.’
June 22.17 ‘Conﬁdence [long pause] . . . Can you say that again for me please?’
Alison 14.10 ‘I don’t know, I’ve never got it back completely. Scared to go out because I thought I was
going to make a fool of myself . . .’
Leon 16.2 ‘I lose a lot since my strokes. Thing is, conﬁdence is something I believe in, but you know, like my
walking, for instance, how can I explain it? I walk inside here because the door is there. I hold on to there,
right? But if I get outside, there’s nothing to hold on to . . .’
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29To three of the participants, conﬁdence is about doing, choice and engaging in everyday activity.
Two participants struggled with its deﬁnition in this direct context; however, were able to deﬁne the
impact of conﬁdence elsewhere in the data. A further two immediately describe losing their conﬁdence
and to these participants, conﬁdence has a negative connotation and relates to fear and safety.
Further analysis and interpretation is embedded within the themes that follow.‘Robbed of life’The notion that having a stroke questions who you are was articulated by many of the participants. Skill
loss, decreased competency and lack of engagement in activities were described as contributing to a
general feeling of being a lesser person, and uncertainty as to how competent one feels after
having a stroke.
June illustrates a perceived link between activity and identity, associating what she does, to who she is:© Que
Health
provid
addres
Park, SCan’t walk far, can’t play badminton. I’m just a totally different person.
June 11.9The data indicated that the participants’ sense of competence after stroke was challenged. Not feeling
able to engage in previous, often familiar, skills or roles, such as ‘washing the pots or walking the dog
[laughter]’ (Ryan 9.17) contributed to loss of conﬁdence. However, embedded in the data, successfully
regaining skills contributed to increased competence and self-beliefs, resulting in a regaining of conﬁdence
in their abilities.51
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QUALITATIVE STUDY: METHODS AND RESULTS
52Fear of having another strokeSome element of fear was identiﬁed by all participants; however, the impact of fear on losing conﬁdence
and also regaining conﬁdence varied between participants. The ﬁrst fear that participants described was
the fear of having another stroke:NIHR. . . Every time I had a headache, I feel lightheaded, my leg hurts, there is always that question, erm,
maybe [laughs], just kinda maybe.
Mick 13.2. . . you never know what is going to happen tomorrow.
June 17.6. . . I am going to have another stroke? – So that was on my mind.
Ted 12.1. . . alert to any changes in my body at all, you know? Anything, because I think now, perhaps this is
going to be the big one, you know.
Barbara 19.4Participants described living with this fear and how it prevented them from participating in everyday
activities. Mick experienced a second stroke, and articulates this period, as:cementing the fear in my brain
Mick 12.14.This second event had a huge impact on his recovery and conﬁdence to leave the house, and resulted in a
period of avoiding going out. For Mick, conﬁdence has been about gradually overcoming this fear to
enable him to regain conﬁdence, to enable him to engage in what he chooses. He describes this process
as gradual, and experiences ‘good and bad days’, suggesting conﬁdence has a temporal component.
Similar meanings evolved from June, indicating that fear is a factor that underpins her participation in
going out of her home environment. Ted’s fear of having another stroke directly impacted on feeling
anxious in crowds, and cites shopping centres as a place that held a particular anxiety. Avoidance was his
coping strategy.Fear of going out/social conﬁdenceFear of going out and being socially active after a stroke was a major concern voiced throughout the
interviews by all of the 10 participants. Some were able to address their fears early on in their recovery,
whereas others found it more difﬁcult and, years after recovery, have not fully been able to achieve this,
resulting in an avoidance of going out and a general sense of a diminished social lifestyle and
social conﬁdence.I don’t know whether it was that I was self-conscious about the fact that I was struggling with my
wheelchair, or struggling to walk, people looking at me or not, but . . .
Ryan 15.13Eventually, as your confidence grows, your bubble starts to get bigger, erm, the garden, then the
street, then the shops, eventually.
Mick 19.2Journals Library www.journalslibrary.nihr.ac.uk
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avoiding activities that caused fear.
Although participants acknowledged huge fears about going out and social interactions with others,
coupled with this fear was an immense desire to overcome these fears. For example, Ryan states ‘I had
coping strategies pinned all over the wall’ (15.17). It is clear from the descriptions evolving from
participants that conﬁdence improves over time. Nevertheless, for some this is a slow process that may
never be fully resolved. In summary, fear has a huge impact on daily activities and lives after stroke, often
linked with low self-efﬁcacy and avoidance of engagement in tasks, roles and events.Team conﬁdence/collective efﬁcacyThe inﬂuence of signiﬁcant others, as touched on within the previous theme, impact on levels of
conﬁdence. Although, not surprisingly, participants described positive inﬂuences as enablers to regaining
conﬁdence and conversely, negative inﬂuences act as barriers, the negatives and positives are not always
overt in the context of participant’s daily lives and often require a period of reﬂection. Inﬂuence from a
supportive friend, coupled with self-determination, one participant’s conﬁdence levels increased to a point
that enabled her to pursue ambitions she would not have considered prior to her stroke:© Que
Health
provid
addres
Park, SHe [Friend] said ‘Let’s go to Cyprus.’ I said I’m not going to CYPRUS [increased tone: laughter] – you
see I’ve never flown before, you see, so we flew to Cyprus.’ [laughter]
Freya 41.7Conversely, another participant describes her family’s ‘help’ as being restrictive:They don’t let me, well, I can’t go out of the back door without someone going with me.
Helen 11.13Independently mobile and competent, this participant describes feelings of inadequate opportunities, to
fulﬁl her potential. A message underpinning success for another participant, fundamental in gaining the
conﬁdence to mobilise outside after stroke, was a physiotherapy intervention:. . . the best thing that happened to me, and the most erm, useful one to me, was being referred
to a physiotherapist.
Barbara 11.1Initially, unable to mobilise to the kerb without fear of falling, and apprehensive about physiotherapy
intervention, she described factors such as humour, empathy, positive reinforcement and encouragement
as the components that led to a positive treatment outcome. Keen to feedback her perceived success,
once her treatment was completed, she describes telephoning the physiotherapist who delivered
her treatment:And I said to him, I can walk into town now, I can walk as far as Marks and Spencer’s, and he said ‘I
can’t believe it, that’s wonderful.’ But I can, and I can now get as far as the shopping centre.
Barbara 24.19Increased conﬁdence after stroke appears to have a component that is inﬂuenced by the actions of others,
in addition to the actions of self.53
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54Role conﬁdenceParticipants perceived that ‘loss of roles’ had an impact on decreased conﬁdence.
Loss of a driving role was considered hugely important to two participants and both these participants
reported being more conﬁdent and active once they were able to resume their driving role. A gardening
role, for another participant, despite a memory issue since stroke, still enables her to participate in an
enjoyable role:NIHRCouldn’t remember when they were supposed to flower, if they flowered and all those kind of things,
but it didn’t bother me.
June 26.38Conﬁdence in meaningful roles appeared to make a difference to all participants. Increased conﬁdence
was evident when participants were motivated to engage in similar roles that were important pre-stroke or
when they had found replacement roles that generated similar beneﬁts.‘It’s not I can’t, it’s I can’: skill masteryParticipants illustrated many examples of how relearning skills and becoming successful in mastering a new
skill as being one of the biggest factors in regaining conﬁdence. Some participants were slow to start to
regain skills and gave examples of how they avoided activities that evoked fear and uncertainly. Others
described being successful in a particular task or skill, which enabled them to believe they could increase
their range of activities. This correlates closely to the self-efﬁcacy theory. Participants who described
themselves as conﬁdent pre-stroke tended to also describe a higher level of self-efﬁcacy. This process is
best described by participants:Once I could get up and take a step, I knew I could do it, I know it seems daft.
Ryan 10.13Gradually your confidence builds. The first time is always kinda nervous [pause] well it is for me
now anyway.
Mick 31.4Eventually, started cooking for myself, I thought, oh I can manage to do different things instead of
using the microwave all the time.
Freya 30.2Once participants began to succeed and achieve by repetitive practice, their motivation and conﬁdence
levels improved enabling them to move on to other activities. Practising skills was described as increasing
competence and conﬁdence; nonetheless, when practice did not improve skill, participants described
becoming frustrated and found that their conﬁdence decreased.‘Inner strength’ and conﬁdenceThe ﬁnal theme examines how the phenomenon of conﬁdence is associated with other components of
psychological distress. For three participants, episodes of depression were prevalent after stroke. Other
participants identiﬁed periods of low mood, and most had some experience of anxiety. Low conﬁdence
was cited as underpinning their daily lives throughout these experiences. One participant stated being
depressed ‘makes you feel a bit useless’ (Helen 23.7) and another describes similar sentiments: ‘Some days
I feel helpless, alone’ (Mick 20.10). Interestingly, a participant describing herself as having very lowJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29self-esteem and a history of depression prior to her stroke, perceives she has a raised self-esteem and
higher self-efﬁcacy beliefs as a result of her stroke journey – ‘an inner strength almost that I didn’t realise
I had’ (Freya 35.19). She illustrates this by telling us:© Que
Health
provid
addres
Park, S. . . the main barrier is within yourself, I think. The biggest one is within yourself, you think I can’t do
that and you think about it and you think I’ll try. But you don’t try very hard because you think you
can’t do it, you see? So you have to try a bit harder and then you realise you can do it, you know.
So often the biggest barrier is within yourself.
Freya 50.11Although focusing on doing and achieving, a process that increased self-efﬁcacy beliefs was experienced
by some participants; others clearly described it being a struggle to achieve the same:I know in the back of my head there was something telling me you had to try and do these things,
because, if you don’t June, you’ll just sit and vegetate, and life is too important for that.
June 23.17As soon as I see a crowd of people I start to lose my balance. Go ‘hold me’ someone hold me [panic
in tone of voice].
Alison 15.1This latter quote suggests that success is about more than skill and ability. Alison was able to illustrate
how negative thinking can often lead to an unsuccessful outcome.
Reinforcement from others suggests that another participant is not enough on its own: ‘Everybody kept
saying “Oh, you are doing so well” but it wasn’t enough for me’ (Helen 8.2), suggesting that positive
reinforcement does not compensate for intrinsic worth. The data signify that participants’ conﬁdence levels
have been affected by having a stroke to varying degrees. In seeking to explore the meaning of conﬁdence
after stroke, connections and interrelations between themes were identiﬁed, and similarities and
differences in the data and between participants were disentangled, conﬁrming that the phenomenon of
conﬁdence is multifaceted and complex.Summaryl Loss of conﬁdence after stroke is a common experience.
l The impact of stroke is truly realised only when a stroke survivor begins to establish routines, and
continues with his/her life. Loss of former roles and a lack of competence when trying to engage in
previously familiar tasks is prevalent in the early stages of stroke recovery, often linked to questioning
self-identity.
l Gradually regaining skills and re-establishing identity appeared to increase conﬁdence over time.
l Fear was identiﬁed in this study as a huge barrier to being conﬁdent to do the things participants
wanted or needed to do.
l Avoidance behaviours were evident and described in the data, lowering participant’s self-efﬁcacy
beliefs, further limiting the opportunity to become more competent and conﬁdent in activities
and tasks.
l Social conﬁdence, fear of social interactions and stigma, was also embedded within the study’s
ﬁndings. Gracey et al.67 argued, if these issues fail to be resolved, a poor psychosocial outcome long
term after stroke is realised.
l Strategies that enable stroke survivors to resolve loss of conﬁdence in social situations should be
considered a necessary treatment component in stroke rehabilitation.55
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56l Conﬁdence in ‘team’ and/or ‘partner’ was evident in the data. Descriptions of encouragement,
patience and positive reinforcement are examples of factors that helped improve conﬁdence and
self-efﬁcacy beliefs.
l Prevention of opportunities for independence and choice of activities resulted in loss of conﬁdence,
control and disengagement during recovery.
l A model to increase conﬁdence in sport, which uses a multivaried framework encompassing
self-conﬁdence, role conﬁdence, partner conﬁdence, cohort conﬁdence, team conﬁdence, coach
conﬁdence and organisational conﬁdence68 might be suitable for stroke patients when trying to
improve outdoor mobility.
l Highlighted in the literature is the concept that physical appearance often impacts on self-conﬁdence;
this was not prevalent in these study ﬁndings.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29Chapter 6 DiscussionKey ﬁndingsStroke patients can become housebound, miserable and in poorer health because they cannot participate
in outdoor mobility.14 This report presents the ﬁndings of a multicentre RCT to evaluate an outdoor
mobility rehabilitation intervention for people with stroke. The intervention under evaluation was a
complex mix of goal setting, practising outdoor mobility (which included walking outside), psychological
support, and provision of information and self-monitoring of outdoor mobility through daily travel
calendars. These calendars were used as an outcome measure. It was delivered by NHS therapists based in
the primary care setting. The aim of the study was to replicate a single-centre study that found signiﬁcant
improvements in outdoor mobility participation when stroke patients were given the intervention by one
highly skilled therapist. It aimed to evaluate whether the results were generalisable to NHS therapists in
different UK locations. In addition, health-related quality of life and cost-effectiveness were measured.
The multicentre study replicated the methodology used in the single-site study. It reached its recruitment
target on time. There was a high rate of follow-up at both the 6-month follow-up (to measure for
an immediate effect of the intervention) and the 12-month follow-up (to assess whether it had a
longer-lasting effect), and 70% of all travel diaries were returned. Stroke survivors and therapists were
keen to take part in the study and although no formal qualitative study was completed to assess
processes, it would appear from the proportion of patients who completed the travel diaries that getting
out of the house is a major issue, even many years after stroke. A total of 568 participants from
15 UK-based sites were recruited over 18 months. The intervention was delivered, according to the
protocol, to 287 participants, by 29 therapists, and was similar to that delivered in the single-centre study.
Outcomes were collected by postal questionnaire and participants were supported, if needed, in their
completion by RAs blind to allocation. The results were analysed using an intention-to-treat analysis, with
the effect of different therapists at different sites being taken into consideration. A small qualitative study
explored how a reduction in conﬁdence might have affected people in the intervention group. The primary
outcome measure used to calculate the sample size was health-related quality of life, as assessed by the
Social Function domain of the SF-36v2. In addition, outcome measures used in the single-centre study –
SWOM, travel journeys, activities of daily living ability and psychological well-being – were completed.
A full economic evaluation was undertaken. This chapter will discuss the intervention, results, strengths
and limitations of the study.Intervention deliveryThe intervention in this trial was developed over a number of years (2000–8), a treatment manual was
produced and the CI taught therapists how to deliver it by a 2-hour training session. The intervention was
a mixture of physical, psychological and planned preparation to achieve getting out of the house.
Therapists were instructed to provide treatments as needed up to a maximum of 12 sessions over a
4-month period. They reviewed and planned their treatments following local protocols.
We consider that the intervention was delivered as per protocol to the majority of participants. We make
this assertion because the intervention was delivered by occupational therapists and physiotherapists or
by supervised rehabilitation assistants 100% of the time. These therapists had been trained to use the
outdoor mobility manual by the study CI. It may have been that the manual was too prescriptive and
did not allow therapists the possibility of providing more treatment sessions, but, owing to research
methodology and ﬁnancial restraints, therapists had to stop treatment after 12 sessions. The ﬁdelity of
treatment checking recorded that 100% of sample indicated that the therapists were delivering the correct57
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58treatment. We have to acknowledge that the ﬁdelity of treatment checklist was not a standardised
assessment owing to a lack of published measurements and that the last question which gave us this
100% rate had not undergone psychometric testing. The participants received a median of seven
rehabilitation sessions with a duration of 3.5 hours. This is similar to that delivered in the single-centre
study (six sessions, duration 4 hours). However, when the range of the intervention sessions was explored,
it was found that approximately equal numbers (20 had one session, 20 had two sessions . . . , 20 had
11 sessions) but 60 participants received 12 sessions. It would appear that some patients may have needed
> 12 sessions to achieve their goal. This could be the reason that nearly one-third did not complete their
rehabilitation to the satisfaction of the therapist. Studies of upper limb rehabilitation suggest that
> 3 hours per day for 30 days is needed to measure an improvement.69
Although the number of intervention sessions was restricted to replicate what might be provided by the
NHS, the content of the intervention had been developed to be person centred and therapists could be
ﬂexible in how it was delivered. Therapists who provided the intervention and participants provided
informal feedback and said they felt it was an appropriate and clinically relevant treatment technique.
The research team have received over 50 requests for the intervention manual and training over the last
3 years. This indicates a real need for an evidence-based outdoor mobility programme. A more recent
study developed a person-centred rehabilitation intervention by asking 132 participants to prioritise their
main goals. The goals stated were mainly related to active recreation, household and community
management, mobility and socialisation, information on stroke and prevention of new strokes, outdoor
mobility and transportation.70Effect of the intervention on health-related quality of lifeThe primary outcome measure of health-related quality of life found no signiﬁcant differences between
the control and intervention group at either the short- or long-term follow-up. The Social Function domain
of the SF-36v2 was used to assess health-related quality of life in this population because the SF-36v2, as a
whole, has been subjected to psychometric testing, used in numerous descriptive and intervention studies,
and can be completed in < 10 minutes by self, proxy, interviewer or telephone.71 This allows comparisons
to be made with other health-care treatments. It includes a range of domains, such as loss of role,
participation away from the home and social inclusion, which are areas that therapists hope to improve
through the type of rehabilitation under evaluation. The Social Function domain of the SF-36v2 consists of
two questions and was completed by most (500) participants out of the original sample (568 participants).
The two questions were:
1. During the past 4 weeks, to what extent has your physical health or emotional problems interfered with
your normal social activities with family, friends, neighbours or groups?
i. (Please tick one.) Not at all/Slightly/Moderately/Quite a bit/Extremely
2. During the past 4 weeks how much of the time have your physical health or emotional problems
interfered with your social activities (like visiting friends, relatives, etc.)?
i. (Please tick one.) All of the time/Most of the time/Some of the time/A little of the time/None of
the timeThis measure was not used in the single-centre study and other trials of rehabilitation using this type of
measure have found similar neutral ﬁndings.72–74
Therapists and participants were concerned about the use of this measure, as they felt that the
intervention aimed to improve outdoor mobility participation and the expectation that it would impact
on social participation was overambitious, especially as the intervention was limited to 12 sessions overNIHR Journals Library www.journalslibrary.nihr.ac.uk
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of reasons: getting to the doctors, dentists, shopping and work, which might not be classiﬁed as an
improvement in quality of life as measured by these two questions. Improvement in outdoor mobility
therefore might not have an impact on health-related quality of life as measured or it might take longer
for the beneﬁts to be realised. We conclude that the results were reliably collected and that the outdoor
mobility intervention delivered in this study did not effectively improve stroke patient’s quality of life as
measured by the Social Function domain of the SF-36v2. We suggest, however, that this is not a reason to
stop outdoor mobility rehabilitation beginning offered to stroke patients. We believe that this targeted
intervention has potential to increase outdoor mobility participation, which we consider an important part
of activities of daily living. In addition, we have to consider whether the control group received a treatment
that may have a role to play with patients for whom there have been many years since their stroke.
We present our reasoning below.Effect of the intervention on outdoor mobility participationThe main ﬁnding of the single-site study24 was that the intervention group were signiﬁcantly more likely to
participate in outdoor mobility. This positive outcome was considered an important clinical beneﬁt. Stroke
patients have complained about becoming housebound, isolated and miserable. This single-centre study
demonstrated that, with a relatively short period of rehabilitation, patients could be taught how to
increase their outdoor mobility. This included walking, using buses and electric pavement scooters. The
outcome was assessed using two measures: SWOM participation and number of journeys. In the
multicentre study, the intervention participants were no more satisﬁed with their outdoor mobility
participation than the control participants at both 6 and 12 months but they were more likely to make
journeys than those participants in the control group. However, this difference in number of journeys was
apparent only when the data were adjusted to take the therapist effect into consideration. It appears that
some therapists are able to produce these signiﬁcant results, whereas others are not. We do not know
whether it was the way the intervention was delivered, the characteristics of the participant or the skills of
the therapist that produced this signiﬁcant result. This outcome was measured using participant-reported
journeys, which included outdoor walking, by travel diaries collected each month by post. Participants
were taught how to use the calendars at the baseline visit by the RA and were encouraged to send them
back using pre-paid envelopes. We feel that this was an objective measure as participants had to record
each time they left the house and went somewhere. All participants completed the diaries and, as 70% of
all travel diaries were returned, we feel this is a reliable outcome.
The results replicate those found in the single-site study, for which intervention participants took
signiﬁcantly more journeys at both 4 and 10 months. We need further research to explore the therapist
and site effects in more detail. We consider that an increase in the number of outdoor journeys is
an outcome that patients and health-care providers will feel is worthy of investment. It may be that an
increase in outdoor mobility is helping people get to the doctors or health centre, they maybe going to
work, or helping family with childcare. We know that people wish to get out of the house ‘just for the
sake of it’ or ‘to get fresh air’ or to ‘enjoy just moving around’.23 In addition, there is evidence from a
systematic review of exercise after stroke, which found improvements in health-related quality of life in the
short term.75 It is possible that the outdoor mobility intervention provided in our study, which was mostly
mobility training with the aim of walking > 100m, was providing an exercise programme.
Satisfaction with outdoor mobility was measured using a single question: ‘Do you get out of the house as
much as you would like?’ Although this measure was not designed as a patient-reported outcome measure
(PROM) to assess health-related quality of life, it has many of the elements. It measures how people
perceive the impact of a health intervention, is pertinent to the intervention being delivered and is easy to
complete. Prior to this multicentre study, the measure had been subjected to some reliability testing76 and
we have no reason to believe that the participants in the multicentre study found the question ambiguous.
When we compared the groups we found no signiﬁcant difference in outcome for this measure.59
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60Effect of the control on outdoor mobilityThere was very strong evidence that the control group improved markedly over time. At baseline, 259 out
of 281 (92.2%) participants were dissatisﬁed with outdoor mobility but at the 6-month assessment this
had reduced to 78% (160/205), a 15% reduction. The corresponding reduction in the intervention group
was slightly greater (18%) with 268 out of 287 (93.4%) expressing dissatisfaction with outdoor mobility at
baseline and 171 out of 227 (75.5%) expressing this at the 6-month assessment.
Participants in the control group must have been provided with a treatment that affected a change. It
would be expected that people 3.5 years after stroke would remain stable over the next 6 months. This
was a pragmatic trial and the therapists were told to deliver the baseline control as they would in the NHS.
This was to replicate that given in the single-centre study. However, the combination of a face-to-face
baseline visit presenting tailored (and participant focused) local transport and mobility information and use
of daily travel diaries led to an effect in both the control and intervention groups. The baseline visit
included a discussion about potential goals, which could have focused the participant’s thoughts towards
improving outdoor mobility. We state previously that passive provision of leaﬂets and information is
ineffective. However, we feel, with the motivated people who took part, that the control (targeted
provision of leaﬂets and information) has acted in a different way. In addition, it is established that
providing patients with daily diaries (e.g. food diaries) can lead to behavioural changes and an effect on
the outcome being recorded. They provide a reference point for reﬂection on past and current behaviours,
and they allow people to track changes over time and bring their behaviour to the front of their mind. In
essence, they are a self-monitoring tool. Diaries have been used in behaviour modiﬁcation programmes for
a range of problems from weight loss and exercise programmes through to managing incontinence,
tinnitus and migraines/headaches. Greenhalgh77 who investigated the feasibility of using diaries to
measure the daily impact of multiple sclerosis on participants found that by completing a dairy participants
became more aware of their symptoms, and this resulted in increased reporting. This impact may be
further improved by the participants being aware that each month we would request the information they
had recorded.Effect of the outcome on functional ability and
psychological distressThe intervention did not lead to greater levels of activity or reduce participant or carer psychological
distress. The assessments used to collect the outcomes were well known and standardised measures used
in many stroke studies.78–81 We have to conclude that the intervention, as delivered, does not impact on
these areas. This result is in line with previous studies, which has found that a targeted rehabilitation
intervention delivered over approximately six sessions can improve the speciﬁc domain being addressed but
does not affect other domains.82Was the intervention cost-effective?In the base-case analysis the mean incremental cost (total NHS and PSS cost) was estimated to be
£3413.75 (95% CI –£448.43 to £7121.00) with an incremental QALY gain of –0.027 (95% CI –0.060 to
0.007). This would suggest that the intervention was dominated compared with the control. The sensitivity
analyses were broadly in line with the results of the base case.Effect of the intervention on fallsFalls occurred in all age groups of stroke patients, with a median of three falls per year compared with one
in four people from an aged-matched, non-stroke population falling each year.83 It may be that we needNIHR Journals Library www.journalslibrary.nihr.ac.uk
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between the intervention group and the control group, providing evidence that the intervention did not
cause people to fall over more often.What did we learn about conﬁdence after stroke?Strongly emerging themes indicated that barriers to high levels of conﬁdence included loss of former self,
negative reinforcement from others including health professionals, loss of conﬁdence in roles and fear of
everyday activities. Conﬁdence levels were found to change over time, with participants having ‘good and
bad days’, but, generally, the participants spoke of improved conﬁdence as time since stroke increased.
The factors that helped stroke patients regain their conﬁdence were positive reinforcement from others,
successful skill mastery and self-deﬁned positive changes in roles. The study demonstrated that stroke
survivors in this study were experts of the conﬁdence phenomenon by identifying a variety of factors that
have both enabled them to achieve and succeed, resulting in increased conﬁdence levels, and also
identifying barriers that prevent them from regaining conﬁdence. These ﬁndings suggest there is a need
for therapists to understand the impact that low conﬁdence might have on outdoor mobility and to aim to
provide interventions to overcome this barrier.Adverse eventsWe had a small number of adverse events [20 from 17 (17/287; 5.9%) participants] within the intervention
group during the delivery of the intervention. There was no evidence to suggest that the intervention led
to an increase in falls that required the assistance of a health-care professional.Methodological issues
Comparison with other studies
This Getting out of the House Study evaluated a complex, but targeted, outdoor mobility intervention for
community-based people who had experienced a stroke many years previously. Owing to the number of
unique methodological features there is only one study to which we can compare the results. This was the
single-centre study on which this multicentre study was based.24 We aimed to replicate the recruitment
and intervention delivery but a major difference between the studies was the time from stroke. In the
single-centre study, participants were recruited 10–11 months after stroke, whereas in the multicentre
study they were recruited 37–40 months after stroke. By completing a pragmatic multicentre trial and
recruiting participants many years after stroke, we may have found a population more adapted to their
situation and less likely to respond to the intervention. This could have contributed to the neutral effects
found in the multicentre study compared with the positive effects found in the single-centre study. This
highlights the difﬁculty of completing a pragmatic study over an explanatory study where inclusion criteria
are more rigid. It would appear by comparing the two studies that the population most likely to beneﬁt
from the outdoor mobility training are those 1 year after their stroke. The other major difference between
the studies is that in the single centre only one therapist delivered the intervention, whereas in the
multicentre 29 therapists provided the intervention. The results from both studies provide some evidence
that outdoor mobility rehabilitation is more effective when provided by speciﬁc therapists. However, we
are not sure what characteristics these therapists need to have to elicit the beneﬁt. Again, owing to the
multicentre study being pragmatic and using routine NHS therapists, we consider that the results are more
likely to be those seen if the intervention was provided to all stroke patients.Generalisability of findings
The intervention delivered in this study was developed through university academics working with NHS
and international partners. It was found to be feasible for delivery in the NHS by both occupational61
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62therapists and physiotherapists in all parts of the UK and suitable for patients, both men and women,
many years post stroke. The age of the population was similar to the stroke population generally, so the
intervention could be delivered to routine patients. The results cannot be generalised to patients early after
stroke, who are most likely receiving Early Supported Discharge services or Community Rehabilitation.
The evidence from the single-centre study is most applicable to this population and provides evidence that
outdoor mobility participation can be increased by receiving a targeted intervention.Strengths and limitations
The main strengths of the study are that it was conducted and reported following the CONSORT
recommendations.84 The Nottingham CTU managed the data collection, keeping the group allocation
locked until the analysis had been completed. The study was overseen by an independent TSDC who
provided rigorous governance checks. The patient and carer outcomes were collected by post to reduce
bias and three statisticians independently checked the analysis. This study was designed to be as pragmatic
as possible by recruiting participants from a variety of settings and using NHS staff to deliver the
intervention in 15 different sites across Scotland, Wales and England. The participants were randomised
using a secure and independent service and the baseline characteristics of the two groups are balanced,
providing evidence that the randomisation process worked. Key areas of strengths and weakness are
discussed below.Economic evaluation
The study was strengthened by having the economic data collection and evaluation being nested within
the trial. The analysis was predeﬁned and completed by a research team at a separate university.
A weakness was that a number of assumptions were required in order to estimate some of the cost
variables, for example it was unclear (for a few participants) whether they were reporting average times
per carer/home help visit or total times for the week. That said, the results are broadly consistent, for
example for the different cost perspectives, so it does not seem that this has any great effect on the results
of the cost-effectiveness analysis.Qualitative study
The inclusion of a small qualitative interview study that explored conﬁdence levels in participants who
received the intervention provided some indications that conﬁdent people with stroke are very keen to
get out of their houses and are often restricted by a reduction in conﬁdence as much as a physical
impairments. A major limitation of this study was that a full qualitative study to explore processes was not
undertaken. This may have reinforced the main ﬁndings, provided valuable implementation information
and let us understand how the therapist effect was inﬂuencing the travel journeys. In future studies of this
kind it is recommended that participants, staff, commissioners and managers are interviewed.Choice of outcome measures
The study was strengthened by measuring outcomes at the functional and social participation level, using
standardised patient-reported outcomes but weakened by not having available measures that have been
used in people late after stroke. The main outcome measure has been discussed above. The rest of the
measures have been used successfully with people in other stroke rehabilitation trials8 up to a year after
stroke. There are very few outcome measures designed for changes in people with long-term neurological
conditions. The participants would most likely have a number of comorbidities that may have affected their
outcomes, such as arthritis. Therapists who provided the intervention were concerned that the clinical
changes they observed were not measured. They felt that a goal attainment scale might have been a
better primary outcome measure as it would have reﬂected the diverse needs of the patients. Some were
aiming to walk 20m and some were aiming to use the bus.Participant identification and randomisation
Originally, we calculated that seven sites would be needed to reach the sample size over the period of the
study. It was obvious that recruitment was slower than anticipated and the sites were doubled, and then
the recruitment period was lengthened by 4 months. This improved the generalisability, as the sites wereNIHR Journals Library www.journalslibrary.nihr.ac.uk
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seasons. Invitations from patients identiﬁed from stroke registers led to a higher proportion of randomised
participants than identiﬁcation from the GP database, with anecdotal evidence of involvement of the
stroke survivor’s original rehabilitation team leading to enhanced response rates. This also indicated that
more use of stroke rehabilitation services in stroke research would be beneﬁcial for participant
identiﬁcation and recruitment purposes, as well as these services acting as hosts to future research.
Whether there is a correlation between participant perception of stroke care from the sender of the
invitation and their willingness to participate is unclear and deserves further investigation. GP approach
yielded a poor response rate; however, this is not unusual among other research studies from a
range of disciplines.
The majority of participants who were not randomised did not meet eligibility criteria, with a small number
wishing to enter the study only if they could receive the intervention. Overall, there was a high level of
acceptance and enthusiasm for the study and the intervention in particular. Whether the acceptance and
enthusiasm was due to existing services not meeting the participants needs and the opportunity to receive
any sort of therapy was appealing is not clear, but again deserves further investigation. Anecdotal evidence
from participants showed that they were very appreciative of receiving the intervention and found it of
great beneﬁt; however, conversely, there were high levels of dissatisfaction and frustration from
participants in the control group, indicating that maybe there is a strong desire from participants to receive
ongoing therapy to address ongoing issues with their recovery from stroke. The eligibility criteria was very
broad, with an aim to include as many potential people as possible, so people living in care homes,
including those in wheelchairs who needed hoisting to transfer. Although this makes the ﬁndings very
generalisable it often caused concerns to the treating therapists, as they felt that 12 sessions was not
enough to achieve the goals in severely impaired patients.
An additional concern from the sites, but again with no real evidence, was that delivery of the intervention
to the quality expected by NHS staff was sometimes difﬁcult despite the great deal of enthusiasm and
support from research networks to recruit participants to the study.Collection of follow-up data
The dual approach of collection of follow-up questionnaire by either postal approach or RA approach
proved very effective and logistically was easily managed. Response rates for travel diaries were surprisingly
strong considering that only a single postal attempt per month was implemented. These diaries were the
source of a vast number of data and, potentially, for future trials, could be adapted to collect additional
information, for example social activity and resource use (GP appointments, carers).Issues of unblinding
Although there was a high level of unblinding either prior to or during 6-month visits by the RA, it was
tempered by the fact that the outcomes were still participant reported and the RAs were not assessing a
subjective outcome measure for either primary or secondary outcomes. However, there was evidence from
personal communication with RAs that they clariﬁed certain questions that participants (in the opinion of
the RA) had a tendency to misunderstand or misinterpret. Any impact of this bias will be minimal in the
overall interpretation of the data, as this incidence is likely to be equally distributed across both treatment
groups and occurred independently of participant allocation or RA unblinding status.
There was a clear risk of unblinding when collecting outcome data in a complex intervention in
stroke patients via RA-assisted questionnaires, so there is a need for prevention methods and
alternative approaches to be evaluated, while balancing that with the potential bias to outcome data
from unblinding.Differential follow-up
A common issue with studies that have a participant-perceived differential beneﬁt, as apparent as in the
Getting out of the House Study, is that a proportion of participants will be inclined to feel that continued63
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64participation in the control group is of no overall beneﬁt. This beneﬁt is related to the participant
themselves, whereas others feel that it is of no beneﬁt to study data overall. Although the former may be
true, of course, at the outset of the study there was only preliminary evidence that the intervention was
effective and the latter is deﬁnitely not the case. Despite efforts to maintain engagement with participants
wishing to withdraw, of which the majority were in the control group, there was still differential follow-up
between the two groups. However, this does not affect the overall study results, as we have 6-month
follow-up data from both groups within predeﬁned attrition rates.Attention control
One of the biggest limitations of this study was the input given to the control participants. The exploratory
data imply that control-group participants were given a treatment that caused an improvement, which was
more than that expected from routine care. This is a methodological weakness and one that is difﬁcult to
overcome in rehabilitation research. We considered that the information given to all participants was
similar to that provided routinely but collaborating therapists disagreed. They would have preferred in
retrospect for control participants to receive nothing, as they believe this is what routine care is at present
for people late after stroke. The addition of the monthly travel diaries seems to have changed the
behaviour of participants whom therapists would have expected to be stable. As with other rehabilitation
research projects it is impossible to complete a double-blind trial and control participants may have been
eager to use the travel information and the monthly diaries to change their lives.Therapist and site effect
A strength of the analysis undertaken in this study was that the statistical analysis plan was predeﬁned and
locked prior to the start of the analysis (see Appendix 1).
The two patient groups were compared using an adjusted modelling method, which took into consideration
the fact that many therapists were providing the intervention and that some patients would be treated by a
number of different therapists. This technique has been recommended for studies of this kind,85,86 as there
is the potential for clustering of outcomes (owing to which site a patient is at and which therapist treated
them). However, this adjusted modelling method has not been readily used in rehabilitation studies and is
therefore a point of discussion.
Before the adjusted modelling method could be used, a weighting for each therapist providing the
intervention needed to be calculated using an approach that considered the number of therapists treating
each patient and the number of times that each patient was treated. This weighting was then applied to
the outcome results while the groups were compared using the adjusted method. The adjusted results
and the unadjusted results can be seen in Tables 8–10. Only one of the outcomes was affected by the
therapist and site adjustments, and that was the number of journeys made. The result went from a neutral
one to a signiﬁcant positive one. A concern, though, is that the descriptive data in the 6- and 12-month
tables suggests that the control group are perhaps slightly more likely to do more journeys. Another
concern for the number of journeys outcome is that it was not possible to calculate the sizes of the
obviously inﬂuential site and therapy effects (owing to the modelling process used). This meant that it was
therefore impossible to determine which of these effects had the most weight on the adjusted result.
However, even if it was possible to calculate the site and therapy effects for the number of journeys
outcome, as was done for the other outcomes of this study, it would be very difﬁcult to determine how
these effects speciﬁcally altered the outcome. For instance, it would be hard to discover if any of the
individual sites or therapists had a strong (or weak) inﬂuence on an outcome.
These results have been checked by three medical statisticians. This therapist effect can be explained by
understanding that the intervention is a combination of the therapist and the techniques prescribed in the
manual. It is very reliant on the skills of the therapist and the willingness of the participant. This type of
analysis and understanding of the therapist effect needs further research.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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among stroke survivors even after many years. It demonstrates that rehabilitation interventions that aim to
improve outdoor mobility are appropriate for delivery by NHS therapists and, therefore, the results provide
deﬁnitive and generalisable answers to clinically important questions.
The intervention has the potential to increase outdoor mobility participation in stroke patients as measured
by journeys and SWOM but it has to be delivered in a speciﬁed way. In the single-centre study that found
similar results, the patients were treated by the same therapist who was experienced and skilled in stroke
care. This multicentre study has highlighted the issues of implementing an intervention that was developed
for a single-centre study across the NHS.
The intervention had no measureable effect on quality of life (social function), activities of daily living or
mood so we cannot recommend that this intervention is used to improve limitations in these areas.
Unfortunately, a major limitation of this study is that control participants who were expected to remain
stable over the period of the study improved in their SWOM over the ﬁrst 6 months. We suggest that the
information and verbal advice plus monthly travel diaries may have acted as a treatment that may have
affected the results of the primary analysis. The intervention was more costly than the control and did not
improve quality of life compared with control.Implications for clinical practiceThis study replicated the results found in the single-centre study. An outdoor mobility intervention can
increase outdoor mobility participation but this change does not appear to have a signiﬁcant effect on
quality of life (social function) compared with a control. So is this increase in journeys a clinically relevant
ﬁnding that NHS commissioners will be paying for?
To implement this intervention into clinical care, it would appear from the single-centre study that the
intervention needs to be provided by one experienced and stroke-trained therapist, who would provide all
of the intervention sessions therefore becoming an expert in outdoor mobility.
To implement the control, outdoor mobility information and verbal advice needs to be personalised and
provided face to face by an expert in community services. This needs to be supported by a self-reporting
process that allows patients to let the therapists know how they are progressing.Recommendations for research1. Further research is needed to ﬁnd new and innovative techniques and interventions that might help
stroke patients get out of their houses as much as they would like. The results of our multicentre study
indicated that we should be looking at the control, where we targeted the motivated participants, gave
people decent information, and provided a structured behavioural change programme that included
charting the behaviour changes.
2. Research is needed to explore alternative outcome measures that are clinically relevant but that can be
used to compare health-care techniques. In this multicentre study we used a health-related quality of65
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66life (social function) measure but the intervention was targeted at outdoor mobility participation. Stroke
patient’s value increased outdoor mobility in its own right. Further qualitative research is needed to
explore how increased journeys may impact on quality of life.
3. We recommend that research is completed to explore the divergence in results between single-site and
multisite studies. This successfully completed multicentre trial followed from a positive single-centre
study. However, the results were different. We considered that we had replicated the methodology
used in the single-centre study as far as possible when completing a pragmatic study, but we realise
that this was a complex intervention delivered in a complex way to complex patients.
4. Research is needed to develop stroke-speciﬁc falls prevention interventions and psychological
interventions to improve conﬁdence. In this study falls occurred in all age groups of stroke patients and
more often than in an age-matched group without stroke. Fear of falling and reduced conﬁdence have
been shown to reduce outdoor mobility.
5. Data from this study need to be shared with other research groups to allow discussion and comparison
of multiple modelling analysis.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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NAbbreviationIHR Journals Library www.journalslibrary.nihr.ac.ukDescriptionREC Research Ethics CommitteeR&D Research & Development departmentSAE Serious Adverse EventTCC Trial Coordinating CentreTMG Trial Management GroupTSC Trial Steering Committee1. INTRODUCTION AND PURPOSEThis document details the rules proposed and the presentation that will be followed, as closely as possible,
when analysing and reporting the main trial results.The purpose of the plan is to:l Ensure that the analysis is appropriate for the aims of the trial, reﬂects good statistical practice in
general, and minimises bias by preventing inappropriate post hoc analyses.
l Explain in detail how the data will be handled and analysed to enable others to perform the actual
analysis in the event of sickness or other absence.
l Protect the project by helping it keep to timelines and within scope.
Additional exploratory or auxiliary analyses of data not speciﬁed in the protocol are permitted but fall
outside the scope of this analysis plan (although such analyses would be expected to follow Good
Statistical Practice).
The analysis strategy will be made available if required by journal editors or referees when the main papers
are submitted for publication. Additional analyses suggested by reviewers or editors will, if considered
appropriate, be performed in accordance with the Statistical Analysis Plan, but if reported the source of
such a post hoc analysis will be declared.
Amendments to the statistical analysis plan will be described and justiﬁed in the ﬁnal report of the trial.2. SYNOPSIS OF STUDY DESIGN AND PROCEDURES
2.1. Trial objectives and aims
The purpose of this trial is to conﬁrm or refute the clinical effectiveness and cost effectiveness of treating
outdoor mobility limitations after stroke with a novel targeted rehabilitation therapy intervention versus
standard clinical practice.2.1.1. Primary objectivel The health care objective is to improve the quality of people’s lives after a stroke by enabling them to
get out of the house more often and when they wish.
l The research objective is to test the effectiveness and cost effectiveness of treating people who have
had a stroke with a new outdoor mobility rehabilitation intervention.
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The secondary objectives are to measure whether this new therapy intervention is associated with:
l improved mobility in and outside the house
l improved patient mood
l improved participation in everyday activities
l improved carer mood
l improved health-related quality of life.2.2. Trial design and configuration
This is a multicentre parallel group randomised controlled trial. The trial consists of an initial baseline visit
to provide information and explain the study, take informed consent, provide the standard clinical stroke
rehabilitation treatment, completion of set of questionnaires and provide a travel diary with instructions.
All participants will have to complete travel diaries every month and questionnaires at baseline, 6 and
12 months.2.3. Trial centres
Approximately 15 Primary Care Trusts throughout the UK.2.4. Eligibility criteria
2.4.1. Inclusion criteria1. Age 18 years or over.
2. At least six weeks since stroke.
3. Wishing to get out of the house more often.
4. The participant must give informed consent before completing any study-related procedure, which
means any assessment or evaluation that would not have formed part of their normal care.2.4.2. Exclusion criteria1. Not able to comply with the requirements of the protocol and therapy programme, in the opinion of
the assessor.
2. Still in post-stroke intermediate care or active rehabilitation.
3. Previous enrolment in this study.2.5. Description of interventions
A novel rehabilitation technique (intervention) group will be compared with a usual care (control) group.Control group
Participants will receive what is considered clinically to be routine intervention for outdoor mobility
limitations. That is verbal, advice and provision of leaﬂets provided during the baseline assessment visit.Intervention group
This group will receive the same treatment as the control group but in addition, participants in this group
will receive up to 12 rehabilitation outdoor mobility sessions of about an hour each over 4 months. The
main component of the intervention is that therapists go repeatedly with patients to try outdoor mobility,
including, buses, taxis, walking, voluntary drivers and mobility scooters until they feel conﬁdent to go
alone or with a companion.
The number of intervention depends entirely on the participant. If they feel they do not require any further
interventions, for whatever reason, then the interventions can stop. If they feel they require additional
intervention, for whatever reason, they can continue the intervention up to a maximum of 12 visits.77
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782.6. Randomisation procedures
The randomisation will be based on a computer generated pseudo-random code using random permuted
balanced blocks of randomly varying size, stratiﬁed by age (< 65 years, ≥ 65 years) and centre. All
participants will be given the control group standard information intervention prior to randomisation in
order to minimise performances and reduce contamination.
Participants will be randomly allocated (1 : 1 ratio) to either intervention or to the control group.2.7. Sample size and justification
Our sample size calculations are based on the primary outcome measure, the Social Function domain of
the Short Form 36 version 2 (SF-36v2) at six month follow-up. Although this was not used in the original
study a recent study has suggested a minimally clinically important difference (MCID) for the social
function domain is 12.5 points (Wyrwich, Tierney et al. 2005). The estimate of the standard deviation is
taken from Brittle’s study (Brittle, Brown et al. 2008) and this closely matches the standard deviation
obtained by assuming the distribution of the nine possible integer-valued scores follows a roughly
right-angled triangular distribution (i.e. that is positively skewed). This follows the general approach
suggested by Deeming for schematic distributions. Assuming a power of 90% and a two-sided
signiﬁcance level of 5%, we estimate that to detect a difference in mean SF-36 scores of 12.5 points
assuming a common standard deviation of 28.2 (Brittle et al. 2008) a sample size of 135 patients per arm
is required. This calculation assumes an attrition rate of 20% over 6 month period.
Clustering by delivery of treatment was allowed for by generating simulated data to mimic the multilevel
structure of the proposed trial, with centre-speciﬁc variation between therapists. The likely existence of
sharing of therapists by patients was addressed by a multiple membership model, and the variance of the
treatment effect so found was compared with that of a regression model ignoring clustering (both models
treating centre as a ﬁxed effect). The data sets and analyses were performed in Stata v10. The variance
inﬂation observed was insensitive to variation in the simulated between-centre variance and the average
between-therapist variance, and a rounded value of 2.5 was selected as the multiplier for a sample size
based on a naive analysis. After the allowance for clustering by delivery of treatment a sample size of
338 participants per arm is required.
A further sample size was also calculated using an alternative and easier to replicate method. This analytic
approach was based on the same assumptions of the original sample size calculation and assumed that
there would be 7 centres and within each centre there would potentially be 4 therapists delivering the
intervention in the intervention group and one therapist delivering the control intervention in both groups
(verbal advice and provision of leaﬂets at baseline visit prior to randomisation). In these calculations we
assumed a therapist effect ICC of 0.02 (obtained from personal communication) and a centre effect ICC of
0.04 [obtained from Aberdeen University’s database of ICCs (http://www.abdn.ac.uk/hsru/epp/iccs-web.
xls)]. This gave a revised total sample size (with no allowance for attrition) of 596 participants. If an
attrition rate of 20% is assumed a total sample size of 746 would be required.
Owing to an increase in the number of sites, the sample size was revised. Power calculations to detect a
difference in means of 12.5 (as in the original sample size calculation) and assuming a total sample size of
440 with the number of centres ranging from 7 (as originally planned) to 14 were then performed. These
calculations were based on the same assumptions made in the analytic sample size above (i.e. SD = 28.2,
two-sided signiﬁcance level of 5%, ICC of 0.02 for therapist effect and ICC of 0.04 for centre effect).
These indicated that a sample size of 440 would have a power of 86% (assuming no attrition) and a
power of 82% (assuming attrition rate of 20%) to detect a difference in means of 12.5 if there were
7 centres and if there were 12 or more centres the corresponding power would be at least 90% if an
attrition rate of 20% was assumed. There are a total of 15 centres in this trial so this meets the
latter calculations.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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calculations are based on the best estimates we could obtain there is some uncertainty about the true
values of the ICCs used to adjust for clustering. We therefore intended to be cautious and aimed to recruit
a sample size of 506 (440 + 15%) to ensure we have recruited enough participants.2.8. Blinding and breaking of blind
The research assistants (RA) who will help the participants complete the travel diaries and questionnaires,
will not be aware of which group the participant has been randomised to. Following any visits, at 6 and
12 months, to assist with questionnaire completion the RA will complete a blinding questionnaire to assess
if the blind had been broken.
Neither the participants nor the therapist are blinded to the intervention. The RA and the outcome
assessors are blinded to the allocation of the treatment group and there is no foreseeable situation
whereby they would need to know the treatment allocation of a particular participant. As a result there
will be no procedures in place for breaking the randomisation code.2.9. Trial committees
A number of committees will be assembled to ensure the proper management and conduct of the trial,
and to uphold the safety and well-being of participants.
Trial Management Group (TMG): The TMG will oversee the operational aspects of the trial, which
include the processes and procedures employed, and the day-to-day activities involved in study conduct.
Trial Steering and Data Committee (TSDC): The TSDC has the overall responsibility for ensuring a
scientiﬁcally sound study design, a well-executed trial, and accurate reporting of the study results.
The Data Monitoring part of this committee will evaluate the outcome and safety data in the context of
the overall trial and the currently existing information about the study. The DM will consider the
appropriate timeframe for reviewing the data during the course of the study. The TSDC will have access
to all trial data.2.10. Outcome measures
2.10.1. Primary outcomel The primary outcome is the mean social function domain score of the SF-36v2 questionnaire measured
at 6 months. The ﬁnal social function domain score is then transformed into a 0–100 scale
(see section 3.2).2.10.2. Secondary outcomes1. Functional ability (Nottingham Extended Activities Daily Living scale)© Que
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Park, SA 22-item questionnaire developed to detect how people who have suffered a stroke can carry out
complex everyday tasks such as outdoor mobility and shopping. Each of the 22 item has the
following categories ‘0 = not at all’, ‘0 =with help’, ‘1 = on your own with difﬁculty’ and ‘1 = on your
own easily’. The ﬁnal score is a score that ranges from 0–22 and higher values indicate
greater independence.2. Mobility (Rivermead Mobility Index)
This is a 15 item questionnaire used as a measure of disability related to bodily mobility. It
demonstrates the patient’s ability to move his/her own body. All 15 items are ‘yes/no’ answers with
values of 1 = yes and 0 = no. These are summed together to give a ﬁnal score that ranges from 0 to
15 with higher values indicating greater mobility.79
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803. The number of journeys (travel diaries)NIHRThe travel diaries are in the form of a calendar and the participants are given 12 months worth of
travel diary. The participants indicate the number of journeys (any journeys out of the house) they
took for each particular day of the month for 12 months.4. Satisfaction with outdoor mobility assessed using one yes/no question ‘Do you get out of the house as
much as you would like?’
This question is included in the baseline, 6 months and 12 months questionnaires and asks the
participant ‘Do you get out of the house as much as you would like’ with a binary answer of either
yes/no.5. Participant Mood (General Health Questionnaire – 12)
6. Carer psychological distress (General Health Questionnaire – 12)
7. The GHQ-12 is a 12 item questionnaire and it is administered in exactly the same way for participant
and carer. Each of the 12 items are scored on a 0–3 scale. The ﬁnal score is calculated by summing
together the scores for these questions, giving a score that ranges from 0 to 36 with lower scores
indicating a better outcome (mood/psychological distress).2.11. Interim analysis
No formal interim analysis is planned.3. GENERAL ANALYSIS CONSIDERATIONS
3.1. Analysis populations
Safety set: All randomised participants who receive at least 1 intervention.
Full analysis set: All randomised participants for whom the 6 month assessment of primary endpoint
is available.3.2. Derived variables
1. Social Functioning score (SF-score) transformed to 0–100 scale
The ﬁnal SF-score is the addition of the 2 items (questions 6 and 10) from the SF36 questionnaire and the
range for this is from 0–10.
Question 10 of the SF36 (focusing on how much of the participants time their physical health or emotional
problems has interfered with their social activities) has the following categories; ‘1 = all the time’, ‘2 =most
of the time’, ‘3 = some of the time’, ‘4 = a little of the time’ and ‘5 = none of the time’.
Question 6 of the SF36 (focusing on the extent to which the participants physical health or emotional
problems has interfered with their normal social activities with family, friends, neighbours or groups) has
the following categories; ‘1 = not at all’, ‘2 = slightly’, ‘3 =moderately’, ‘4 = quite a bit’ and ‘5 = extremely’.
However, the scoring of this question was reversed to ‘1 = extremely’, ‘2 = quite a bit’, ‘3 =moderately’,
‘4 = slightly’ and ‘5 = not at all’ to ensure that higher values indicate better scores.
The ﬁnal score is therefore the score of the questions 6 and 10 summed together and it ranges from 2 to
10, where high scores indicate better social functioning. However we need to transform this into a
0–100 scale and is calculated as shown below.
SFscore ð0 100Þ ¼ actual calculated raw SFscore−lowest possible SFscore
possible SFscore range
100
Lowest possible SFscore = 2, Possible SFscore range = 8Journals Library www.journalslibrary.nihr.ac.uk
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The total NEADL score is the addition of 22 items questionnaire with each item having the category
‘0 = not at all’, ‘0 =with help’, ‘1 = on your own with difﬁculty’ and ‘1 = on your own easily’. Hence, the
range for the total NEADL score will be 0–22.3. Rivermead Mobility Index (RMI) score
The total RMI score is the addition of the 15 items of the RMI questionnaire. Each item is either ‘1 = yes’ or
‘0 = no’ and so the range will be 0–15.4. General Health Questionnaire – 12 (GHQ-12) score
The GHQ-12 is a 12 item questionnaire with each item is scored on a 0–3 scale.
Usually the categories for questions 2, 5, 6, 9, 10 and 11 are reversed before scoring, since the GHQ-12
questionnaire is composed of positively phrased and negatively phrased statements about mood states.
However in our questionnaire the categories for questions for questions 2, 5, 6, 9, 10 and 11 were placed
in reverse order so there is no need to reverse the scoring for these questions.
This questionnaire is completed by both the participant and the carer and so there will be a GHQ-12 ﬁnal
score for both participant and carer. The range of this ﬁnal score will be 0–36.5. Calculation of age
Age is calculated as age at inclusion → (consent date – date of birth)/365.253.3. Procedures for missing data
A complete case analysis will be conducted for the primary and secondary outcome measures. The
replacement of missing data with imputed data (either by single or multiple imputation, as appropriate)
will then be performed as a sensitivity analysis.3.4. Levels of significance
The tests will be two-tailed and a result will be declared ‘statistically signiﬁcant’ if p < 0.05 for all
outcomes. Results will be presented with 95% conﬁdence intervals.3.5. Study centre effects
Centre will be handled as a random effect.3.6. Outliers
Basic data explorations using summary and graphical statistics (i.e. box plots, etc.) will be conducted to
check for any outliers. If after additional investigation there is no evidence that these are errors then the
analyses will be repeated after winsoring the data to assess the robustness of the results.
Winsoring involves replacing extreme values (outliers) with a speciﬁed percentile of the data. In this case,
data values below the 5th percentile will be replaced with the 5th percentile value and data values above
the 95th percentile will be replaced with the 95th percentile value.81
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824. DESCRIPTION OF SUBJECT CHARACTERISTICS
4.1. Disposition
A ﬂow of patients through the trial will be summarised in a CONSORT diagram that will include the
eligibility, reasons for exclusion, numbers randomised to the two treatment groups, losses to follow-up and
the numbers analysed.
Number of participants screened
n=...
Excluded (N=...)
Reason 1 (n= ...)
Reason 2 (n= ...)
Randomised to therapy group
(N= ...)
Randomised to control group
(n= ...)
Completed primary end point
(n= ...)
Completed therapy (n= ...)
Did not receive allocated
therapy (n= ...)
Reasons:
Withdrew/lost to follow-up
(N= ...)
Reason 1 (n= ...)
Reason 2 (n= ...)
Withdrew/lost to follow-up
(N= ...)
Reason 1 (n= ...)
Reason 2 (n= ...)
Withdrew/lost to follow-up
(N= ...)
Reason 1 (n= ...)
Reason 2 (n= ...)
Completed 12 month follow-up
(n= ...)
Withdrew/lost to follow-up
(n= ...)
Deceased (n= ...)
Withdrew/lost to follow-up
(N= ...)
Reason 1 (n= ...)
Reason 2 (n= ...)
Number of participants randomised
n= ...
Completed primary end point
(n= ...)
Completed 12 month follow-up
(n= ...)
Withdrew/lost to follow-up
(n= ...)
Deceased (n= ...)NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 294.2. Baseline characteristics
Participants in the two arms will be described separately with respect to age, sex, ethnicity and time since
last stroke (see Table 1).
Continuous data will be summarised in terms of the mean, standard deviation, median, lower and upper
quartiles, minimum, maximum and number of observations. Categorical data will be summarised in terms
of frequency counts and percentages.5. ASSESSMENT OF STUDY QUALITY
5.1. Eligibility checks
The number of participants meeting the eligibility criteria will be tabulated (see Table 2).5.2. Randomisation checks
The randomisation sequence as generated was evaluated using a multiple logistic model with treatment
arm as response and block, sequence in block and stratum as explanatory variables. The AIC was used to
conﬁrm that the best ﬁtting (minimum AIC) model was the null one, with no explanatory variables.5.3. Data validation
The data validation checks will be conducted in-accordance to the CTU standard operating procedures.
Final analyses will be conducted once the data validation programs developed within the CTU have
checked for and cleaned the original data sets and saved them as new ‘Stata.dta’ data sets so that the
original data sets are not tampered.5.4. Withdrawals
The number and percentage of withdrawals will be summarised by treatment arm (see Table 3).5.5. Compliance
Compliance in this trial will focus on the completion and returning of all diaries and questionnaires.
Baseline questionnaires will be required to be completed before randomisation and so in practice this
means 12 monthly travel diaries and 2 sets of assessment questionnaires, one each at 6 months and
12 months.
l Compliance of diary calendars:© Qu
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Park,The number (%) of diary calendars returned at each month will be summarised (see Table 4).
l Compliance of questionnaires returned and completed:The number (%) of questionnaires returned will be summarised (see Table 5).¢ The number (%) of participants who returned outcome questionnaires completed in full will
also be summarised for each outcome measure (Table 5).5.6. Extent of study intervention
The total number of therapy sessions each participant received will be summarised for the treatment group
only (see Table 6).
Also the number of therapists providing the intervention in each centre will be presented (see Table 7).
Furthermore, the minimum and maximum number of therapists treating the participants will be provided.5.7. Protocol deviations
A listing of all participants with a protocol deviation will be provided (see Table 8).83
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845.8. Specify & justify changes made to the planned statistical analyses1. Centre will be handled as a random effect rather than ﬁxed effect (as mentioned in the protocol) due
to the increase in the number of centres, we feel that adjusting for centre as a ﬁxed effect will take up
a lot of degrees of freedom.6. ANALYSIS OF EFFICACY
6.1. Mis-randomised patients
Patients will be analysed as randomised, in order to follow the ITT principle.6.2. Summary of primary and secondary outcomes
Baseline summaries of primary and secondary outcomes are described in the baseline characteristics table
(see Table 1).6.3. Primary analysis
The mean Social Function score (SFscore) will be compared between treatment arms using a multiple
membership form of mixed effects multiple regression analysis adjusting for centre (as a random effect),
age and baseline SFscore as covariates and therapist as a multiple membership random effect (87).
The table below gives examples of the multiple membership effect of therapist:NIHR Journals Library www.journalslibrary.nTherapist 1ihr.ac.ukTherapist 2 Therapist 3Patient 1 × (8) × (2) × (2)Patient 2 × (12)Patient 3 × (6) × (2)Accounting for the therapists
The effect of therapists will be accounted for by assigning weights. Based on the table above, patient 1
attended all the 12 sessions and was treated by therapist 1 eight times, therapist 2 two times and
therapist 3 also two times.
Hence the total number of sessions attended by patient 1 was 12 and the weight that will be attributed to
each therapist will be:
l therapist 1 is 8/12 = 0.667
l therapist 2 is 2/12 = 0.167
l therapist 3 is 2/12 = 0.167.
Patient 2 also attended all 12 sessions but this patient was only treated by therapist 1 throughout the
study and so therapist 1 will be assigned all the weight, i.e. 1.
Hence each therapist will be given a weight depending on the number of therapy sessions he/she
conducted for a particular participant. (Note: The therapist effect at baseline will be ignored since we are
only interested on the therapist effect during the intervention period.)
A 3-level multiple membership model will be conducted using MLwiN once the data has been sorted and
converted into the appropriate format for MLwiN. Centre will be the level 3 variable, with therapists as a
multiple membership form level 2 and participants as level 1.
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gender and residential status (see Table 9 and Appendix 12.2.A for code). Deviance will be used to
compare the performance of the models. Regression coefﬁcients and 95% conﬁdence intervals will be
presented for the model with the lowest Deviance.6.4. Secondary analyses
The secondary outcome measures are collected at 6 months and 12 months. Data for the 6 months and
12 months will be analysed separately. The time point of primary interest is at 6 months.
1. Nottingham Extended Activities of Daily Living Scale (Functional ability)© Que
Health
provide
addres
Park, SThe range of the NEADL score will be 0–66, with higher scores means greater independence.
The mean NEADL score will be compared between treatment arms using the same approach as for
the primary outcome measure, namely a multiple membership form of mixed effects multiple
regression analysis adjusting for centre (as a random effect), age and baseline score as covariates and
therapist as a multiple membership random effect (see Table 10). The robustness of these ﬁndings will
be assessed by repeating the analysis and including baseline variables gender and residential status.
Deviance will be used to compare the performance of the models. Regression coefﬁcients and
95% conﬁdence intervals will be presented for the model with the lowest Deviance.2. Rivermead Mobility Index (Mobility)
The range of the RMI score will be 0–15 with higher scores indicating greater mobility.
The mean RMI score will be compared between treatment arms using the same method of analysis
used for the primary outcome measure (see Table 11).
The robustness of these ﬁndings will be assessed by repeating the analysis and including baseline
variables gender and residential status. Deviance will be used to compare the performance of the
models. Regression coefﬁcients and 95% conﬁdence intervals will be presented for the model with
the lowest Deviance.3. Travel Diary (number of journeys)
Participants are required to complete 12 months worth of travel diary. They are asked to record how
many journeys (any journey out of the house) they made on each particular day of the month for the
period of 12 months.
The total number of journeys will be compared between treatment arms using a multiple membership
form of mixed effects Poisson regression model adjusting for centre (as a random effect), age as a
covariate and therapist as a multiple membership random effect (see Table 12). The robustness of
these ﬁndings will be assessed by repeating the analysis and including baseline variables gender and
residential status.
Deviance will be used to compare the performance of the models. Regression coefﬁcients and
95% conﬁdence intervals will be presented for the model with the lowest Deviance.4. Yes or no question: ‘Do you get out of the house as much as you would like?’ (Satisfaction with
outdoor mobility)
This question asking the participant ‘Do you get out of the house as much as you would like’ is part of
the baseline, 6 months and 12 months questionnaires. The response is a binary variable coded as
either 1 = yes or 0 = no.
The proportion of participants saying they get out of the house as often as they would like will be
compared between treatment arms using a multiple membership form of mixed effects logistic
regression model adjusting for centre (as a random effect) and age as covariates and therapist as a
multiple membership random effect (see Table 13).
The robustness of these ﬁndings will be assessed by repeating the analysis and including baseline
variables gender and residential status. Deviance will be used to compare the performance of the
models. Odds ratios and 95% conﬁdence intervals will be presented for the model with the
lowest Deviance.5. General Health Questionnaire (GHQ-12) (Mood)85
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APPENDIX 1
866. GHQ-12 (Carer psychological distress)NIHRThe GHQ-12 score is a score that ranges from 12 to 48 with lower scores indicating better mood.
The mean ﬁnal GHQ-12 score for the participant and for the carer will be compared (using separate
models) between treatment arms using the same method of analysis used for the primary outcome
measure (see Tables 14 and 15).
The robustness of the ﬁndings for the GHQ-12 score (assessed by repeating these analyses and
including baseline characteristics for gender and residential status) will only be assessed for the
participant. Deviance will be used to compare the performance of the models. Regression coefﬁcients
and 95% conﬁdence intervals will be presented for the model with the lowest Deviance.7. Participant mortality (death data) will be collected from NHS IC/NHS Central Register
The number and percentage of participants who died during the period of follow-up will be reported
by treatment group.8. EQ-5D and SF-6D (subset of SF-36 v2) – Resource use of health and social care and provision
of equipment
This outcome will be analysed by the health economist (see Health Economics section).6.5. Sensitivity analysis
Sensitivity analyses will be conducted for all outcome measures accounting for any outliers and
missing data.6.6. Exploratory/other analysis
Additional analyses include descriptive summaries (by treatment group) for the NEADL scale categories
(see below):
l mobility – questions 1–6
l kitchen – questions 7–11
l domestic – questions 12–16
l leisure – questions 17–22 (see Tables 16–18).
Basic descriptive summaries (by treatment arm) for the total number of journeys made will also be
conducted (see Table 19).
A description of the components of the intervention will be presented. The type of intervention received by
each participant and the number of sessions the participants received for each type of intervention will be
summarised in terms of n (%)s, Mean (SD), Median (IQR) and Min;Max (see Table 20).
The type of goals to be achieved by each participant is recorded as a list. This information will be
categorised into standard categories and the number of participants assigned each type of goals will be
presented as n (%) (see Table 21).6.7. Assessment of blinding
All participants ﬁll out the questionnaires either by post or require the help of a research assistant (RA).
Of those that require the help of a RA, the number and percentage [n (%)] of the RAs who became
unblinded will be presented by treatment group (see Table 22).7. HEALTH ECONOMIC DATA ANALYSISThis analysis will be conducted separately by a Health Economist. This evaluation aims to estimate the
incremental cost effectiveness of an outdoor mobility rehabilitation intervention, compared with usual care,
from a health and personal social services perspective. In addition the patient and carer perspective will be
examined separately.Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29Any censored data will be adjusted for, using appropriate published techniques. If non-dominance occurs,
an incremental cost effectiveness ratio will be produced. The conﬁdence region around the ratio will be
estimated using appropriate statistical techniques such as the non-parametric bootstrap method. This
stochastic analysis will enable a cost effectiveness acceptability curve to be produced illustrating the
uncertainty surrounding the optimal decision.
Probabilistic sensitivity analysis will be undertaken to test the robustness of the results. Estimates of the
incremental cost, incremental cost effectiveness and the uncertainty around these estimates will enable us
to discover whether ‘The getting out of the house intervention’ offers value for money.8. QUALITATIVE DATA ANALYSISData from the semi-structured interviews to assess the participants’ conﬁdence after their stroke will be
analysed by a qualitative researcher. Data will be analysed using Interpretive Phenomenology Analysis (IPA)
principle using a six stage framework (89). The aim is to identify enablers and barriers to regaining
conﬁdence from the patient perspective.9. ANALYSIS OF EFFICACYFidelity of treatment will be assessed by reviewing the notes of therapists against a predeﬁned checklist to
determine whether the intervention was being delivered according to the protocol. Furthermore, a
selection of therapy visits will be observed and scored against a predeﬁned checklist.10. ANALYSIS OF SAFETY
10.1. Adverse events
All participants who experience any adverse events will be listed by treatment group (see Table 23).10.2. Falls data
Each participant was asked to record in their diaries whether they had experienced a fall on a given day of
the month.
The total number (%) of falls day, i.e. number of days when the participants recorded they experienced at
least one fall, will be described by treatment group and by age group (see Tables 24–25).11. FINAL REPORT TABLES AND FIGURES
COMMENT
Specify layout, for example by presenting dummy tables. The following rules may be adopted when
creating the summary tables:
Number of decimal places (DP):
l for minimum and maximum the number of DPs will be the same as the raw data
l for mean, median and SD the number of DPs will be one more than the raw data
l percentages – Round up to the nearest whole number
l p-values – 3 decimal points will be presented
l no more than 4 signiﬁcant numbers will be used.87
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88Data presentation:
l Treatment group will be in columns with the visits in rows.
l Column headers in mixed case, with ‘(n = nn)’ below treatments to denote the denominator.
l Decimal places will be aligned.
l n (%) as a separate column rather than included in brackets for each element of the table.
l Categories (i.e. in column 1) in sentence case, in the order on the CRF.
l Ordering of statistics N, Missing, Mean, SD, CV%, Minimum, Median and Maximum. Geometric
Means inserted between Mean and SD for pharmacokinetics.11.1. Subject characteristics and background summariesTABLE 1 Baseline characteristics
Variable Parameter
Treatment arm
A B
Total N
Age at inclusion Mean (SD)
Median (IQR)
Minimum, maximum
Sex Female n (%)
Male
Ethnicity White n (%)
Black – Caribbean
Black – African
Black – Other
Pakistani
Indian
Bangladeshi
Chinese
Mixed
Not given
Other
Residential status Lives alone n (%)
Lives with others
Living in care home
Time since stroke Mean (SD)
Median (IQR)
Minimum, maximum
NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 1 Baseline characteristics (continued )
Variable Parameter
Treatment arm
A B
Social functioning score Mean (SD)
Median (IQR)
Minimum, maximum
NEADL1 score Mean (SD)
Median (IQR)
Minimum, maximum
Rivermead Mobility Index score Mean (SD)
Median (IQR)
Minimum, maximum
Satisfaction with outdoor mobility Yes n (%)
No
General Health Questionnaire (Participant) Mean (SD)
Median (IQR)
Minimum, maximum
1 =Nottingham Extended Activities of Daily Living Scale (Functional ability).
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Inclusion criteria Yes No
Is the participant aged 18 years or older?
At least 6 weeks but no longer than 5 years since stroke?
Wishing to get out of the house more often?
Has the participant given written informed consent?
Exclusion criteria Yes No
Not able to comply with the requirements of the protocol and therapy programme, in the opinion of
the assessor?
Still in post-stroke intermediate care or active rehabilitation?
Previous enrolment in this study?
89
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TABLE 3 Withdrawals
Withdrawals A (n = . . .) B (n = . . .)
Total
(n = . . .)
1. Participant withdrew from the study
2. Participant lost to follow-up
3. Participant experienced an adverse event
4. Investigator withdrew participant
5. Other (specify)
*all values are n (%)’s unless speciﬁed.
TABLE 4 Compliance of diary calendars
Compliance of the diary calendars Total overall (N = . . .)
Total excluding any
withdrawals (N = . . .)
n (%) returned no calendars
n (%) of participants who returned 1 month of travel calendar
n (%) of participants who returned 2 months of travel calendar
n (%) of participants who returned 3 months of travel calendar
n (%) of participants who returned 4 months of travel calendar
n (%) of participants who returned 5 months of travel calendar
n (%) of participants who returned 6 months of travel calendar
n (%) of participants who returned 7 months of travel calendar
n (%) of participants who returned 8 months of travel calendar
n (%) of participants who returned 9 months of travel calendar
n (%) of participants who returned 10 months of travel calendar
n (%) of participants who returned 11 months of travel calendar
n (%) of participants who returned 12 months of travel calendar
*all values are n (%)’s unless speciﬁed.
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TABLE 5 Compliance of the questionnaires
Compliance of the questionnaires Total (N = . . .)
n (%) of the 6 months questionnaires returned
n (%) of the participants who completed the SF361 questionnaire in full
n (%) of the participants who completed NEADL2 questionnaire in full
n (%) of the participants who completed RMI3 questionnaire in full
n (%) who answered the SWOM4 question
n (%) of the participants who completed the GHQ-125 questionnaire in full
n (%) of the 12 months questionnaires returned
n (%) of the participants who completed the SF361 questionnaire in full
n (%) of the participants who completed NEADL2 questionnaire in full
n (%) of the participants who completed RMI3 questionnaire in full
n (%) who answered the SWOM4 question
n (%) of the participants who completed the GHQ-125 questionnaire in full
*all values are n (%)s unless speciﬁed.
1 = Questions 6 and 10 of the SF36 questionnaire.
2 = Nottingham Extended Activities of Daily Living Scale.
3 = Rivermead Mobility Index.
4 = Satisfaction with outdoor mobility.
5 = General Health questionnaire–12.
TABLE 6 Extent of study intervention
Extent of study intervention Total (N = . . .)
1. n (%) of participants received 1 therapy session
2. n (%) of participants received 2 therapy sessions
3. n (%) of participants received 3 therapy sessions
4. n (%) of participants received 4 therapy sessions
5. n (%) of participants received 5 therapy sessions
6. n (%) of participants received 6 therapy sessions
7. n (%) of participants received 7 therapy sessions
8. n (%) of participants received 8 therapy sessions
9. n (%) of participants received 9 therapy sessions
10. n (%) of participants received 10 therapy sessions
11. n (%) of participants received 11 therapy sessions
12. n (%) of participants received all 12 therapy sessions
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TABLE 7 Number of therapists providing the intervention in each centre
Centre No. of therapists providing the intervention
Nottingham City PCT
Nottinghamshire County Teaching PCT
Lincolnshire PCT
Gateshead PCT
NHS Lanarkshire
North Somerset PCT
Wolverhampton PCT
East Kent Community Services
Tower Hamlets
Southend
Aberdeen
Norwich
Cwm Taf
Cardiff & Vale
Bristol PCT
(Min; Max) No. of therapists seen by the participants
TABLE 8 List of protocol deviations
Patient number Treatment arm Description of deviation Date of deviation
APPENDIX 1
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DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 2911.3. Primary outcome results at 6 monthsTABLE 9 Primary outcome table
Social Functioning Score Mean Standard error p-value 95% credible interval
Treatment A (baseline) – – – –
Treatment B XXX XXX XXX XXX to XXX
Age XXX XXX XXX XXX to XXX
Constant XXX XXX XXX XXX to XXX
Random-effects parameters Mean Standard error 95% credible interval
Level 3: Centre XXX XXX XXX to XXX
Level 2: Therapist XXX XXX XXX to XXX
Level 1: Participants XXX XXX XXX to XXX11.4. Secondary outcomes results at 6 monthsTABLE 10 Nottingham Extended Activities of Daily Living (NEADL) Scale
Burn-in period = xxxx No. of observation = xxx
Chain = xxxx Estimation algorithm =MCMC
Thinning = xxxx
Deviance = xxxx
Bayesian deviance = xxxx
NEADL score Mean Standard error p-value 95% credible interval
Treatment A (baseline) – – – –
Treatment B XXX XXX XXX XXX to XXX
Age XXX XXX XXX XXX to XXX
Constant XXX XXX XXX XXX to XXX
Random-effects parameters Mean Standard error 95% credible interval
Level 3: Centre XXX XXX XXX to XXX
Level 2: Therapist XXX XXX XXX to XXX
Level 1: Participants XXX XXX XXX to XXX
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TABLE 12 Number of travel journeys
Burn-in period = xxxx No. of observation = xxx
Chain = xxxx Estimation algorithm =MCMC
Thinning = xxxx
Deviance = xxxx
Bayesian deviance = xxxx
Travel journeys Mean Standard error p-value 95% credible interval
Treatment B – – – –
XXX XXX XXX XXX to XXX
Age XXX XXX XXX XXX to XXX
Constant XXX XXX XXX XXX to XXX
Random-effects parameters Mean Standard error 95% credible interval
Level 3: Centre XXX XXX XXX to XXX
Level 2: Therapist XXX XXX XXX to XXX
Level 1: Participants XXX XXX XXX to XXX
TABLE 11 Rivermead Mobility Index (RMI) Scale
Burn-in period = xxxx No. of observation = xxx
Chain = xxxx Estimation algorithm =MCMC
Thinning = xxxx
Deviance = xxxx
Bayesian deviance = xxxx
RMI score Mean Standard error p-value 95% credible interval
Treatment A (baseline) – – – –
Treatment B XXX XXX XXX XXX to XXX
Age XXX XXX XXX XXX to XXX
Constant XXX XXX XXX XXX to XXX
Random-effects parameters Mean Standard error 95% credible interval
Level 3: Centre XXX XXX XXX to XXX
Level 2: Therapist XXX XXX XXX to XXX
Level 1: Participants XXX XXX XXX to XXX
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TABLE 13 Satisfaction with outdoor mobility
Burn-in period = xxxx No. of observation = xxx
Chain = xxxx Estimation algorithm =MCMC
Thinning = xxxx
Deviance = xxxx
Bayesian deviance = xxxx
Satisfaction with outdoor mobility (yes/no) Coef. Standard error p-value 95% credible interval
Treatment B – – – –
XXX XXX XXX XXX to XXX
Age XXX XXX XXX XXX to XXX
Constant XXX XXX XXX XXX to XXX
Random-effects parameters Mean Standard error 95% credible interval
Level 3: Centre XXX XXX XXX to XXX
Level 2: Therapist XXX XXX XXX to XXX
Level 1: Participants XXX XXX XXX to XXX
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 2911.5. Primary endpoint at 12 monthsTABLE 14 GHQ-12 participant
Burn-in period = xxxx No. of observation = xxx
Chain = xxxx Estimation algorithm =MCMC
Thinning = xxxx
Deviance = xxxx
Bayesian deviance = xxxx
GHQ-12 participant score Mean Standard error p-value 95% credible interval
Treatment A (baseline) – – – –
Treatment B XXX XXX XXX XXX to XXX
Age XXX XXX XXX XXX to XXX
Constant XXX XXX XXX XXX to XXX
Random-effects parameters Mean Standard error 95% credible interval
Level 3: Centre XXX XXX XXX to XXX
Level 2: Therapist XXX XXX XXX to XXX
Level 1: Participants XXX XXX XXX to XXX
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TABLE 15 GHQ-12 carer
Burn-in period = xxxx No. of observation = xxx
Chain = xxxx Estimation algorithm =MCMC
Thinning = xxxx
Deviance = xxxx
Bayesian deviance = xxxx
GHQ-12 carer score Mean Standard error p-value 95% credible interval
Treatment A (baseline) – – – –
Treatment B XXX XXX XXX XXX to XXX
Age XXX XXX XXX XXX to XXX
Constant XXX XXX XXX XXX to XXX
Random-effects parameters Mean Standard error 95% credible interval
Level 3: Centre XXX XXX XXX to XXX
Level 2: Therapist XXX XXX XXX to XXX
Level 1: Participants XXX XXX XXX to XXX
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This is the same analysis as 6 months, repeated for data at 12 months.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 2911.7. Exploratory/other analysis resultsTABLE 16 Summary for NEADL scale categories at baseline
Category
Treatment arm
A B
Mobility
n
Mean (SD)
Median (IQR)
Min. to max.
Kitchen
n
Mean (SD)
Median (IQR)
Min. to max.
Domestic
n
Mean (SD)
Median (IQR)
Min. to max.
Leisure
n
Mean (SD)
Median (IQR)
Min. to max
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TABLE 17 Summary for NEADL scale categories at 6 months
Category
Treatment arm
A B
Mobility
n
Mean (SD)
Median (IQR)
Min. to max.
Kitchen
n
Mean (SD)
Median (IQR)
Min. to max.
Domestic
n
Mean (SD)
Median (IQR)
Min. to max.
Leisure
n
Mean (SD)
Median (IQR)
Min. to max.
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TABLE 18 Summary for NEADL scale categories at 12 months
Category
Treatment arm
A B
Mobility
n
Mean (SD)
Median (IQR)
Min. to max
Kitchen
n
Mean (SD)
Median (IQR)
Min. to max.
Domestic
n
Mean (SD)
Median (IQR)
Min. to max.
Leisure
n
Mean (SD)
Median (IQR)
Min. to max.
TABLE 19 Summary of travel journeys
Travel journeys
Treatment arm
A B
Total journeys
Mean (SD)
Median (IQR)
Min. to max.
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TABLE 20 Summary of type of intervention received by the participants in the treatment group
Intervention type n (%) Participants
No. of sessions
Mean (SD) Median (IQR) Min –Max
Mobility
Conﬁdence
Information
Goal Setting
Referral
Other Rehab
Adaptive Equipment
TABLE 21 Summary of type of goals set to participants in the treatment group
Goal type* n (%) Participants
Goal 1
Goal 2
. . .
Goal N
TABLE 22 Assessment of unblinding of research assistants (RA)
Unblinding
Treatment arm
TotalA B
n (%) of RAs unblinded
APPENDIX 1
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Ref-no Record no AE name AE start date AE ongoing AE end date Action takenTTABLE 24 Falls data summary by treatment arm
Fall days
Treatment arm
TotalA B
Total n (%) of fall days
Mean (SD)
Median (IQR)
Min. to max.
TABLE 25 Falls data summary by age
Fall days
Age
Under 60 60 plus
Total n (%) of fall days
Mean (SD)
Median (IQR)
Min. to max.12. APPENDICES12.1. Stata code for derived variables
1. Social Functioning score into 0–100 scale
*Transformation into 0–100 scale (Higher score are better)
gen ﬁnal_SF=(sfscore-2)/8
replace ﬁnal_SF=100*ﬁnal_SF
drop sfscore2. Age
*Generate the age variable
gen age=int( (condat-dobdat)/365.25)101
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1023. Nottingham Extended Activities of Daily Living Scale (NEADL) score
*Recode to range from 0 to 1
foreach var of varlist nea01_n - nea22_n {NIHR Journgen 'var'_s='var'-1 if 'var'==1
replace 'var'_s='var'-2 if 'var'==2
replace 'var'_s='var'-2 if 'var'==3
replace 'var'_s='var'-3 if 'var'==4
drop 'var'
rename 'var'_s 'var'
}*Generate the total NEADL score
egen NEADL=rowtotal(nea01_n nea02_n nea03_n nea04_n nea05_n nea06_n nea07_n
nea08_n nea09_n nea10_n nea11_n nea12_n nea13_n nea14_n nea15_n nea16_n nea17_n
nea18_n nea19_n nea20_n nea21_n nea22_n)4. Rivermead Mobility Index (RMI) score
*Generate the total NEADL score
egen RMI=rowtotal(rmi_01 - rmi_15)5. General Health Questionnaire-12 (GHQ-12) score
*Recode to range from 0 to 3
foreach var of varlist ghq01_n - ghq12_n {
gen 'var'_s='var'-1
drop 'var'
rename 'var'_s 'var'
}*Generate the total GHQ-12 score
egen GHQ12=rowtotal(ghq01_n ghq02_n ghq03_n ghq04_n ghq05_n ghq06_n ghq07_n
ghq08_n ghq09_n ghq10_n ghq11_n ghq12_n)6. Number of journeys made by each participant
*Now count how many days are recorded for each participant
bysort refno: gen days=_n
*Now use the collapse command to get a summary for each participant
collapse (count) days (sum) fallen journ_n, by(siteid patno refno sex age)
sort refnoals Library www.journalslibrary.nihr.ac.uk
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9.2.A. Primary analysis code and instructions
*Status.dta
use ‘data/0610TOMAS_status.dta’, clear
*Generate age
gen age=int( (condat-dobdat)/365.25)
keep refno siteid patno age status
*Merge with sf36.dta
merge 1:m siteid patno using ‘data/0610TOMAS_sf36.dta’
sort siteid patno visno
*Only need baseline and 6 months data
drop if visno==4
*Only keep the relevant variables
keep siteid patno refno visno sfscore age status
/*Transform SFscore into 0–100 scale
SFscore is calculated from 2 items (6 and 10) of the SF36 questionnaire and both range from 1–5 hence
the ﬁnal range for SFscore is between 2–10.
lowest possible score = 2
range = 10 – 2 = 8
Transformation = (sfscore – 2)/8
*Transformation into 0–100 scale (Higher score are better)*/
gen ﬁnal=(sfscore-2)/8
replace ﬁnal=100*ﬁnal
drop sfscore
*Reshape
reshape wide ﬁnal, i(siteid patno age status) j(visno)
rename ﬁnal1 baseline
rename ﬁnal3 ﬁnal
sort siteid patno
order refno siteid patno baseline ﬁnal
*Now save this ﬁle
save ‘Final analyses/primary.dta’, replace103
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104*Now sort the visits.dta
use ‘data/0610TOMAS_visit.dta’, clear
sort siteid patno visno
*Only keep relevant variables
keep siteid patno refno visno therid1 therid2
/*The variable ‘therid2’ is a recording of another therapist that was present at some
interventions stages. Pip Logan (CI) said that the 1st therapist delivered the treatment and that
the second therapist only supported. Hence we only account for 1st therapist.
*/
drop therid2
/*The following will replace all recordings of therapists at baseline to be ‘.’ as we are only interested in the
therapist effect for the therapy sessions and they are not done at baseline.
Also this recording of therapist at baseline is inconsistent as there are recording of therapist for some but
not for all at baseline. */
replace therid1=. if visno==1
*Need to replace all missing values and this is necessary to do else data set will not assign weights in
MLwiN
replace therid1=0 if therid1==.
/*Now reshape to wide format
Note: in doing this we will use the refno as the ‘stub’ and this will therefore be deleted and will need to
be re-created later */
reshape wide refno, i(siteid patno visno) j(therid1)
*Need to re-generate the original patno
egen refno=rowtotal(refno0-refno24)
*This will give the names and values as we want it
qui forval i=0/24{NIHR Journcap gen refno'i'=.
cap replace refno'i'='i' if refno'i'!=.
cap rename refno'i' therapist'i'
}*Drop any unnecessary variables
drop therapist0
order refnoals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29*The following therapist names were not involved in delivering the intervention → Therapist2–15, 17–23
forval i=1/24{© Queen’s Pr
Health. This is
provided that
addressed to:
Park, Southamorder therapist'i', last
order refno siteid patno visno
}*This will count how many session each participant had with each therapist
collapse (count) therapist1- therapist24, by(siteid patno)
sort siteid patno
save ‘Final analyses/visits.dta’, replace
merge 1:1 siteid patno using ‘Final analyses/primary.dta’
/* _merge = 3 means matchedinter and
sue may
suitable
NIHR Jou
pton SO_merge = 2 means some data in the status data set but not in the visits data
set
_merge = 1 means some data in the visits data set but not in the status data
set and this needs investigating*/
list refno siteid patno status if _merge!=3
order refno siteid patno baseline ﬁnal
keep if _merge==3
drop _merge
gen cons=1
*Generate weights
qui forval i=1/24{
gen w_therapist'i'=.
}order refno siteid patno baseline ﬁnal cons therapist1-therapist24
w_therapist1-w_therapist24
egen a=rowtotal(therapist1 - therapist24)
/*This will count the total therapists support involved per-participant
EG: If say refno=1001 had 12 total interventions of which 6 were done by therapist 1 and for other 6
interventions, therapist 2 was involved. The participant had the max 12 sessions, i.e. 6 from therapist 1
and 6 from therapist 2.
Hence, the weights will be: Therapist 1 = 6/12 = 0.5 and Therapist 2 = 6/12 = 0.5
The weight for the other therapists will be ‘0’ for this participant.
*/
*Assigning weights based on the example shown above105
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106qui forval i=1/24{NIHR Journreplace w_therapist'i' = therapist'i'/a
replace w_therapist'i' = 0 if w_therapist'i'==.
}Important decision
Now that we have established how many sessions each participant did and how many sessions each
therapist delivered, we need to change the no of sessions by each therapist to be replaced by the therapist
number (see example below).
refno therapist1 therapist2 w_therapist1 w_therapist2 Total
1001 6 6 6/12 = 0.5 6/12 = 0.5 12
1. So initially we will have the number of interventions each therapist did of the total for the participant.
2. So in this example we can see that therapist1 did 10 out 12 interventions.
3. Hence the weight for therapist1 is 10/12.
4. Now that we have calculated the weights, we need to rename the therapist columns by their
appropriate number.
5. So for this example we need to change the therapist1 column to be ‘1’ instead of ‘10’ and similarly for
all therapists.
6. Note we leave the weights as they are.
7. So for the example above we need to change it so it looks like this (see below).
refno therapist1 therapist2 w_therapist1 w_therapist2 Total
1001 1 2 6/12 = 0.5 6/12 = 0.5 12
This needs to be done for all the therapists columns and the code below will do this.
*/qui forval i=1/24{
replace therapist'i'='i' if therapist'i'!=0
}*Save data set
save ‘Final analyses/primary.dta’, replaceInstructions in MLwiN1. Open the saved ﬁle in MLwiN
2. Select model and equations and the equations window should appear
3. In the equations window at the bottom, select notation and unselect the multiple subscript option,
and click done
4. Now click on the ‘Y’ in the equations window and select the SFscore from the list
5. Select the 3 levels from the N-Levels options
6. Then select level 3 to be siteid, level 2 to be therapist1 and level 1 to be refno
7. Now select ‘B0’ from the equations window and choose it to be the constant vector of 1’s and select
this to be random at level 3, level 2 and level 1.als Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 298. Now click on ‘Add term’ option at the bottom of the equations window and select the covariates
described for the primary analysis (Note: none of these should be selected as a random effect)
9. Once all the terms are added, make sure that the estimation procedure is on the option ‘IGLS’ and
click on start
10. Then change the estimation procedure to MCMC and run the model once more
11. Once the model is run using MCMC, click on Model/MCMC/Classiﬁcation from the menu bar
12. Select the option for multiple classiﬁcation Level 2 option and in the option for number of columns
enter the number of columns there are for the therapists
13. Then click on the drop down menu for Weight start column and click on the variable from where the
weight for the ﬁrst therapist is
14. Then click on start and run the model for the ﬁnal time and the results will be the ﬁnal results to be
used for the analysis
All other secondary analyses will be done in the same manner as the primary endpoint.13. References© Qu
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manualIntroductionAn Outdoor Mobility Rehabilitation Training Manual was produced for therapists to provide a guide on an
outdoor mobility intervention to be offered to stroke patients. As this was a large multicentre trial, this
manual served as an important guide to ensure that therapists followed a similar treatment programme
across sites. The intervention outlined in the manual was based on knowledge gained during an earlier
single-centre study. In this study the intervention was found to have made a massive difference to people’s
lives by helping them out of the house more often. The manual is split into different sections and each
section is summarised below.BackgroundBackground information on the prevalence of stroke, and the effect of strokes upon the lives of people
with stroke, is provided in this section. Research data are provided to support the ﬁgures presented. The
section moves on to provide the rationale behind providing an outdoor mobility training intervention for
people with stroke. Research is cited to support the need for such an intervention study.
It is outlined in this section that the multicentre trial, to which the manual relates, follows on from a
single-centre study that found clear beneﬁts with the intervention. However, the generalisability of this
study was limited as the intervention was delivered by a single therapist, in one city, and there was no
health-economic evaluation. It is argued that a multicentre trial is now needed to determine whether the
intervention is effective and cost-effective before it can be recommended for wider adoption across
the NHS.Models and approaches to rehabilitationIn everyday practice, therapists use a combination of physical and psychological models and approaches
when devising treatment programmes for stroke patients. These models and approaches provide a
theoretical base for the intervention. Therapists will often use a combination of models and approaches
when deciding on a treatment programme. Although there have been papers published describing the
models there is very little research to evaluate or compare the models. There is no strong evidence to
suggest that one model or approach is superior to another. The manual therefore lists and describes
models and approaches that therapists may choose to use in their treatment sessions. These may be used
together with the practice of outdoor mobility activities. The models described include the Compensatory
or Functional model, the Model of Human Occupation, the Cognitive Frame of Reference, and the
Adaptive Skill model. The neurodevelopmental approach is also described, along with the main techniques
used by therapists, including the Bobath, Rood, Conductive Education, Proprioceptive Neuromuscular
Facilitation and Sensory Integration techniques. It is stressed in the manual that this is not a comprehensive
list and other models and approaches can be adopted.109
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110Beneﬁts and barriers to going outsideThis section looks at why people wish to get out of their home and the barriers preventing this. It includes
two checklists. The ﬁrst checklist provides a list of possible destinations. This serves as an aid to prompt
patients to identify outings of personal interest to them. The second checklist provides a list of possible
factors that may hinder trips out of the home for the patient. These issues can then be discussed and
addressed by the therapist and patient.Assessing for limitationsThis section provides a screening form to be completed with the patient to help the therapist and patient
to plan the outdoor intervention. The form includes 11 screening questions on transport options and
outdoor mobility. The form is completed during the treatment planning stage of the intervention. The form
can also be used at intervals during therapy if progress seems slow.Building a useful address and information resourceThis section provides a template for the therapist/other team members/patient to insert useful contact
details of local transport and community services. Examples include the Blue Badge Scheme for car
parking, Dial-a-Ride, voluntary car schemes, Shopmobility and the local Disability Living Centre
contact numbers.Goal planning and activity analysisThe importance of goal setting is emphasised in this section. Several activities are broken down into
smaller more detailed goals as examples of possible outdoor goals that could be completed with patients.
The activities include walking outside, driving a car, using the bus and train, using Dial-a-Ride, the
voluntary driver scheme and electric pavement scooters.Pre-outing checklistIn this section a checklist is provided to help the therapist and patient to identify any potential risks,
hazards or challenges that might arise during community outings. This checklist is completed prior to the
ﬁrst outing. It ensures that factors are considered which will help to make the trip both safe and more
successful. The checklist includes mobility, upper limb function, cognitive and perceptual function, vision
and continence. Each area is broken down into skills and abilities that need consideration.
It is recommended in the manual that the therapist observes performance around the home before
venturing outside.Protocol for the ﬁrst outingThis section prompts the therapist to assess and plan ahead for all contingencies prior to the ﬁrst outing.
Examples of early outings recommended in the manual are walking to the garden gate, walking to the
street corner, walking to the closest bus stop or a walk around the block. A checklist is provided of
considerations and contingencies for this ﬁrst outing, along with consideration of activities that can be
practised ﬁrst in the home environment.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29Protocol for outdoor walkingIn the single-site outdoor mobility study, walking outdoors was found to be an important goal for patients.
Of the 78 main goals recorded, 22% focused on walking outdoors. In the protocol it is recommended that
this activity starts with simple and small goals, such as walking to the garden gate, and progresses once
skills are consolidated to encompass more demanding situations. The protocol stipulates setting practice
targets between sessions aimed at increasing conﬁdence and ﬁtness, and includes activities such as daily
trips to the street corner with a family member.
The protocol for walking is broken down into three levels. The ﬁrst level incorporates walking over a short
distance in a quiet environment, requiring minimal attention and physical demands. The second level
progresses to incorporate more moderate demands involving road crossings, kerbs and gradients. The ﬁnal
level requires multitasking activities, such as carrying a bag, handling money while standing, and walking
in a busy location.Protocol for using the busIn the single-site outdoor mobility study, catching the bus was the second most popular goal. Of the
78 main goals recorded, 17% focused on taking a bus. It is recognised in this protocol that not all
therapists themselves may be familiar with using public transport. To this end guidance is provided on the
steps and skills to consider for this activity, including recognising and hailing the correct bus, managing
money and ticketing, boarding and disembarking the bus, and recognising the correct destination.
Once again the protocol is broken down into three levels. The ﬁrst level involves home practice of reading
timetables, handling money, and preparing contingency plans. The second level moves on to supervised
outings. Maximum prompting and close supervision is provided at this level. The ﬁnal level progresses to
just standby or distant supervision.Protocol for using the trainAs with the bus protocol it is recognised in this section that not all therapists will be familiar with using
trains. Equally people with stroke may not be familiar with this mode of transport, particularly if they drove
before their stroke. To this end guidance is provided on the steps and skills to consider for this activity,
including reading the indicator board, purchasing a ticket, accessing the platform, identifying the correct
train, negotiating crowds, and boarding and leaving the train.
Similar to the bus protocol the train protocol is broken down into three levels. The ﬁrst level involves home
practice of reading timetables, managing money and preparing contingency plans. The second level
progresses to supervised outings with close supervision and maximum prompting. The ﬁnal level involves
just standby or distant supervision.Protocol for using outdoor pavement scootersIn the single-site outdoor mobility study, being able to use a (personally owned) motorised scooter was a
primary goal for six people with stroke, although using a scooter on a temporary loan for shopping around
town (part of the Shopmobility service in England) was a primary goal for another six people with stroke.
The protocol for using an outdoor pavement scooter is broken down in the manual into two levels. The
ﬁrst level involves a trial off road. This enables practice operating the scooter controls and familiarisation
with charging the scooter battery. The second level progresses to a trial on the road. Practice progresses111
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112from quiet to busy roads, crossing at trafﬁc lights, negotiating kerbs, slopes, gradients, obstacles and
pedestrians, and parking the scooter outside shops and home beside the battery-charging location.
Once again, the protocol includes a checklist of the skills and competencies needed to safely drive an
outdoor pavement scooter.
Each level of the protocol for outdoor walking, using the bus, using the train and using outdoor pavement
scooters is clearly stipulated so that therapists across sites follow similar treatment programmes for each
activity. Family members are encouraged to assist in the practice of skills and, importantly, the protocols
advocate the setting of practice targets between sessions to assist in the consolidation of skills.Intervention record formThis section provides the therapist intervention paperwork for the study, which includes:
l A form requiring the therapist to break down the components of each intervention into minutes.
The therapist records the time spent on mobility task training, other rehabilitation training, adaptive
equipment, referral to other agencies, information provision, conﬁdence and motivation, and
goal-setting activities.
l A form to record the patient’s goals and their relevant medical history.
l A form to record the running records of each session completed.Case vignette of treatment plansA case vignette taken from rehabilitation notes is provided as a guide for therapists in this section when
planning treatment sessions. This vignette outlines a clinical history of a person with stroke. Information is
provided on their ability and skills around personal and domestic activities of daily living, their transfer
ability and their level of mobility. The vignette incorporates their social situation and outlines their local
environment, including access to their home property. The vignette moves on to focus on the person’s
experience of using different modes of transport, and then highlights the goals set with this person.
This is followed by a detailed breakdown of the six treatment sessions completed.Conﬁdence and motivationAs self-conﬁdence to complete a task and the motivation to persevere are such important aspects of the
outdoor mobility intervention, this section of the manual is dedicated to explaining the signiﬁcance of
these two attributes.
Self-conﬁdence in relation to the study is about having the conﬁdence to complete outdoor mobility. This
not only relates to conﬁdence in self, but also to having conﬁdence and trust in others, such as the
therapist. This is particularly important when therapists are encouraging people with stroke to try new
activities or to push themselves harder.
Motivation is the activation or energisation of goal-orientated behaviour. It requires that those enrolled on
the study have some desire to undertake outdoor mobility. Individuals need to be able to identify
meaningful reasons why they wish to attain goals in order to have the motivation to succeed.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18290 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 29Sample letter for requesting help with purchasing equipmentIn this section a sample letter is inserted to provide therapists with guidance when seeking to apply for
funding for outdoor mobility equipment for their patients. In the UK, motorised scooters are not generally
available via government schemes. Individuals therefore have to purchase their own scooter, and may seek
ﬁnancial assistance from philanthropic agencies, local church groups or service clubs. In these situations
therapists may wish to support their applications by writing a letter, as per the sample provided.ReferencesThis section of the training manual provides the full references that have been quoted in the main body of
the manual.PowerPoint slidesThe PowerPoint (2007) slides (Microsoft Corporation, Redmond, WA, USA) presented during the
therapist training days are provided in this section. The training was provided by Dr Pip Logan, CI;
Dr Annie McCluskey, external expert; Professor Marion Walker, Professor of Stroke Rehabilitation; and
Dr Matt Leighton, Trial Manager. The training day provided information on the following:
l An overview of the multicentre outdoor mobility rehabilitation study.
l Roles and responsibilities of those working on the study, and lines of communication and help.
l Information on the earlier single-site outdoor mobility study.
l The mobility outcome measures being used in the outdoor mobility rehabilitation study.
l Timings of baseline visits, intervention visits and follow-up visits.
l The outdoor mobility rehabilitation study documentation.
l Goal setting.
l The role of the Stroke Research Network.
l The role of the Collaboration in Leadership in Applied Health Research and Care (CLAHRC).
l Information on CLAHRC trials being completed.
l Information on an Australian study that audited the amount of outdoor mobility training being
incorporated into therapy intervention programmes. The barriers behind including outdoor mobility
intervention were studied, training on outdoor mobility was provided, and a repeat audit of outdoor
mobility intervention was completed.Published papersThe following published papers are included in the ﬁnal section of the manual:
Logan PA, Gladman JRF, Radford KA. The use of transport by stroke patients. Br J Occup Ther
2001;64:261–4.
Logan PA, Gladman JRF, Avery A, Walker MF, Dyas J, Groom L. Randomised controlled trial of an
occupational therapy intervention to increase outdoor mobility after stroke. BMJ 2004;329:1372–5.
Logan PA, Walker MF, Gladman JRF. Description of an occupational therapy intervention aimed at
improving outdoor mobility. Br J Occup Ther 2006;69:1, 2–6.113
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